DISCOVERY AND CHARACTERIZATION OF THE INTERPHASE FUNCTION OF MITOTIC MOTORS IN PROTEIN SYNTHESIS by Bartoli, Kristen Marie
  
 
DISCOVERY AND CHARACTERIZATION OF THE INTERPHASE FUNCTION OF 
MITOTIC MOTORS IN PROTEIN SYNTHESIS  
 
 
 
 
 
 
 
 
by 
Kristen Marie Bartoli 
B.S., Temple University, 2004 
 
 
 
 
 
 
 
 
Submitted to the Graduate Faculty of 
University of Pittsburgh School of Medicine in partial fulfillment  
of the requirements for the degree of 
Doctor of Philosophy 
 
 
 
 
 
 
 
 
 
University of Pittsburgh 
2010 
 
  ii 
UNIVERSITY OF PITTSBURGH 
SCHOOL OF MEDICINE 
 
 
 
 
 
 
 
 
This dissertation was presented 
 
by 
 
 
Kristen Marie Bartoli 
 
 
 
It was defended on 
September 1, 2010 
and approved by 
Stefan Duensing, M.D., Associate Professor, Microbiology and Molecular Genetics 
Saleem A. Khan, Ph.D., Professor, Microbiology and Molecular Genetics 
Laura J. Niedernhofer, M.D., Ph.D., Associate Professor, Microbiology and Molecular 
Genetics 
John L. Woolford, Jr. Ph.D., Professor, Biological Sciences 
 William S. Saunders, Ph.D., Major Thesis Advisor, Associate Professor, Biological 
Sciences 
 
 
  iii 
Copyright © by Kristen Marie Bartoli 
2010 
  iv 
 
Mitotic motors have gained considerable interest as anticancer targets given their often essential 
functions during mitosis. Furthermore, mitotic motors are thought to represent ideal targets 
because their functions are believed to be confined to mitosis; thus, only rapidly dividing cells 
would be susceptible to inhibitors of mitotic motors. The work presented herein challenges the 
concept of mitotic motors as specific targets of dividing cells by exploring the interphase 
function of three mitotic motors Kid, Eg5, and MKLP1. Our results demonstrate that all three 
motors associate with the nucleolus and with the ribosomal subunits. Furthermore, it is 
demonstrated Eg5 functions to increase the processivity of the ribosome, the first cellular factor 
to be characterized with that property.  Additionally, as loss of Kid results in an increase in focal 
adhesion proteins throughout the cell and increased protein synthesis in its absence, our data are 
consistent with a role for Kid in mRNA silencing and transport of mRNAs for site-specific 
translation. Also, evidence is presented that suggests a role for Kid in ribosome biogenesis and/or 
ribosomal function, similar to nucleophosmin. Finally, both Kid and Eg5 participate in stress 
granule dynamics, with Kid and Eg5 functioning in stress granule formation, and Eg5 
participating in stress granule coalescence, transport and dissolution. Collectively these findings 
demonstrate diverse interphase functions for these mitotic motors in nearly all phases of the 
ribosome’s life cycle. These studies not only call into question the potential safety of mitotic 
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motor inhibitors for the treatment of cancer, but also open a new avenue of exploring polypeptide 
synthesis. 
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1.0  INTRODUCTION 
Mitotic microtubules motors have previously thought to only function in mitosis (Burris, Jones et 
al.) (Lad, Luo et al. 2008), however recently I have identified an interphase function for a select 
group of motors in protein synthesis. The outline of this thesis is as follows. First, the 
introductory Chapter 1 will provide the reader with detailed background information necessary to 
place our research findings in their proper context. In Chapter 2, our finding regarding the 
dynamic interphase nucleolar localization of three mitotic motors Kid, Eg5 and MKLP1 will be 
presented. Furthermore, the mechanism of nucleolar retention for Kid will be discussed. Chapter 
3 delves further into the findings of Chapter 2 by examining (patho)physiological conditions 
which induce Kid to shuttle from the nucleolus to the nucleus.  Chapter 3 concludes with 
hypothesizing the interphase function of Kid is to facilitate ribosome biogenesis. In Chapter 4, 
we eagerly present that the three motors that localize to the nucleolus during interphase also 
associate with mature ribosomal subunits. This Chapter focuses on the role of Eg5 and its ability 
to aid efficient translation by ensuring the processivity of the translating ribosome. In Chapter 5, 
we further extend our novel findings from Chapter 4 to examine the role of Kid and Eg5 in stress 
granule formation, coalescence, and dissolution. From this, Chapter 5 will demonstrate that both 
Kid and Eg5 participate in stress granule formation and that Eg5 participates in stress granule 
coalescence and dissolution. Finally, Chapter 6 examines some preliminary, but very exciting 
data examining the role of Kid in focal adhesion assembly. Specifically, we will provide data to 
  2 
support the hypothesis that Kid functions to transport mRNAs for site-specific translation and in 
doing so serves as a translational repressor.  The results are the collimation of a 6 year labor-of-
love which has spanned many diverse fields, but is ultimately unified by a central theme: at least 
some mitotic motors have previously uncharacterized interphase functions. 
 
1.1 PROTEIN TRANSLATION 
The translation of proteins is an essential process. As many readers may be generally familiar 
with ribosome biogenesis and maturation, and the steps of protein translation (initiation, 
elongation, and termination), it may be advisable for such readers to skip section 1.1. This 
section contains material that is intended to provide a background for readers who may be less 
familiar with the aspects of protein translation.  
Eukaryotic translation consists of a series of orchestrated events that produce large 
biological macromolecules that make up 44% of the human body’s dry weight (Davidson S.D. 
1973). Proteins are the workhorse of the cell, having numerous roles in structure, transport, 
catalysis, and regulation, amongst others. Much of the cells energy and resources are devoted to 
translation and the synthesis of components necessary to carry out translation such as the making 
of mRNAs, ribosomes (both rRNA and ribosomal protein components), tRNA’s, enzymes, and 
proteins. The energetic commitment to translation can be seen all the way down to 
Saccharomyces cerevisiae, which when rapidly growing contain more than 200,000 ribosomes 
produced at ~2000 ribosome/min in the cytoplasm, occupying as much as 30-40% of the 
cytoplasm (Warner 1999). 
  3 
1.1.1 Ribosome Biogenesis 
Ribosome biogenesis begins in the nucleolus where ribosomal DNA (rDNA) is transcribed into 
rRNA, which is then packaged with associated proteins into pre-ribosomal subunits (Raska, 
Koberna et al. 2004; Olson and Dundr 2005). rDNA genes are compiled in tandem repeats within 
the fibrillar center of the nucleolus, also known as nucleolar organizing regions (NOR’s) and 
consist of five different chromosomes, 13, 14, 15, 21, and 22 (Raska, Koberna et al. 2004; Olson 
and Dundr 2005). Ribosomal biogenesis is a linear process of moving ribosomes, where rDNA 
are transcribed into ~7000 nucleotide long pre-rRNAs, by RNA polymerase I (RNA pol I) 
occurring on the border of the fibrillar center and the dense fibrillar component (Raska, Koberna 
et al. 2004). Nonribosomal proteins and small nucleolar proteins (snoRNAs) associate with this 
nascent transcript during this process before the 5S rRNA is added. Next, the rRNA transcript is 
processed resulting in the 18S, 5.8S, and 28S rRNAs.  These rRNAs are processed further to 
form the pre-40S and pre-60S complexes, while ribosomal proteins are added during the 
assembly process. These pre-ribosomes, with ribosomal proteins and nonribosomal proteins 
attached, are transported out of the granular component, through the nucleus and the nuclear 
pores, and into the cytoplasm (Olson and Dundr 2005; Zemp and Kutay 2007). In the cytoplasm 
it undergoes the maturation steps and specific splicing events, ultimately producing the mature 
ribosome, which then functions to translate mRNA into proteins.  
1.1.2 Steps of Translation 
For translation to occur, two ribosomal subunits, a small 40S subunit and a large 60S subunit 
must associate together along the mRNA to form the 80S ribosomal complex.  When more than 
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two 80S complexes form on a given mRNA, the resulting complex is called a polysome or a 
translating complex. Each of these ribosomal subunits is made up of a distinct subset of RNAs 
and proteins; the small 40S subunits consists of a 18S RNA and ~33 proteins, whereas the large 
60S subunit consists of three RNAs (5S, a 28S, and a 5.8S) and ~49 proteins in humans. The 
small 40S ribosomal subunit contains three different sites, the A-site, the P-site and the E-site, 
which will allow binding of different translational components during the synthesis of a protein.  
The process of translation occurs in three different stages, the initiation phase, elongation 
phase, and the termination phase. Each phase is described below.  
1.1.2.1 Translation Initiation: Cap-dependent 
 
There are two types of translation initiation, cap-dependent, which will be discussed here, and 
cap-independent which will be discussed later.  
Translation initiation is a highly orchestrated series of events. Initiation is the first step of 
translation and ultimately leads to the assembly of the 80S ribosome on the initiation site of 
mRNA. Cap-dependent translation initiation requires the 40S and 60S ribosomal subunits and at 
least 12 well-characterized initiation factors (eIFs) to aid in the process (Hinnebusch 2006). 
Phosphorylation of these initiation factors not only controls the rate of ribosomes binding to an 
mRNA, but it is also a key factor in affecting and regulating translation (Pierrat, Mikitova et al. 
2007); these phosphorylation events are highly context-dependent as such events can either 
inhibit or facilitate translation (Kozak 1992; Gray and Wickens 1998).   
Translation initiation begins when a ternary complex consisting of eIF2, GTP, and Met-
tRNAiMET (initiator tRNA) is recruited to the mRNA. The 43S pre-initiation complex, consisting 
of the 40S subunit and multiple initiation factors, is able to “scan” the mRNA in the 3’ direction 
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disrupting any mRNA secondary structure until it reaches the first start codon, AUG, at which 
time the pre-bound initiator tRNA basepairs with the first AUG.  
1.1.2.2 Elongation 
 
The elongation phase of translation consists of the addition of amino acids to the elongating 
polypeptide chain intended for the message that is being translated. The process of elongation is 
a time consuming process; as many as 20 different charged tRNA’s can be tested on each codon 
prior to finding the correct match.  
Initiation ends with the initiator tRNA in the P-site of the ribosome and the A-site 
awaiting the correct aminoacyl-tRNA, pertaining to the next codon on the mRNA, to enter and 
bind. The elongation phase is completed by a series of steps that are continuously repeated until 
the mRNA stop codon is reached. The steps involved are, binding of the correct aminoacyl-
tRNA into the A-site of the ribosome, formation of the peptide bond, and translocation of the 
tRNA from either the A-site to the P-site or the P-site to the E-site in preparation for the next 
codon to be translated. Various elongation factors are used to complete these steps mentioned, 
including eEF-1, eEF-2, and most recently eIF5A (Saini, Eyler et al. 2009); each of these 
proteins requiring ATP and GTP to carry out their functions.  In fact it is worth noting that 
almost all of the energy used during protein synthesis is exploited during the elongation step, as 
the addition of the new amino acid to the chain and the translocation step of the peptide utilize at 
least 7 ATPs/GTPs. 
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1.1.2.3 Termination 
 
Translation elongation continues until one of the stop codons appears in the ribosome A-site, 
causing release of release factor proteins (RF) and terminating translation.  To be accurate, stop 
codons are not read by a tRNA, rather they are recognized by RF proteins. There are two classes 
of RF proteins, the first class function in recognizing the stop codon (eRF1), whereas the second 
class of RF proteins functions as a GTPase (eRF2). The first stage of termination occurs when 
the eRF1 protein recognizes the stop codon. When eRF1 binds to the ribosome with the stop 
codon in the A-site, hydrolysis is induced at the peptidyl-tRNA bound to the completed protein 
in the P-site, allowing for immediate dissociation of the completed protein from the ribosome. 
The function of the second RF protein, eRF3, is to remove eRF1 from the ribosome after release 
of the completed polypeptide chain, but its exact and detailed function in eukaryotes termination 
remains obscure. In other systems, such as the eubacteria, a third class of RF factors have been 
found and aid in ribosome recycling, but to date no eukaryotic homolog has been found (Pavlov, 
Freistroffer et al. 1997; Pisarev, Skabkin et al. 2010).  
1.1.2.4 Processivity 
 
There exists a debate as to whether a translating ribosome exhibits processivity; processivity 
being defined as the distance a ribosome can travel before dropping-off its transcript. 
Processivity is a property used to describe attributes of DNA and RNA polymerases. One such 
example is the RNA polymerase in bacteria that has demonstrated to randomly release from the 
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DNA (von Hippel and Yager 1991). The debate centers on whether a ribosome exhibits any 
probability of dropping-off while actively translating. Arguing against processivity of a ribosome 
are a collection of articles which study the kinetics of translation on a specific transcript 
(Bretscher 1968; Bergmann and Lodish 1979). These studies found no evidence of ribosomal 
drop-off based on modeling studies derived from fitting experimental kinetic data. However 
inside a cell the picture of translation is far more complex because the ribosome is not asked to 
translate only one given transcript, but rather the entire transcriptome. Recent evidence 
examining translation in its native environment and has uncovered a propensity of a ribosome to 
exhibit drop-off while translating including treatment with elongation inhibitors (Chan, Khan et 
al. 2004), during conditions that decrease amino acid levels leading to slowed elongation (Caplan 
and Menninger 1979), or even by microRNAs which were shown to cause ribosome drop-off as 
a way of controlling protein synthesis (Petersen, Bordeleau et al. 2006). Each of these examples 
will be discussed further in Chapter 4.  
If a ribosome exhibited any degree of drop-off during protein synthesis, one could 
envision the cell incorporating fail-safe mechanisms to inhibit the ribosome from falling-off the 
mRNA prematurely. As you will see, one such fail-safe mechanism is through association with 
mitotic motor Eg5 and the microtubules. As I will demonstrate, we believe the ribosome is 
anchored to microtubules via Eg5 and it is this arrangement that aids the ribosome in continued 
processivity during translation.    
A central reason for this debate has been the lack of experiments, and thus methods, 
designed or intended to test processivity. In Chapter 4, we will present a simple, yet robust assay 
to measure processivity.  
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1.2 MECHANISMS OF TRANSLATIONAL CONTROL 
1.2.1 mRNA 
The central dogma of biology states that mRNA is transcribed from DNA and possesses the 
information required to make a protein. The life cycle of an mRNA begins with transcription and 
addition of a 5’-cap (RNA 7-methylguanosine m7G cap) in the nucleus which is then edited  and 
transported to the cytoplasm where it is spliced in the nucleus, translated, made into a protein, 
and eventually degraded. mRNA can form secondary and tertiary structures, based on its 
sequence, allowing for regulation of the mRNA for translation, silencing, etc.  The extent of 
secondary and tertiary structure of the 5’-UTR is believed to confer an additional level of 
translational control as the extent of secondary structure can influence the efficiency of the 
initiation phase of translation (Hershey 1991; Kozak 1992; Pierrat, Mikitova et al. 2007). The 3’-
UTR is thought to have sequences encoded in it that direct the mRNA for cytoplasmic 
localization and site-specific translation (Vuppalanchi, Coleman et al. ; Shestakova, Singer et al. 
2001), as well as control the half-life of the mRNA (Ross 1996; Newbury 2006). The poly-A tail, 
at the end of the mRNA, aids in transport of the mRNA from the nucleus to the cytoplasm and 
protects the mRNA from degradation. Though, it should be noted, that not all mRNA’s use their 
5’-cap structure to begin translation, rather it has been shown that about 85 cellular mRNAs, as 
of 2006,  are found to be  regulated by internal ribosomal entry sequences (IRES) (Dani, 
Blanchard et al. 1984; Holcik 2004).  
Every mRNA has a different half-life that can range from minutes to days (Aviv, Voloch 
et al. 1976; Dani, Blanchard et al. 1984). This stability of an mRNA determines how many 
proteins can be produced from the same mRNA. The cell controls the stability of the mRNA so 
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that it can rapidly change the translation status of a protein at any given time (Hershey 1991). 
There is a balance between the processes of translation and mRNA decay, and this balance is 
reflected in the size of processing bodies (P-bodies) (Balagopal and Parker 2009). P-bodies are 
structures where mRNA can be sequestered, or degraded, and consist of many different enzymes 
involved in mRNA turnover. Functions of P-bodies include: removing the 5’ cap, degradation 
and/or storage of the mRNA, and translational repression.  
1.2.1.1 Translation Initiation: Cap-independent 
 
As mentioned previously, there are two types of translation initiation, the traditional cap-
dependent and the untraditional cap-independent. Cap-dependent was discussed in section 
1.1.2.1.  Cap-independent translation initiation occurs through the use of an internal ribosome 
entry sites (IRES), where the 5’-UTR region of these mRNAs are shown to recruit ribosome 
binding as an alternate mechanism of initiating translation. Many viral mRNAs and some cellular 
mRNAs that encode proteins involved in apoptosis, growth control and differentiation, have 
conserved 5’-UTRs that are several hundred bases long (Holcik 2004; Baird, Turcotte et al. 
2006); these regions appear to have secondary and tertiary structures, making it difficult for 
initiation factors to bind and to allow scanning by the 43S pre-initiation complex, therefore 
yielding poorly translated mRNAs.   
Viruses contain most of the necessary components to amplify their genomes, however 
when it comes to translation, viruses are entirely dependent on the infected cell’s native 
translation machinery to translate viral mRNAs. Thus, viruses use various techniques to co-opt 
the host cell’s translational machinery for translation of their own mRNAs, while inhibiting 
translation of the host cell’s mRNAs by cleavage and/or modifications of translation initiation 
  10 
factors or phosphorylation of elongation factors. Poliovirus, a well studied cytoplasmic virus 
belonging to the Picornaviridae family, preferentially inhibits translation of the host mRNAs by 
cleavage and modifications of several translation initiation factors, while allowing its own viral 
mRNA to be translated. Analysis into how poliovirus was able to translate its protein while 
inhibiting its cell’s host mRNA, revealed a 750 nucleotide 5’-UTR region containing various 
AUG codons and extensive secondary and tertiary structures (Lenk and Penman 1979). This lead 
to the discovery that viral mRNA does not contain a 5’-cap structure, rather they contain a 5’pU 
(polyuridine) sequence. This analysis suggested that viral mRNA must be translated in a cap-
independent manner, independent of the cleaved and modified initiation factors. Confirmation 
that viruses use cap-independent translation came from studies utilizing bicistronic assays (Nie 
and Htun 2006), where an mRNA using cap-dependent translation is placed upstream of an 
mRNA thought to use cap-independent translation; if the viral mRNA is translated it would be in 
a cap-independent manner. Further studies inserting the 5’-UTRs of the poliovirus, as well as 
other viruses, into bicistronic plasmids demonstrated that the viral mRNA is able to be translated 
independent of the upstream sequence suggesting that viral mRNA translation occurs in a cap-
independent mechanism, whereby the 5’-UTR can recruit the 80S ribosome binding independent 
of initiation factors and 5’-cap. Various RNA and DNA viruses have been found to use IRES 
elements to initiate translation, but the necessity for various host translation initiation factors 
differ from virus to virus. 
1.2.2 Translational control by initiation factor eIF2 
Translational control in protein synthesis is crucial to regulate gene expression. One of the most 
well-studied and highly controlled translational control mechanisms in eukaryotic cells is the 
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recruitment of translation initiation factor eIF2 to the mRNA (Sarre 1989; Perry and Meyuhas 
1990; Hershey 1991; Proud 2002). This protein contains three different subunits, and each 
subunit has a specific function in translation ranging from formation of the initiator ternary 
complex, thereby beginning translation, to phosphorylation of its subunit and inhibition of 
translation.  
1.2.2.1 Phosphorylation of eIF2α 
 
The phosphorylation status of eIF2 α is a key regulatory event and is activated in response to 
various stresses and direct stimuli. The level of eIF2 α phosphorylation can lead to inhibition of 
protein synthesis.  Phosphorylation of eIF2 α  is a dynamic and regulated system, as various 
kinases and phosphatases for the eIF2 α  system exist to control it.  
1.2.3 Stress Granules 
One such regulatory event that occurs after phosphorylation of eIF2 α  is stress granule 
formation. Stress granules are dynamic cytoplasmic foci that rapidly aggregate in response to 
cellular stress and translational inhibition from heat shock, oxidative stress, viral infection, and 
UV irradiation (Kedersha and Anderson 2002; Kedersha and Anderson 2007). Stress granules 
are believed to be sites of mRNA triage, where mRNAs are stored, degraded, or inhibited from 
translation during stress. The ability to form stress granules in response to a given stimuli allows 
the cell to divert its resources to responding appropriately to the stimuli, while allowing the rapid 
resumption of translation and thus normal physiological process. These stress granules primarily 
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form in response to eIF2α phosphorylation (Anderson and Kedersha 2002). Stress granules 
consist of stalled 48S complexes (from disassembling polysomes), mRNA bound to initiation 
factors (eIF4E, eIF3, eIF4A, and eIF4G), small ribosomal subunits, RNA binding proteins, 
transcription factors, RNA helicases, nucleases, kinases, and other signaling regulatory proteins. 
More recently, stress granules have been shown to contain microRNAs, mRNA-editing proteins, 
enzymes (Anderson and Kedersha 2009), and as I will show in Chapter 5, mitotic motors. Most 
recently, it has been found that kinesin and dynein microtubule motor complexes participate in 
stress granule dynamics (Loschi, Leishman et al. 2009). The dynein-dynactin-binding protein 
Bicaudal-D1 (BICD1) was demonstrated to be required for stress granule assembly, while 
kinesin 1 was shown to be required for stress granule disassembly (Loschi, Leishman et al. 
2009). The use for motor-based assembly and disassembly is intriguing, but the identification of 
motors functioning in stress granule assembly or disassembly is. Chapter 5 addresses this 
question by providing two new motors involved in stress granule dynamics. 
1.2.4 Translation inhibition during mitosis 
It is well known that translation is inhibited during mitosis when cell division occurs, however, 
the stage at which protein synthesis is inhibited (i.e., initiation, elongation, termination) 
continues to be investigated. In 1970, Fan and Penman published that the inhibition of translation 
occurred at the initiation stage (Fan and Penman 1970); however, most recently, Sivan, et al. 
demonstrated that translation inhibition in mitosis leads to a build-up of polysomes along the 
actively translating mRNA during mitosis, leading the authors to hypothesize that those 
transcripts arrested in mitosis are arrested in the elongation stage (Sivan, Kedersha et al. 2007). 
This satisfyingly explains how the cell is able to rapidly resume translation after the completion 
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of mitosis and save energy in the process. This inhibition of elongation during mitosis is shown 
to occur through phosphorylation of eEF2. This paper does not rule out that translation is not 
inhibited at the initiation stage, rather it provides evidence that global translation inhibition does 
not occur exclusively at the initiation stage during cell division. 
As I will demonstrate in Chapter 4, the mitotic motor protein Eg5 functions not only 
during mitosis in bipolar spindle separation, but also during translation elongation in interphase. 
It is quite interesting to speculate that the cell has developed fail-proof quality control 
mechanisms to control protein synthesis at the elongation phase through the use of mitotic 
motors such as Eg5. This would suggest that during interphase Eg5 functions in translation, yet 
at the onset of mitosis when it becomes phosphorylated, Eg5’s role as well as translation is 
inhibited so that Eg5 can complete its mitotic function.  
1.2.5 Protein synthesis and cancer 
Protein translation is a complex and extremely multifaceted process regulating molecular 
processes that control ribosome biogenesis and mRNA translation; one can foresee that 
deregulation of any or all of these processes or signaling pathways may lead to a physiologically 
dysfunctional cell. Regulation of protein synthesis could be predicted to have a great impact on 
cancer development and progression, as the pathways that are controlled on a translation level 
include mitogenic signal stimulation, cell growth and proliferation pathways, as well as 
responses to nutritional deprivation or cellular stresses. Protein synthesis has recently been found 
to be aberrantly regulated in cancer cells (Cuesta, Gupta et al. 2009), as cancer cells can easily 
exploit misregulation of translation at the level of mRNA and protein expression (Watkins and 
Norbury 2002).  Various dysregulated components in cancer cells involving the translation 
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machinery exist including ribosome synthesis, ribosomal proteins, translational factors, tRNAs, 
regulatory proteins, and expression or translation of various mRNAs (Le Quesne, Spriggs et al. ; 
Brewer 2001; Watkins and Norbury 2002; Perkins and Barber 2004; Belin, Beghin et al. 2009). 
The effects of such abnormal regulation results in overexpression of proteins, up-regulation of 
protein synthesis, and selective translation of checkpoint proteins that are typically used to 
inhibit cells from dividing or proliferating if defects are found (Le Quesne, Spriggs et al. ; 
Watkins and Norbury 2002; Perkins and Barber 2004; Rice 2009).   
1.3 PROTEIN SYNTHESIS IN VIVO 
Most of the discussion of translation has been done so in the context of just the translational 
machinery.  In fact, as discussed thus far, the sequence and events of translation can be 
reconstituted with in vitro purified enzymes. However, protein translation is significantly more 
complex in vivo. This section highlights the complex regulation of protein translation carried out 
by the cell in vivo.  
1.3.1 Interactions during protein synthesis 
Studies have demonstrated that polysomes, mRNA, aminoacyl-tRNA synthetases, initiation 
factors and elongation factors all associate with the cytoskeleton. Compartmentalization of 
mRNAs with the cytoskeleton has also been shown to occur, while the three major filament 
structures of the cytoskeleton have been demonstrated to be involved in mRNA targeting and 
transport.  
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1.3.2 Translation and the cytoskeleton 
The cytoskeleton of eukaryotic cells during interphase has a high degree of organization which is 
required for its cellular functions. The cytoskeleton consists of three different filament structures: 
microtubules, intermediate filaments, and actin filaments (microfilaments), which function in 
cell movement, cell shape, organelle positioning, vesicle and RNA transport, as well as 
centrosome and chromosome segregation. As I will discuss, there exists a relationship between 
the cytoskeleton filaments, associated microtubule motors and translational components, but the 
exact motors involved and their function in translation is incompletely understood. Chapter 4 
offers penetrating insight into this multifaceted relationship.  
Although it has been previously thought that mRNAs are transported from the nucleus to 
the cytoplasm and become randomly distributed, recent evidence exists that disputes this 
conclusion. It is now believed that mRNAs are tightly associated with the cytoskeleton, although 
the fraction of associated mRNA or polysome complexes differs from 15-75%, depending on the 
cell type and experimental approach used (Jansen 1999) (Singer, Langevin et al. 1989; Taneja, 
Lifshitz et al. 1992; Hesketh 1996; Hovland, Hesketh et al. 1996).  
The first line of evidence stems from the observation that the cytoskeleton fraction from 
cell lysates was found to be enriched in polysomes, translation initiation factors, elongation 
factors, and cellular mRNA (Jansen 1999). Importantly, these translational components remained 
associated with the cytoskeleton in the presence of high ionic conditions, implying strong 
physical binding rather than a weak association of RNA to the cytoskeleton.  
The second line of evidence is derived from microscopy studies where it was observed 
that mRNA and polysomes are found quite close to cytoskeleton structures (Jansen 1999). From 
analysis of immunofluorescence experiments, ribosomes, initiation and elongation factors 
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demonstrated an intracellular distribution that resembles that of the microtubule and actin 
cytoskeleton.  
Protein translation efficiency benefits from the close and spatial proximity for the 
association of all factors involved in translation, as actively translated mRNA is often found in 
cytoskeletal-associated polysomes. For examples, in sea urchin embryos, upon egg activation, 
polysomes were found to become attached to the cytoskeleton, at the same time when translation 
of messages was induced (Moon, Nicosia et al. 1983). Also, during viral infection host cell 
translation is shut down, however newly synthesized viral-RNA containing polysomes are found 
to be cytoskeletally-associated (Lenk and Penman 1979; van Venrooij, Sillekens et al. 1981; 
Bonneau, Darveau et al. 1985). Despite these provocative findings, little is known about the 
nature of the association between translational components and cytoskeletal elements. Without 
knowing which proteins mediate such interactions it is impossible to study the physiological 
consequences of the association between translational components and cytoskeletal elements. 
Chapter 2 identifies candidate proteins that mediate such interactions and Chapters 4 and 6 
directly address the physiological functions of such interactions.  
1.3.3 Microtubules and translation 
Microtubules are long hollow cylindrical filamentous structures that carry out a number of 
intracellular functions including capture of chromosomes and transport during mitosis, provide 
for spatial organization and remodeling of the cytoskeleton, facilitate recruitment of organelle 
and membranous structures through their interaction with motors. The walls of the microtubule 
are composed of 13 protofilaments organized in alternating alpha and beta dimers in long chains. 
Microtubules are typically oriented so that their dynamic plus-ends are pointed towards the cell 
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periphery, and their minus-ends are anchored in the microtubule organizing center (MTOC). 
These microtubules serve as roadways for the microtubule motors to carry various cargoes.  
There exists an interaction between microtubules and translational components.  Since 
the late 1980’s, microtubules (Suprenant 1993; Jansen 1999) have been implicated in mRNA 
targeting and cellular transport. Microtubule organization and distribution, dynamic instability, 
and microtubule motors all provide a highly-organized network for anchoring or distributing 
mRNA within cells; dynamic instability as defined as the constant growth and shrinkage at the 
microtubule ends.  
1.3.3.1 mRNA localization with microtubules 
 
Recent evidence within the last 20 years has demonstrated that specific mRNAs are localized and 
transported in a microtubule-dependent manner in oocytes and embryos of Xenopus (Yisraeli, 
Sokol et al. 1990), Drosophila (Pokrywka and Stephenson 1991), Zebrafish (Palacios and St 
Johnston 2001), and mammalian cells (Finch, Revankar et al. 1993; Hovland, Hesketh et al. 
1996) . Vg1 RNA in Xenopus  (Yisraeli, Sokol et al. 1990), cyclin B and bicoid mRNA in 
Drosophila (Pokrywka and Stephenson 1991), are just a few of the known mRNAs to be 
transported along microtubules (Jansen 1999). Several factors may determine which mRNAs are 
localized with the cytoskeleton such as specific localization signals known as the ’zip codes’  
found in the 3’-UTR region of mRNAs identified in Vg1, bicoid, and nanos transcripts 
(Kislauskis, Li et al. 1993). Additionally, interactions of other translational components, 
proteins, or even ribosomes with the mRNA may mediate the mRNA localization with the 
cytoskeleton (Hovland, Hesketh et al. 1996). 
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1.3.3.2 Microtubules and ribosomes 
 
There are several examples demonstrating interactions between ribosomes and microtubules. In 
mammalian cells, ribosomes have been shown to be clustered around microtubules and attached 
to the microtubule walls by short filaments (Suprenant, Tempero et al. 1989; Hamill, Davis et al. 
1994). In ovaries of the hemipteran insects, it has been shown that ribosomes move slowly at a 
speed of 20 µm/h through nutritive tubes from the anterior ovarioles to the developing oocyte 
toward the minus-ends of microtubules (Stebbings 1986). In the mitotic spindles, ribosome-like 
particles were shown to be linked to microtubules by filamentous arms (Turner and McIntosh 
1977; Salmon 1982; Suprenant, Tempero et al. 1989). In sea urchin embryos, it has been shown 
that ribosomes associate with microtubules through a stalk-like structure, and association may be 
regulated, as polysomes, but not monosomes were shown to interact with microtubules 
(Suprenant and Rebhun 1983; Suprenant, Tempero et al. 1989; Suprenant 1993). Finally, in 
ovaries of Pyrrhocoris, newly synthesized RNA component has been found to move at both, slow 
(30 µm/h) and fast (200 µm/h) speeds, arguing against the bulk flow of ribosomes and favoring a 
microtubule based movement (Macgregor and Stebbings 1970).  
1.3.3.3 Mitotic apparatus and ribosomes/RNA 
 
The mitotic apparatus has been demonstrated to contain bound RNA and ribosomes in sea urchin 
embryos, suggesting that even in mitosis, an organization of microtubules and RNA/ribosomes 
exist (Mazia and Dan 1952; Suprenant 1993). In the presence and absence of detergent-extracted 
spindles, ribosomes have been shown to localize along microtubules in the centrosome complex 
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and on vesicle surfaces (Salmon 1982). Using quick-freeze, deep-etch electron microscopy, 
ribosomal particles were found to be tightly attached on the mitotic apparatus to the microtubule 
by fine filamentous arms, and can only be released in the presence of high salt (Hirokawa, 
Takemura et al. 1985).  
1.3.3.4 RNA transport 
 
Microtubules have also been demonstrated to be involved in RNA transport through the use of 
microtubule motors. mRNA transport is facilitated by the packaging of mRNAs into large 
ribonucleoprotein particles or granules. The motors that are used to transport the RNA will be 
discussed in section 1.42.  
1.3.4 Microtubules and translational regulation 
Not only do microtubules play a role in mRNA localization and transport, but there is significant 
evidence suggesting roles for microtubules in formation of cytoplasmic translation complexes. 
mRNA transport from the nucleus to the cytoplasm was shown to be inhibited by colchicine 
treatment in rat liver nuclei (Schumm and Webb 1982). Microtubules are also needed for the 
formation of membrane-bound polysomes in hepatectomized rats, as colchicine treatment caused 
dissociation of membrane-associated polysomes (Walker and Whitfield 1985). It was further 
determined that the mRNAs were released and degraded from the ribosomes, leaving the 80S 
ribosome intact and bound to the membrane (Walker and Whitfield 1985). Furthermore, loss of 
microtubules in the regenerating liver prevented ribosomal subunits from dissociating and 
reforming the initiation complexes.  
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1.3.5 Site-specific translation 
mRNA localization is relevant in highly polarized cells like neurons, where the site of 
transcription can be distances away from the final location of the protein. Therefore, localized 
protein translation aids the problem of transporting proteins over long distances, which can 
sometimes take longer than the half-life of a protein (Campenot and Eng 2000). In neurons, site-
specific protein translation has been shown to occur in dendrites, prominent compartments which 
account for most of the postsynaptic sites in the nervous system (Eberwine, Miyashiro et al. 
2001; Tang and Schuman 2002; Wu, Zeng et al. 2007). Neurons are polarized cells where 
mRNAs move and are targeted to allow localized translation to take place. This polarized 
localization is essential for proper functioning of the neuron. 
Using electron microscopy, a number of components of translation machinery have been 
found to localize near one another in the neuron (Martin ; Job and Eberwine 2001). Ribosomes 
have been found throughout the dendritic shafts, polysomes have been found in the necks of 
dendritic spines and beneath the spine synapses, endoplasmic reticulum/Nissl bodies and spine 
apparatus/Golgi apparatus all have been found in distal regions of the dendrites (Job and 
Eberwine 2001). Also, mRNAs have been shown to localize to the synaptic sites and to move in 
a microtubule-dependent manner (Roegiers 2003; Antar, Dictenberg et al. 2005). This active 
transport of mRNA and the presence of translational machinery in close proximity to one another 
indicate that dendrites can synthesize protein in a site-specific manner and independently of the 
main cell body. 
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1.4 MOLECULAR MOTORS 
Molecular microtubule motors are proteins that transport intracellular cargoes within cells by 
moving along microtubules using ATP hydrolysis. They are referred to as motors because they 
convert chemical energy to mechanical energy, using the energy of ATP hydrolysis to carry 
cargo on microtubules. There are two different families of motor proteins, the kinesins and the 
dyneins. The kinesins typically carry cargo along the plus-end of the microtubule, whereas 
dyneins typically carry cargo along the minus-ends of microtubules. Microtubule motors can 
function in a variety of processes including cellular organization, organelle and vesicle transport, 
cell division, mRNA transport, and the motility of cilia and flagella. Intracellular transport by 
kinesins and dyneins has been shown to be essential and loss of these proteins can lead to 
deleterious effects.  
1.4.1 Kinesins 
There are approximately 45 different kinesins in humans (Ohsugi, Tokai-Nishizumi et al. 2003). 
Each of these is defined as containing a conserved motor domain. The kinesins can be separated 
into three different groups based on the location of their motor domain, which can be found on 
the N-terminus, the C-terminus, or in the middle of the protein. Of the 45 kinesins, three have the 
motor domains on the C-terminus and three have the motor domain in the middle of the protein. 
N-terminal kinesins walk toward the plus-end of the microtubule, near the cell periphery, those 
that have C-terminal motor domains walk along the minus-end of the microtubule, near the 
nucleus, whereas those that contain their motor domain in the middle of the protein typically 
function in depolymerization of microtubules. The kinesin family has become so expansive in 
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recent years, that a specific classification system has evolved classifying the kinesins into 
families designated by their function in mitosis.  There are now 14 different kinesin families 
representing, making it easier to distinguish between identified kinesins and aiding in the 
identification and classification of new kinesins (Lawrence, Dawe et al. 2004).  
1.4.1.1 Substructure of kinesins 
 
In general, the structure of kinesins and microtubule motors consist of a motor domain, a head 
connected to a neck linker, and a common stalk leading to the tail domain. Each of these regions 
has a dedicated function. The motor domain is responsible for binding to the microtubule and 
nucleotide hydrolysis. The head that is connected to the neck linker is responsible for the 
directionality of the motor and undergoes nucleotide-dependent conformational changes creating 
a powerstroke by docking and undocking to the nucleotide sites, whereas the tail domain binds to 
the cargo which is being transported.  
1.4.2 Motors and mRNA transport 
1.4.2.1 Kinesin 
 
Kinesin motors have also been implicated in the localization of Vg1 mRNA to the vegetal pole 
of Xenopus oocytes (Betley, Heinrich et al. 2004; Yoon and Mowry 2004) . Kinesin 1 was found 
to co-immunoprecipitate with Staufen protein, which localizes to the vegetal pole with Vg1 
mRNA. Furthermore, oskar mRNA is found to require kinesins to localize to the posterior end of 
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the oocyte (Palacios and St Johnston 2001).  However, there is still an open question whether 
kinesin is directly or indirectly, responsible for these movements. 
1.4.2.2 Dynein and mRNA transport 
 
High resolution time-lapse movies have captured the bidirectional transport of mRNA, as 
transcripts were demonstrated to undergo frequent directional reversal. Dynein is thought to 
transport mRNAs to the anterior end, while kinesin is thought to transport them to the posterior 
end of the oocyte, in Drosophila (Duncan and Warrior 2002).  In these experiments, inhibition of 
dynein led to strong inhibition of transport in both directions, as anticipated given that transport 
by kinesin and dynein requires strong coordinated movements of dynein with kinesin. However, 
it should be noted that recently in mouse brains it was found that dynein is capable of 
bidirectional movement suggesting that the bidirectional movement observed may only be due to 
transport by dynein (Ross, Wallace et al. 2006).  
Dynein has been implicated in the transport of numerous mRNAs including K10, bicoid, 
and gurken, although no RNA binding domain has been found for the dynein. However, recently 
two RNA binding proteins and dynein binding partners have been implicated in this role, 
Bicaudal-D (BicD) and egalitarian (EGL) (Dienstbier and Li 2009). These proteins are found in 
the same complexes with dynein and have been shown to be required for dynein mRNA 
transport, as mutations in dynein light chain that inhibits its binding to EGL impair dynein 
mediated transport of the mRNAs to the oocyte.  
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1.4.3 Mitotic Motors 
Mitotic microtubule motor proteins are important for the carefully organized sequence of events 
that underlie mitosis. Motors not only help to assemble the mitotic spindle and to accurately 
segregate sister chromatids, but they provide the mechanical forces needed to drive mitosis. The 
cellular tasks accomplished by motors is not the result of one individual motor; rather, a 
combinatorial effort from many different motors functioning concurrently which underlie the 
diversity of their functions (Sharp, Rogers et al. 2000). There are a variety of motors during 
mitosis that are shown to have redundant or even antagonistic functions, all working together to 
produce the mitotic spindle and to accurately divide the sister chromatids. Mitotic motors drive 
mitosis by completing four distinct functions relating to cell division: bipolar spindle formation, 
congression of chromosomes, chromosome segregation, and separation of spindle poles prior to 
cytokinesis. They complete these functions by using one of three mechanisms, sliding adjacent 
microtubules relative to other microtubules or other structures, transporting specific mitotic 
cargos along the microtubules, or by regulating microtubule dynamics, such as growth and 
shrinkage along the microtubule ends. Perturbation of the dynamic balance between motors 
during mitosis can lead to segregational defects during cell division. Lagging chromosomes 
during metaphase and anaphase, and multipolar spindle formation can be the result of motor 
defects. 
There are two microtubule motors, Kid and Eg5, whose novel interphase functions will 
be the focus of the research efforts presented later.  However, these motors have known 
functions during mitosis.  
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1.4.4 Kid 
Kinesin-like DNA binding protein (Kid), also known as Kif22, is an N-terminal, plus-end 
directed, chromokinesin motor which belongs to the Kinesin-10 family of proteins (Tokai, 
Fujimoto-Nishiyama et al. 1996; Yajima, Edamatsu et al. 2003). Kid has multiple functions 
during mitosis including maintaining metaphase spindle length, producing polar ejection force, 
and pushing chromosome arms away from spindle poles (Funabiki and Murray 2000; Levesque 
and Compton 2001; Tokai-Nishizumi, Ohsugi et al. 2005).  The known movement of 
chromosomes parallels the mRNA transport function for Kid we will propose in this document in 
Chapter 6. 
1.4.4.1 Kid localization 
 
Localization of Kid during mitosis is primarily found on chromosomes and spindles; Kid has 
been found to localize with condensing chromosomes during prophase, associates with 
chromosomes and spindles during metaphase and anaphase, and primarily associates with 
chromosomes entering daughter cells during telophase (Tokai, Fujimoto-Nishiyama et al. 1996). 
As with other proteins involved in spindle formation and chromosome segregation, the 
localization of Kid to chromosomes and spindles seems to be dependent on phosphorylation. 
Two residues have been shown to be phosphorylated, Ser427 and Thr463, by Cdc2/cyclin B, a 
key regulator of G2/M progression (Ohsugi, Tokai-Nishizumi et al. 2003). More notably, 
phosphorylation of Thr463 was demonstrated to be essential for localization of Kid with 
chromosomes, as the T463A mutation was discovered to localize only with spindles.  
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1.4.4.2 Kid Structure 
 
Characterization of Kid has revealed an ATP-binding site, a motor domain, two phosphorylation 
sites, a DNA binding domain, two microtubule-binding sites, and a coiled-coil domain. Sequence 
analysis suggests that Kid contains three nuclear localization sites that may account for the 
diffuse nuclear localization observed in many cell lines. Kid suppression by siRNA leads to 
lagging chromosomes and a shortening of metaphase spindle length, consistent with Kid function 
as a chromokinesin motor, a motor which binds to chromosomes. 
1.4.5 Eg5 
Eg5, also known as Kif11, is an N-terminal, plus-end directed kinesin motor that belongs to the 
kinesin-5, BimC protein family currently consisting of BimC (Aspergillus nidulans), 
Eg5(Xenopus laevis), KLP61F (Drosophila melanogaster), cut7 (Schizosaccharomyces pombe), 
CIN8 and KIP1 (Saccharomyces cerevesiae) and HsEg5 (human) (Sawin, LeGuellec et al. 1992; 
Kashina, Rogers et al. 1997; Drummond and Hagan 1998). Eg5 typically functions during 
mitosis as a homotetrameric complex in spindle assembly and maintenance in all organisms 
mentioned above. Specifically Eg5 functions to slide adjacent microtubules apart, crosslink 
antiparallel microtubules, and slide microtubules toward the centrosomes aiding in poleward flux 
(Kapoor and Mitchison 2001). Eg5 typically localizes on the spindle poles during mitosis, as 
with other some mitotic motors; the localization of Eg5 to the spindles seems to be dependent on 
its phosphorylation status (Blangy, Lane et al. 1995). Eg5 is phosphorylated at Thr-927 by Cdc2; 
mutation of this residue to T927A blocked Eg5 from localizing to the spindle (Blangy, Lane et 
al. 1995; Sawin and Mitchison 1995).  
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1.4.5.1 Eg5 characterization 
 
The overall architecture of Eg5 comprises an ATP-binding domain, motor domain, region of 
predicted alpha-helices, and a nonhelical tail domain (Sawin and Mitchison 1995). In the tail 
domain, the BimC family of proteins have a 40 residue region that is partially conserved in all 
family members, except CIN8 and KIP1 (Kashina, Rogers et al. 1997). Within this region, 
contains the phosphorylation site which controls the localization of Eg5 and other sequences that 
may be phosphorylated by a proline-directed kinase or ERK-family kinase.  
 
1.4.5.2 Loss of Eg5 in cultured cells 
 
Loss of Eg5, by immunodepletion of extracts led to a phenotype of monopolar spindles.  In 
human cells, microinjection of Eg5 antibody induced 80% of the cells to arrest with a 
prometaphase-like chromosome arrangement but no spindle pole separation (Walczak, Mitchison 
et al. 1996; Goshima and Vale 2005). Furthermore, loss of Eg5 by siRNA, led to monopolar 
spindles with two only slightly separated centrosomes. Therefore, loss of Eg5 inhibits 
centrosome separation and formation of the bipolar mitotic spindle leading to incomplete spindle 
assembly (Blangy, Lane et al. 1995; Goshima and Vale 2005) 
Eg5 is essential and deletion of KLP61F, the Eg5 homolog in Drosophila, and deletion of 
both yeast homologs, Cin8 and KIP1, cause lethality (Roof, Meluh et al. 1992). When the mouse 
knsl1 gene on chromosome 18 was deleted, it resulted in pre-implantation embryonic lethality 
phenotype in the mice homozygous for the Eg5 deletion (Castillo and Justice 2007). However 
female and male mice heterozygous for Eg5 deletion (Eg5 +/-) did not appear any different from 
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control mice homozygous for Eg5. These results suggest that Eg5 is essential in early 
developmental stages and its loss cannot be compensated by any other kinesin motor in single 
copy. 
1.4.5.3 Monastrol 
 
The use of small molecule inhibitors has been instrumental in our understanding of various 
proteins and complex processes. This is particularly true for Eg5, as numerous classes of 
inhibitors have been developed. The first identified small molecules inhibitor, monastrol, was 
reported by the Mitchison lab (Mayer, Kapoor et al. 1999; Kapoor, Mayer et al. 2000). Monastrol 
exerts its inhibitory effects on Eg5 by binding to its motor domain preventing Eg5 from walking 
along microtubules and causing cellular arrest of cells in M phase with monopolar spindles. 
Monastrol does not compete with ATP binding to Eg5, rather Monastrol appears to inhibit 
microtubule-stimulated ADP release. According to the crystal structure of Eg5-monastrol 
complex, monastrol seems to bind a hydrophobic induced-fit pocket, a region that is not 
conserved in kinesins (Maliga and Mitchison 2006; Maliga, Xing et al. 2006).  
Since the discovery of monastrol, several new Eg5 inhibitors have been discovered, some 
of which are in clinical trials. Most of the newly discovered Eg5 inhibitors, bind in the same 
hydrophobic pocket as monastrol (Lad, Luo et al. 2008). Ispinesib, an inhibitor in stage II 
clinical trials, has been quite promising for treatment of non-small cell lung, ovarian, and breast 
cancer that have failed using other treatments (Lad, Luo et al. 2008; Lee, Belanger et al. 2008). 
Ispinesib has been demonstrated to inhibit Eg5 using the same mechanism as monastrol.  
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1.4.5.4 Overexpression of Eg5 
 
Eg5 overexpression has been shown to cause genomic instability and segregational defects 
(Castillo, Morse et al. 2007), as overexpression disrupts the delicate balance of forces generated 
to form and maintain the mitotic spindle. When Eg5 was overexpressed in mice, abnormal 
spindle assembly, genomic instability, and a wide range of tumors including hematopoietic, 
adenoma/adenomacarcinomas, ovarian, sarcomas, as well as others, was observed (Castillo, 
Morse et al. 2007).   
1.5 MITOTIC MOTORS MAY HAVE INTERPHASE FUNCTIONS 
Over the last 20 years the primary focus of Eg5 and Kid motor function has been centered on 
their respective roles during mitosis, premised with the notion that mitotic motors only function 
in mitosis. This is a key rationale for choosing Eg5 as a target for inhibition of cancer.  
However the uniqueness of mitotic motors as cancer targets is being challenged as recent 
examination of their functions during interphase is revealing functions outside of mitosis not 
only in postmitotic neurons, but also in dividing cells. Such interphase functions could render 
these once anti-cancer treatments problematic, as their inhibition may also cause uncharacteristic 
problems to healthy interphasic cells.  
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2.0  CHAPTER II : MITOTIC MICROTUBULE MOTOR KID LOCALIZES TO THE 
NUCLEOLUS DURING INTERPHASE IN A GTP-DEPENDENT MANNER 
2.1 INTRODUCTION 
The nucleolus constitutes the sole site of the early steps in ribosome biogenesis (Hernandez-
Verdun 2006; Cmarko, Smigova et al. 2008). It is a nonmembranous, suborganelle of the nucleus 
that is divided into three different compartments. The nucleolus is subdivided into the fibrillar 
center, where the rDNA genes are located, the dense fibrillar component, where rDNA 
transcription takes place, and the granular component, where the pre-ribosome is packaged and 
moves through prior to being transported out of the nucleus and through the nuclear pores 
(Scheer and Hock 1999).  
Up until the 1990s, it was thought that the nucleolus only had one function, and thus only 
contained proteins that had a role in ribosome biogenesis. However, the true identity of the 
nucleolus as a multitasking organelle with diverse cellular functions was unmasked by proteomic 
studies which revealed numerous proteins found in the nucleolus without any known function in 
ribosome biogenesis (Andersen, Lam et al. 2005; Olson and Dundr 2005). More than 700 
proteins were identified, however the majority of these newly identified proteins do not maintain 
a permanent residence in the nucleolus; rather they are temporarily stored in the nucleolus until 
after they complete their function. The motors I will describe here, Kid, Eg5, and MKLP1, were 
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not found in this proteomic screen. This may be because they used cancer cells to characterize 
the nucleolus-localizing proteins.  
In addition to the expansion of proteins known to localize to the nucleolus, the   
functional role of the nucleolus has similarly expanded. The nucleolus has been implicated in a 
wide array of processes such as regulation of tumor suppressors and oncogenes, cell cycle 
regulation, signal recognition particle (SRP) assembly, modification of small RNAs, control of 
aging, response to cellular stress and telomerase function (Olson, Dundr et al. 2000). This 
diversity of the nucleolus is relevant for our observations of Chapter 2, investigating the role of 
mitotic motors in the nucleolus.  
2.2 RESULTS 
2.2.1 Mitotic microtubule motors Kid, Eg5, and MKLP1 localized to the nucleolus during 
interphase 
As previously published data from our lab demonstrated that the mitotic motor dynein was found 
mislocalized in cancer cells in comparison to normal cells, we pursued the investigation of the 
mitotic localization of other motors in noncancer versus cancer cells. Interestingly, we uncovered 
a previously undescribed localization of some of these motors during interphase. The interphase 
localization could be segregated into two groups: (1) those which displayed distinct nucleolar 
localization (Figure 2.1A) and (2) those which displayed more diffuse nuclear or cytoplasmic 
localization (Figure 2.1B). From the panel of nine mitotic motors examined CENP-E, MCAK,  
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Figure 2.1: Localization of mitotic motors during interphase.  
 
 
 
 
 
 
 
HSET, KIF14, KIF4, cytoplasmic dynein were characterized by diffuse nuclear or 
cytoplasmic localization, while Eg5, Kid and MKLP1, localized at least partially to the 
nucleolus.  
2.2.2 The nucleolar-associating motors localized differently between noncancer and 
cancer cells during interphase 
Quantification of the immunofluorescent localization of these motors between noncancer and 
cancer cells revealed that  Kid localized to the nucleolus ~80% of the time in all noncancer cells 
lines tested, and to the nucleolus less than 35% of the time in cancer cell lines examined (Figure 
2.2A). MKLP1 followed a similar trend, where MKLP1 localized to the nucleolus in noncancer 
cells greater than 60% and in cancer cells, less than 5% of the time, with the exception of 
UPCI:SCC103 cells which had ~80% nucleolar localization. However, analysis of Eg5 
localization revealed opposite results in comparison to Kid and MKLP1 such that in the different 
cell lines, Eg5 was found to localize to the nucleolus in both normal and cancer cells ~60% of 
(A) Kid, Eg5, and MKLP1 demonstrated nucleolar localization during interphase, as 
confirmed by nucleolar marker fibrillarin. Blue, DAPI; red, mitotic motor, green, 
fibrillarin. (B) Other mitotic motors, MCAK, CenpE, demonstrated diffuse nuclear or 
cytoplasmic localization during interphase.  Kif14 did demonstrate nucleolar 
localization in this image, but was inconsistent during this analysis. 
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the time, with the exception of UPCI:SCC103 cells, where it localized less than 25% of the time 
(Figures 2.2B,C). It is interestingly that the three nucleolar-associating motors localized 
differently between the noncancer and cancer cells, specifically it is important to note that in 
UPCI:SCC103 cells, Eg5 localization was found to be absent from the nucleolus, unlike in the 
other cancer cells, whereas MKLP1 was found to localize to the nucleolus in UPCI:SCC103 
cells, unlike the other cancer cell lines. As of now, the reason for this difference is unclear, but as 
motors typically execute a dynamic balance of forces, this result may suggest disruption of the 
delicate balance between motors in this cell line, such that overexpression of MKLP1 causes Eg5 
NoLS to be lost.  
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Figure 2.2: Localization of mitotic motors during interphase between noncancer and 
cancer cells. 
 
 
 
 
 
 
 
(A)  Top: Immunofluorescence analysis of Kid localization appeared to be different 
between noncancer RPE1 cells and cancer UPCI:SCC103. Bottom: Quantitation of 
immunofluorescence between noncancer and cancer cells. Red, Kid; Blue, DAPI; Green, 
fibrillarin. (B) Top: Immunofluorescence analysis of MKLP1 localization in noncancer 
and cancer cell lines. Red, MKLP1; Blue, DAPI Bottom: Quantitation of 
immunofluorescence analysis. (C) Top: Immunofluorescence analysis of Eg5 localization 
in noncancer and cancer cell lines. Red, Eg5; Blue, DAPI Bottom: Quantitation of 
immunofluorescence. *= p value <0.05. 
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Nucleolar localization of these motors were confirmed by co-staining with fibrillarin, a 
protein localizing to the dense fibrillar component (Figure 2.1A), and/or nucleophosmin (NPM) a 
protein localizing to the granular component (Figure 2.3). Furthermore, the nucleolar localization 
of the motors Kid and MKLP1 was validated in tissue by immunohistochemistry of cross-
sections from frozen intestine of eight-week-old mice (Figure 2.4). The nucleolar localization of 
these motors is quite intriguing because an interphase function for these motors has not been 
investigated previously. 
2.2.2.1 Kid localizes to the nucleolus in both noncancer and cancer cells 
 
Additionally, the nucleolar localization of Kid was further confirmed by immunofluorescence of 
isolated nucleoli (Figure 2.5A), immunoblotting of nucleolar enrichment (Figure 5B) and cellular 
fractionation (Figure 2.5C), in collaboration with Maya Ashfag and Dr. Jason Weber.  Nucleolar 
fractionation/enrichment was completed by gently lysing cells, separating the nuclear 
components using a sucrose gradient, and subsequent immunoblot analysis on the fractions. 
Although the immunofluorescence analysis in Figure 2.2A of Kid suggested a distinct 
localization pattern between noncancer and cancer cells, the biochemical fractionation revealed 
that Kid was present in the nucleolus of both noncancer, RPE1 cells, and cancer, UPCI:SCC103 
cells. This biochemical fractionation experiment also demonstrated the specificity of the 
antibody verifying the immunofluorescence staining was not due to cross reactivity with another 
nucleolar protein.  
 
 
  38 
DAPI Kid NPM
Figure 2.3
RPE1
 
 
Figure 2.3: Kid completely co-localizes to the nucleolus similar to NPM, a nucleolar 
marker. 
 
 
 
 
 
 
Untreated RPE1 cells were co-stained for Kid (red) and NPM (green) and DAPI (blue).   
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Figure 2.4 : Kid and MKLP1 localize to the nucleolus in tissue. 
 Eight- week-old frozen mouse intestine cryosectioned tissue was co-stained with 
antibodies to Kid or MKLP1 (in red) and NPM (in green), or DAPI representing the 
nucleus in blue. White arrow represents the cell demonstrating nucleolar localization of 
MKLP1. 
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Figure 2.5: Kid is demonstrated to specifically localize to the nucleolus in both noncancer 
and cancer cells. 
 
 
 
 
 
 
 
 
 
The differences between the immunofluorescence and biochemical fraction data with 
regard to Kid in these two cell lines can be reconciled by noting the presence of bright nuclear 
staining, which likely obscured the nucleolar staining in the cancer cells. Typically, a nuclear 
protein that is excluded from the nucleolus exhibits a “spherical black hole” or “ghost” where the 
nucleolus is located and as the nucleolus exhibited no such “ghost” pattern in these 
UPCI:SCC103 cells, it was determined that the nucleus/nucleolus likely contained a continuous 
distribution of Kid (Armstrong, Franklin et al. 2001).  
2.2.2.2 Kid is not overexpressed in cancer cells 
 
As the staining of Kid during interphase seemed to be more intense and uniform in cancer cells 
as compared to noncancer cells, it suggested that the overall levels of Kid may be greater in 
(A) Isolated nucleoli from RPE1 and UPCI:SCC103 cells demonstrate complete co-
localization with NPM. Green, Kid; Red, NPM. (B) Biochemically fractionated nucleoli 
from RPE1 and UPCI:SCC103 demonstrated specificity of the Kid antibody and 
verified Kid localization to the nucleolus in both RPE1 and UPCI:SCC103 cells. 
NP=nucleoplasm, No=nucleolus, Nup62=nucleoporin. (C) Kid and Eg5 subcellular 
fractionation into cytosol (C) and nucleus (N) in RPE1 and UPCI:SCC103 cell lines. 
KU80=nuclear, cytokeratin=cytosolic markers. 
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cancer cells. An elevated expression level of Kid in cancer cells could explain the differences in 
nucleolar/nuclear localization observed between cancer and noncancer cells. Initially, in 
noncycling cells the expression of Kid was determined to be elevated in some cancer cells in 
comparison to noncancer cells by immunoblot analysis (Figure 2.6A). However because the 
expression of Kid is known to increase during mitosis (Ohsugi, Tokai-Nishizumi et al. 2003), 
(Germani, Bruzzoni-Giovanelli et al. 2000) and cancer cells are known to have at least a 2-3-fold 
increase in the number of mitotic cells compared to RPE1 cells, the same experiment was 
repeated with noncancer and cancer cells arrested in mitosis. Under mitotic arrest, a difference in 
Kid expression in whole cell lysates was not observed between the various noncancer and cancer 
cell lines tested (Figure 2.6B). These results strongly suggest that the difference in nucleolar  
localization observed is not due to a difference in expression levels of Kid.  At this point, we 
turned our attention towards the function of motors associated with the nucleolus, rather than 
furthering characterizing the differences between normal and cancer cells. 
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Figure 2.6: Kid is not overexpressed in cancer cells. 
 
 
 
 
 
 
 
2.2.3 Mechanism of Kid localization to the nucleolus 
As mentioned previously, the nucleolus has diverse functions. To begin to understand which 
nucleolar pathway involved motors, we first examined under what conditions the Kid motor 
localized to the nucleolus. Investigation of the literature revealed that proteins that localize to the 
nucleolus do so through one of two mechanisms. The first is by containing a nucleolar 
localization sequence (NoLS) (Lower, Turner et al. 2002; Song and Wu 2005), or secondly by 
Various unsynchronized (A) or mitotically synchronized (B) noncancer and cancer cell 
lines were analyzed by immunoblotting for their protein expression of Kid. For 
synchronization, cells were treated with 0.003 mM nocodazole for 16 hrs, followed by an 
8 hrs release, and the addition of 0.003 mM nocodazole for an additional 12 hrs. Cells 
were trypsinized, lysed, and subjected to SDS-PAGE and immunoblotting for the 
indicated antibodies. In either case, overexpression was not observed. 
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utilizing a GTP-dependent shuttling mechanism by use of its NoLS (Finch, Revankar et al. 1993; 
Tsai and McKay 2005).   
2.2.3.1 Nucleolar-associating motors contain multiple NoLS’s 
 
Sequence comparison of the 700 proteins found to localize to the nucleolus failed to reveal a 
consensus NoLS; rather a general trend towards basic (arginine and lysine) amino acids of 
various length were observed (Armstrong, Franklin et al. 2001; Lower, Turner et al. 2002; Song 
and Wu 2005) (Figure 2.7). Besides basicity, proper folding has been proposed to be important to 
allow specific secondary structures to form and interact with proteins in the nucleolus. Upon 
examination of the motor sequences, Kid, Eg5, and MKLP1 were found to contain two, three, 
and five putative NoLSs, respectively (Figure 2.7). In order to test whether a putative NoLS-
retention mechanism is responsible for the nucleolar localization of these motor proteins, 
mutagenesis and subsequent localization experiments were required. Kid was the ideal candidate 
motor to assay the NoLS-retention mechanism as Kid contained the least number of NoLSs of 
the three nucleolar motors. Each amino acid was mutated from an arginine or a lysine to an 
alanine, prior to transfection of this construct into RPE1 cells. Unfortunately, as we later learned, 
Kid was not able to be overexpressed in cells under the CMV promoter, as the cells that took up 
the plasmid would arrest and/or undergo apoptosis. Subsequent efforts led to cloning Kid under 
the eF1α promoter, a promoter that allowed Kid to be expressed at only 5-10 times greater than 
its endogenous promoter (Ohsugi, Tokai-Nishizumi et al. 2003). However, even under conditions 
of relatively mild overexpression cells which took up the plasmid arrested in interphase; thus 
future experiments involving the transfection of cells with Kid constructs were halted. However, 
this observation suggests a possible role for Kid in interphase as will be discussed in Chapter 6. 
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Figure 2.7: Nucleolar localization sequences observed in various proteins. 
 
 
 
 
2.2.3.2 Nucleolar-associating motor Kid localizes to the nucleolus through a GTP-
dependent shuttling mechanism 
 
The second mechanism of nucleolar localization is a GTP-dependent shuttling mechanism. 
Previously published literature for other nucleolar proteins have shown that nearly 3% of the 
Kid, Eg5, and MKLP1 are demonstrated to have various putative nucleolar localization 
sequences, in comparison to the 7 proteins with known nucleolar localization sequences 
(MDM2, Coilin, Survivan-delta Exe, Hiv Tat, DEDD, p14Arf, PTHrP). 
 
 
  46 
total proteins with nucleolar localization retain a GTP binding sequence and localize to the 
nucleolus via a GTP-dependent mechanism (Misteli 2005). One such protein is nucleostemin 
which has previously been demonstrated to localize to the nucleolus based on a GTP-dependent 
cycling mechanism (Tsai and McKay 2005). Nucelostemin is found within the nucleolus when 
GTP levels are high using its NoLS to retain the protein within the nucleolus, and when the GTP 
levels decrease, its nucleolar localization sequence is released and nucleostemin shuttles out into 
the nucleus.  In order to determine whether any of these nucleolar motors may also localize to the 
nucleolus based on a GTP-dependent mechanism, their sequences were searched for GTP-
binding domains. There are at least five known GTP-binding consensus motifs, four of which 
were found within the region of the nucleolar motors: (1) the Walker A motif, or P-loop motif, 
consisting of the sequence GxxxxGKS is a known ATP/GTP binding sequence, 2) DxxG motif, 
3) xKxD motif, and 4) ExSA motif. In addition to the variety of motifs identified each, 
nucleolar-localizing motor was found to contain a plurality of such motifs; Kid, Eg5, and 
MKLP1 were found to contain 6, 9, and 6 motifs, respectively (Figure 2.8A).  
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Figure 2.8: Putative GTP binding sequences in Kid, MKLP1,and Eg5 as well as the known 
protein Nucleostemin. 
 
 
 
(A) Kid, MKLP1 and Eg5 are demonstrated to contain multiple GTP binding sequences. 
Armstrong, S.J., 2001. (B) Schematic demonstrating where the GTP binding sequences 
are found. 
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2.2.3.3 Kid shuttles out of the nucleolus when GTP levels are decreased 
 
To begin to determine whether the nucleolar localization of Kid was regulated by a GTP-
shuttling mechanism, we initially took advantage of mutational analysis of the GTP-binding 
motifs, but as overexpression of Kid was found to be toxic to cells when overexpressed, this 
approach proved unuseful. Fortunately, a number of  distinct small molecule inhibitors are 
available that are known to decrease GTP levels within cells, as such we decided to treat cells 
with one of these inhibitors to determine if Kid would leave the nucleolus as a result of lower 
levels of GTP. Two different inhibitors, mycophenolic acid (MPA) and ribavirin, were used 
independently, each inhibiting the same enzyme inosine monophosphate dehydrogenase and 
resulting in decreased intercellular pools of GTP (Finch, Revankar et al. 1993; Tsai and McKay 
2005). Treatment of RPE1 cells with 30 µM MPA followed by immunoflorescence resulted in 
~80% of cells exhibiting Kid localization from the nucleolus to the nucleus (Figure 2.9A,B). 
This change in Kid localization by immunofluorescence analysis demonstrated that the nucleolus 
no longer contained Kid, as the nucleolus was unstained.  However, as Kid changed localization 
from the nucleolus to the nucleus, it seemed as though the expression of Kid may also have 
changed. To examine this, cells were treated with varying amounts of MPA followed by cell 
lysis and immunoblotting. Kid expression was observed to increase when Kid localization 
changed from the nucleolus to the nucleus after treatment with MPA (Figure 2.9C). As MPA 
treatment is known to cause a decrease in RNA and DNA synthesis of ribosomal genes (Lowe, 
Brox et al. 1977), this change in Kid localization is likely reflective of loss of this decreased 
synthesis and may hint at Kids function as discussed in Chapter 6. 
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Treatment with ribavirin for four hours also resulted in a similar percentage of cells with 
Kid localization to the nucleus (Figure 2.9D, top two rows). These data suggest that the 
localization of Kid is regulated by a GTP-dependent shuttling mechanism. As a corollary to this 
proposed mechanism, if GTP levels could be restored with the addition of guanosine, Kid should 
relocalize to the nucleolus. Indeed, when cells were treated for four hours with 100 µM ribavirin, 
followed by the addition of 100 µΜ guanosine for four hours, Kid relocalized to the nucleolus 
(Figure 2.9C bottom row, 9E). Additionally, the shuttling could be blocked by adding ribavirin 
and guanosine at the same time. Therefore this demonstrates that Kid localization to the 
nucleolus requires a GTP-dependent shuttling mechanism. 
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Figure 2.9: Kid translocates from the nucleolus to the nucleus based on a GTP-dependent 
shuttling mechanism in RPE1 cells. 
 
 
 
 
 
 
 
 
 
 
2.2.3.4 MKLP1 does not localize to the nucleolus through a GTP-dependent shuttling 
mechanism 
 
As Kid was observed to change localization in response to decreased GTP levels, we inquired 
whether another nucleolar motor MKLP1 could also change its localization in response to 
decreased GTP levels. When varying concentrations of MPA were added to cells for 4 hrs, a 
change in MKLP1 nucleolar localization was not observed (Figure 2.10). This suggests that not 
all nucleolar-associating motors require a GTP-dependent shuttling mechanism, even though 
GTP binding sequences were found within the MKLP1 sequence.  
 
 
(A) Immunofluorescence analysis of Kid localization before (top row) or after MPA 
treatment (bottom row). (B) Quantitation of Kid localization in the nucleolus after a 4 hr 
treatment with various concentrations of MPA. (C) Immunoblot of RPE1 cells treated 
with varying amounts of MPA. (D) Immunofluorescence analysis of Kid localization 
before treatment with ribavirin (top row), after treatment with ribavirin for 4 hrs 
(middle row), or after a 4 hr treatment with ribavirin followed by a 4 hr treatment with 
guanosine (bottom row). (E) Quantitation of Kid localization in the presence of various 
concentrations of ribavirin  and/or guanosine. DAPI; Red, Kid. Green, fibrillarin. 
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Figure 2.10: MKLP1 is not regulated by a GTP-dependent shuttling mechanism. 
 
 
 
 
2.2.3.5 In cancer cells, Kid also localizes to the nucleolus through a GTP-dependent 
shuttling mechanism 
 
After treatment with MPA or ribavirin, the localization of Kid from the nucleolus to the nucleus 
appeared similar to the localization of Kid in cancer cells, UPCI:SCC103, as cancer cells contain 
high levels of nuclear Kid. We inquired whether the decreased localization of Kid to the 
nucleolus was due to reduced levels of GTP. To test this hypothesis, UPCI:SCC103 cells were 
RPE1 cells were treated with various amounts of MPA, prior to fixation and staining. 
Quantitation of MKLP1 localization in RPE1 cells after various concentrations of MPA 
treatment demonstrated no change in localization. 
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first treated with ribavirin for 4 hrs to cause the complete loss of nucleolar localization of Kid, 
followed by the addition of 300 µM of guanosine to cells for 4 hrs (Figure 2.11). This resulted in 
~80% of cells relocalizing Kid to the nucleolus in the cancer cell population Next, cells were 
treated with varying concentrations of guanosine to determine whether Kid would relocalize to 
the nucleolus in the cancer cells without first decreasing GTP levels more than the endogenous 
levels. UPCI:SCC103 treated with varying concentrations of guanosine (50 µM-1000 µM)  
actually doubled the percentage of Kid cells containing nucleolar localization (Figure 2.12A,B). 
Although this redistribution of Kid is significant, it still falls short of the untreated noncancer 
cells.  Thus, it appears that differences in GTP levels between cancer and noncancer cells can 
account for some of the observed differences in nucleolar localization; although,  additional 
mechanisms are likely exerting their control as well.  
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Figure 2.11: Kid localization to the nucleolus in UPCI:SCC103 cells increased after 
depletion of GTP levels and replenishment of GTP by guanosine. 
 
 
 
Quantitation of UPCI:SCC103 localization after cells were treated with Ribavirin for 4 
hrs (to deplete GTP levels in cells) and the re-addition of guanosine, at various 
concentrations (to increase GTP levels). 
  56 
2 hr
Control
2 hr
50µM
guanosine
DAPI Kid fibrillarin
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
0 50 100 150 200 250
Guanosine [µM]
Figure  2.12
A
B
%
 N
u
cl
eo
la
r 
K
id
 
 
  57 
Figure 2.12: UPCI:SCC103 cells increased localization to the nucleolus in the presence of 
guanosine. 
 
 
 
 
2.2.3.6 GTP-dependent shuttling mechanism of Kid extends to its mitotic function 
Given our exciting and novel findings regarding the dynamic localization of Kid to the nucleolus 
and particularly the mechanism by which the cell is able to control the localization of Kid, we 
sought to determine whether differing GTP levels could account for the known Kid deficient 
phenotype. Loss of Kid during mitosis leads to lagging chromosomes, misalignment of 
chromosomes along the metaphase plate and even lagging chromosomes during anaphase, as Kid 
is responsible for the force that pushes chromosome arms away from spindle poles (Funabiki and 
Murray 2000; Zhu, Zhao et al. 2005). Specifically, we inquired whether the mitotic defects 
known to occur after loss of Kid observed in cancer cells could be due to decreased GTP levels. 
To examine this, the noncancer RPE1 cells were treated with MPA for 4 hr after which mitotic 
defects were examined. Although Kid localization shuttled from the nucleolus to the nucleus 
during interphase, this did not interrupt Kid localization during mitosis (Figure 2.13A). 
Additionally, MPA treatment resulted in a ~5-fold increase in metaphase and anaphase defects, 
suggesting that decreased intracellular GTP levels can lead to defects during mitosis (Figure 
2.13B). Next, we sought to determine whether such defects observed in cancer cells could be 
corrected by elevating the intercellular GTP levels. UPCI:SCC103 cells treated with varying  
(A) Immunofluorescence analysis of UPCI:SCC103 cells treated with guanosine. (B) 
Quantitation of Kid nucleolar localization after various concentrations of guanosine 
were added for 2 hrs. DAPI; Red, Kid; Green, fibrillarin 
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concentrations of guanosine significantly decreased the metaphase mitotic defects; however, no 
difference was observed for  anaphase defects (Figure 2.14). Furthermore, this decrease of 
metaphase defects was linearly concentration-dependent, rather the curative effects of guanine 
seemed to plateau around 60 µM.  Interestingly, this data would suggest that our newly 
uncovered GTP-shuttling mechanism of Kid may extend to its traditional physiological mitotic 
function. 
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Figure 2.13: Kid mislocalization in interphase leads to increased mitotic defects in RPE1 
cells. 
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Figure 2.14: UPCI:SCC103 metaphase defects decreased with the addition of guanosine, 
while anaphase defects remained constant. 
 
 
(A) Kid localizes correctly during mitosis even though Kid did not localize to the 
nucleolus during interphase. Blue, DAPI; Red, Kid. (B) Top: Immunofluorescence of 
mitotic defects observed during mitosis, consistent with Kid function, when Kid was 
mislocalized during interphase. Bottom: Quantitation of mitotic defects in RPE1 with 
various concentrations of MPA to cause Kid mislocalization during interphase. 
50 mM of guanosine was added UPCI:SCC103 cells and mitotic defects were examined. 
Interestingly, increased GTP levels corrected various metaphase defects typically 
observed in UPCI:SCC103 cells, but did not correct anaphase defects. 
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2.3 DISCUSSION 
2.3.1 Why haven’t these motors been identified as nucleolar proteins previously? 
As there are over 700 proteins found to localization in the nucleolus (Andersen, Lam et al. 2005), 
it is not surprising that molecular motors, Kid, Eg5, and MKLP1, are also found to localize to the 
nucleolus. What is interesting though is that during the proteomic analysis of the nucleolus, these 
motors were not identified. This discrepancy can be explained by the fact that the proteomic 
profiling was completed in HeLa cells, which demonstrated very low percentages of Kid and 
MKLP1 in the nucleolus. Although Eg5 was found to localize to the nucleolus in HeLa cells 
>75% of the time, it is not surprising that Eg5 was not identified during the proteomic analysis. 
As I will discuss later in Chapter 4, Eg5 does not co-fractionate with pre-ribosomal subunits in 
the nucleolus, suggesting an unstable association with the nucleolus. Further evidence of a weak 
interaction by Eg5 was provided in Figure 2.5C, wherein Eg5 failed to cofractionate with the 
nucleus. An alternative interpretation of the data provided in Figure 2.5C is that association of 
Eg5 to the nucleolus may be highly sensitive to lysis conditions, resulting in loss of Eg5 
association.  
2.3.2 Kid has ATPase and GTPase activity 
The GTP-dependent shuttling mechanism of Kid regulating the localization is quite intriguing 
because microtubule motors are generally thought to function using their ATPase properties. The 
observation of a motor functioning in response to GTP levels is unique. The Walker A motif, is 
commonly found in the P-loop which is capable of ATPase or GTPase activity and is known to 
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bind and hydrolyze nucleoside triphosphates (Galinier, Lavergne et al. 2002). Although not 
unexpected, the identification of Kid being able to function in response to GTP is unprecedented. 
2.3.3 Kid shuttles from the nucleolus after treatment with clinical GTP inhibitors: 
implications in future studies 
It is quite interesting that Kid translocates from the nucleolus to the nucleus when treated with 
inhibitors to inosine monophosphate dehydrogenase. As GTP is a precursor of nucleic acid 
synthesis and its depletion can cause a reduction of DNA and RNA synthesis, an important 
question would be if nucleic acid synthesis inhibition could cause Kid translocation from the 
nucleolus to the nucleus; experiments which have not been completed but would prove useful for 
future analysis.  
Additionally, as these two drugs are used to decrease intracellular GTP levels in cells, 
they actually have clinically relevant uses for treatment of other diseases and disorders. MPA is 
typically used to inhibit organ transplant rejections as well as to manage autoimmune disorders 
such as systemic lupus, scleroderma, and pemphigus vulgaris (Surjushe and Saple 2008). 
Ribavirin is used as an antiviral drug to treat influenza, heptitus C infections, respiratory 
syncytial virus, as well as various other viral disorders (Chan-Tack, Murray et al. 2009). Thus, it 
would be of significant interest to study the change in Kid localization in response to either of 
these inhibitors in cell culture models of the above mentioned diseases. 
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2.3.4 Why does Kid not localize to the nucleolus in 100% of the cell population?  
Kid had been found to localize to the nucleolus greater than 85% of the time and to the nucleus 
approximately 15% of the time which led us to question exactly why Kid does not localize to the 
nucleolus in 100% of the cells. During the end of G1 and S phase, various nucleolar proteins, 
such as nucleophosmin, have been found to localize to the nucleoplasm (nucleus) (Chou and 
Yung 1995). This nucleoplasm localization is common because it is known that rRNA 
processing occurs mostly during the G1 and S phases;  as such, proteins like NPM have been 
found to be involved in rRNA processing and transport and shuttle  during G1 and S phases 
(Chou and Yung 1995). It is also plausible that during these processes, GTP levels decrease 
sufficiently to allow these proteins to shuttle out of the nucleolus and into the nucleoplasm to aid 
in their interphase functions. Thus it is tempting to speculate that given the shared localization 
within the nucleolus and shared distribution pattern of NPM, Kid may also function in rRNA 
processing and/or biogenesis. The cell cycle specific localization of Kid, demonstrating its 
nucleoplasmic localization during S-phase, will be further discussed in Chapter 3 section 3.2.1.4.   
2.3.5 Kid is observed to localize more to the nucleus in cancer cells because of 
upregulation of ribosome biogenesis 
Furthermore, as the nucleolar localization of Kid in UPCI:SCC103 cells was found to be 
obscured during interphase we believe this can be explained by noting that cancer cells have 
been shown to exhibit upregulation of ribosome processing, biogenesis, and production which 
leads to tumor progression (Belin, Beghin et al. 2009). Certain oncogenes and tumor supressors 
have been demonstrated to regulate ribosome processing; loss of these regulatory mechanisms 
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leads to strong upregulation of proteins involved in ribosomal biogenesis and maturation. For 
example, c-myc oncogene has been shown to activate RNA pol II, as well as RNA pol I and III, 
and overexpression of c-myc leads to elevated ribosome biogenesis, processing, and mRNA in 
those cancers (Oskarsson and Trumpp 2005). Additionally, the dysregulation of major tumor 
suppressor proteins Rb and p53 in cancer cells have been shown to induce strong activation of 
ribosome biogenesis in cancer cells (Trere, Ceccarelli et al. 2004).  Therefore, as cancer cells has 
been shown to upregulate ribosome biogenesis and processing, it seems that the obscured Kid 
nucleolar localization during interphase may be due to upregulation of these processes as Kid 
does play a role in ribosomal processing. 
2.3.6 Overexpression of Kid leads to cellular arrest 
Previously published data have demonstrated that in cancer cells ribosome assembly factors such 
as nucleophosmin are overexpressed (Ye 2005; Grisendi, Mecucci et al. 2006). This 
overexpression has been shown to increase cellular proliferation and inhibition of apoptosis 
leading to tumorigenesis.  However, in normal cells, NPM overexpression has been shown to 
lead to cellular arrest (Ye 2005), very similar to what we observed after Kid overexpression.  
Cellular arrest after Kid overexpression in RPE1, was surprising at first but in retrospect 
the cellular arrest observed was consistent with that observed of other ribosome assembly 
proteins which were overexpressed in noncancer cells. Therefore, in retrospect the 
overexpression of Kid plasmids should have been completed in cancer cells. Cancer cells were 
not chosen at first because it was thought that cancer and noncancer cells might have had 
different mechanisms of Kid localization. It was not until much later that it was demonstrated by 
the nucleolar fractionation data that the cancer and noncancer cells demonstrated nucleolar 
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localization of Kid because the diffuse localization of Kid in cancer cells obscured the nucleolar 
localization by immunofluorescence. Therefore, it would be quite interesting to revisit the 
overexpression studies of Kid in cancer cells, as they may be more tolerant of Kid 
overexpression. Additionally, we would hypothesize that Kid may function similar to other 
ribosomal proteins, such as NPM, and would increase cell proliferation, and lead to 
tumorigenesis but, this hypothesis requires further investigation.  
 
2.3.7 Stable Transfection of Kid in RPE1 cells 
After our overexpression studies were proved uninformative by means of transient transfections, 
we did try to stably overexpress Kid, in RPE1 cells using a Kid overexpression plasmid from 
Ohsugi, et al. (Ohsugi, Tokai-Nishizumi et al. 2003). Although 100% of the cells did take up the 
plasmid and did overexpress Kid approximately 10-15 times its endogenous level, we observed 
many phenotypes that we believed, at that time, cells were displaying atypical phenotypes. The 
phenotypes observed were: 
 
1) Rounding up of the cells, rather than a flat fibroblastic appearance 
2) Increase in cell proliferation 
3) Increase in nucleoplasmic localization of Kid, rather than nucleolar 
 
Because we did not have a control vector to compare our Kid overexpression cells to, we 
were unsure if overexpression of Kid resulted in the observed phenotypes or whether the stable 
transfection of the vector would cause these changes, as these changes we observed were 
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unexpected. However, after looking back and having more insight into the interphase function of 
Kid in ribosome biogenesis and translation, as will be discussed in Chapter 4 and 6, it is now 
very possible that the phenotypes observed were actually a result of overexpression of a 
ribosomal protein, Kid.  
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3.0  CHAPTER III: IDENTIFICATION OF KID FUNCTION IN RIBOSOME 
BIOLOGY 
3.1 INTRODUCTION 
As the nucleolus is the center of ribosome biogenesis and thus has to maintain ribosomal 
subunits to complete protein synthesis during the entire cell cycle, the nucleolus has evolved to 
respond to changes in cellular growth rate and metabolic activity (Boisvert, van Koningsbruggen 
et al. 2007).  Any alteration to the cellular status (DNA damage, cellular stress, or even infection) 
will signal the nucleolus to inhibit ribosome biogenesis in order to focus the energy of the cell on 
repairing the designated problem (Rubbi and Milner 2003; Mayer and Grummt 2005). As we 
have demonstrated in chapter 2, Kid localizes dynamically to the nucleolus and thus experiments 
of this chapter were completed to identify how Kid responds to different types of stress. That is, 
does Kid remain in the nucleolus at all times when the nucleolus is intact, or does Kid shuttle 
from the nucleolus in response to stress or damage?  
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3.2 RESULTS 
3.2.1 Changes in Kid localization 
3.2.1.1 Kid translocates from the nucleolus to the nucleus after UV-C treatment 
To begin to determine whether the nucleolar localization of Kid is altered in response to different 
cellular stresses, cells were first subjected to ultraviolet irradiation (UV). There are three 
different types of UV (UV-A, UV-B, and UV-C) and each subtype of UV corresponds to the 
specific wavelength range; UV-A (long wave) has a wavelength range of 400-315 nm, UV-B 
(medium wave) has a wavelength range of 300-200 nm, and UV-C (low wave) has a wavelength 
range of 280-100 nm. UV-C has been shown to induce significant cellular damage and produces 
DNA lesions, such as thymidine dimers, leading to single strand breaks (SSB) within the DNA 
duplex (Parrilla-Castellar, Arlander et al. 2004). RPE1 cells were exposed to varying amounts of 
UV-C, ranging from 10 Joules/meter2 (J/m2) to 100 J/m2, and were allowed to recover from 1-24 
hrs after treatment (Figure 3.1). Interestingly, Kid was observed to move out of the nucleolus 
within 1 hr after 10 J/m2 of UV-C treatment, while the control nucleolar protein nucleophosmin 
(B23/NPM) remained within the nucleolus. As 1 J/m2 of UV-C is sufficient to cause 40,000 
lesions per cell, it was decided to test lower levels of UV-C treatment to determine if Kid may 
also change localization in response to these lower levels (BEIRV 1990). Therefore, a lower dose 
of UV-C treatments (1-8 J/m2) were employed and were sufficient to also induce an alteration of 
Kid localization from the nucleolus to the nucleus (Figure 3.2). However after further analysis, 
although a change in Kid localization was always observed, the percentage of Kid nucleolar  
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Figure 3.1: Kid moves out of the nucleolus prior to nucleolar breakdown or NPM. 
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Nucleolar localization of Kid
Nucleolar localization of NPM
RPE1 cells  were subjected to various concentrations of UV-C treatment and were 
allowed to recover for 1-24 hrs during analysis.  Top graph represents change in Kid 
localization and the bottom graph represents NPM change in localization after the 
different UV-C treatments. Additionally, NPM began to leave the nucleolus at around 40 
J/m2, consistent with the literature and when nucleolar breakdown is shown to occur. 
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Figure 3.2: Kid localization after low amounts of UV-C treatment. 
 
 
 
 
 
As a change in Kid localization was observed after UV-C treatment and the damage 
exerted on the cells during the 10 J/m2 UV-C treatment were causing approximately 400,000 
lesions per cell, it was investigated whether the cell could recover from this damage and more 
importantly, whether Kid would relocalize to the nucleolus. Notably, the effects of UV-C 
damage on Kid nucleolar/nuclear localization was reversible, as Kid was found to completely 
relocalize to the nucleolus within 6 hrs after 10 J/m2 of UV-C treatment (Figure 3.1, top). 
Furthermore, a time course analysis of Kid localization following UV-C treatment revealed that 
RPE1 cells  were subjected to various concentrations of UV-C treatment (1-8 J/m2) and 
were allowed to recover for 1-24 hrs during analysis.  Kid change in localization after 
the low doses of UV-C  treatment proved to be inconsistent. 
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as little as 5 min after UV-C damage, was sufficient for Kid translocation from the nucleolus to 
the nucleus; suggesting that Kid rapidly alters its localization in response to cellular stress 
(Figure 3.3). 
Even at higher concentrations of UV-C treatment, such as 20 J/m2, Kid was determined to 
change localization from the nucleolus to the nucleus, while NPM remained within the nucleolus 
and thus suggesting that the nucleolus was still intact (Figure 3.4). Previously published data, as 
well as analysis of my experiments, determined that NPM was able to leave the nucleolus after 
~30-40 J/m2 of UV-C treatment (Lee, Smith et al. 2005). Furthermore, this treatment of UV-C 
was shown to cause loss of Kid prior to nucleolar disruption in RPE1 cells.  
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Figure 3.3: Kid changed localization from of the nucleolus within 5 min after UV-C 
treatment. 
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Time after 20 J/m2 of UV treatment
RPE1 cells were treated with 20 J/m2 of UV-C and were allowed to recover for 5 min-24 
hrs. Blue bars represent Kid nucleolar localization. 
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Figure 3.4: Time course and immunofluorescence analysis after 20 J/m2 of UV-C. 
 
 
 
 
3.2.1.2 Kid translocates from the nucleolus to the nucleus after UV-C treatment in a 
microtubule-independent manner 
 
Given the known motor function of Kid, we sought to address whether Kid alters its localization 
from the nucleolus to the nucleus by the use of microtubules. Cytoskeletal filaments, such as 
microtubules or actin, have never been found in the nucleus of mammalian cells, but their 
respective soluble components, β-tubulin and soluble actin, have been found within the nucleus. 
To determine whether the movement of Kid is dependent on the presence of microtubules, cells 
were treated with two different concentrations of nocodazole (0.1 µg/ml or 1 µg/ml) and were 
incubated for 1 hr prior to UV-C treatment (20 J/m2) after which time cells were allowed to 
recover from the UV-C treatment with or without nocodazole. The results of this experiment 
demonstrate that the movement of Kid out of the nucleolus as well as the relocalization of Kid 
occurs through a microtubule-independent mechanism, as the absence of microtubules at any 
time did not alter the anticipated localization of Kid (Figure 3.5).  
 
 
Top: RPE1 cells  were subjected to 20J/m2 and were allowed to recover from 1-24 hrs. 
Bottom: Quantitation of Kid and NPM shuttling from the nucleolus. Blue, DAPI; Red, 
Kid; Green, NPM. Kid was demonstrated to leave the nucleolus prior to NPM. 
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Figure 3.5: Kid staining decreases in the nucleolus after UV-C treatment in a microtubule-
independent manner. 
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Figure 3.5
Nocodazole
RPE1 cells were treated with or without nocodazole and/or 20 J/m2 UV-C treatment. 
Immunofluorescence analysis (top) demonstrates microtubule depolymerization and 
quantitation (bottom) represents Kid localization after UV-C treatment. 
Noco=Nocodazole 
  76 
3.2.1.3 Kid remains within the nucleolus after IR treatment 
 
Given that Kid changes localization in response to UV-C treatment, we sought to determine the 
generality of this effect by challenging the cells with another form of cellular stress, ionizing 
radiation (IR). IR is a form of radiation that can cause DNA double-strand breaks (DSBs) (Zha, 
Alt et al. 2007). When RPE1 cells were treated with 0.1-1.2 Gy of IR and were allowed to 
recover for 24 hrs, Kid was found to remain within the nucleolus (Figure 3.6); interestingly, the 
nucleolar localization of Kid seemed to increase significantly. Similar results were also obtained 
for another cell line, UPCI:SCC103 cells, an oral squamous carcinoma cell line. Next, Kids 
recovery after IR treatment was examined using 0.4 Gy of IR, as this treatment was determined 
to give the lowest amount of DSBs, as assessed by immunoflorescence analysis of phospho-
H2AX (Figure 3.7A).  After 0.4 Gy of IR, Kid was found to remain within the nucleolus for all 
time points tested (5 min-24 hrs), thus demonstrating that Kid translocation is not triggered by all 
forms of DNA damage (Figure 3.7B,C). Additionally, Kid localization actually increased to the 
nucleolus after ionizing radiation in two different cell lines tested. This increase of nucleolar Kid 
localization is consistent across both, cancer and noncancer cell lines. Comparing the basal 
nucleolar Kid localization, one can anticipate that if this was a true physiological response that 
the cancer cells could be induced to localize Kid similar to noncancer RPE1 cells.  Given that 
was not the case, the small increase is likely reflective of secondary effects caused by IR rather 
than changes in Kid activity.  
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Figure 3.6: : Kid remains in the nucleolus after IR treatment. 
 RPE1 and UPCI:SCC103 cells were treated with varying doses of IR and were allowed 
to recover for 24 hrs prior to fixation and staining.  No decrease in Kid staining was 
observed. 
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Figure 3.7: Kid localization after 0.4 Gy of IR. 
 
 
 
 
 
 
3.2.1.4 Kid localization inversely correlates with phospho-H2AX foci 
 
Interestingly, in the previous experiment, upon examination of untreated control cells stained 
with phospho-H2AX, a DSB marker, an inverse correlation was observed between Kid nuclear 
localization and phospho-H2AX staining. In untreated cells that contain one or very few 
phospho-H2AX foci, Kid retained its localization to the nucleolus; however, in cells that 
contained an abundance of phospho-H2AX foci, Kid was found to translocate from the nucleolus 
to the nucleus (Figure 3.8). This correlation was observed in multiple cell lines suggesting a 
general phenomenon. Examination of the literature revealed that the presence of phospho-H2AX 
foci in untreated cells that are in S-phase for one of three possibilities: 1) as a result of stalled 
replication forks at sites of damage that occur during normal replication,  2) during a block in 
replication when DNA polymerase is stalled, resulting in a Y-shaped DNA structure (Takahashi 
and Ohnishi 2005). This structure is recognized by a nuclease that nicks the template strand 
DNA near the blocking lesion resulting in a DSB, which is recognized by phospho-H2AX. 3) 
phospho-H2AX may recognize multiple SSB in close proximity to each other as DSB and 
therefore become upregulated (Takahashi and Ohnishi 2005). In either of these cases, the 
(A)Immunofluorescence analysis of DSBs in RPE1, as demonstrated by phospho-H2AX 
foci, after 0.4 Gy of IR and the indicated recovery listed above images. Red, Kid; Green, 
phospho-H2AX. (B) Quantitation of Kid localization in RPE1 and UPCI:SCC103 cells 
after IR treatment. And recovery. (C) Immunofluorescence of RPE1 cells during 
recovery after 0.4 Gy of IR. Blue, DAPI; Red,Kid; Green, fibrillarin. 
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upregulation of phospho-H2AX during S-phase along with the inverse correlation of nuclear Kid 
localization, implied that the 15% cells containing nuclear Kid were probably a reflection of cells 
in S-phase, thus, the localization of Kid maybe cell cycle dependent.  
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Figure 3.8: Inverse correlation between Kid localization and phospho-H2AX foci. 
 
 
 
 
In untreated RPE1 and UPCI:SCC103 cells, an inverse correlation was observed 
between Kid localization and phospho-H2AX foci; nuclear Kid was found in cells 
containing phospho-H2AX foci, while nucleolar Kid was in cells containing little to no 
foci. Blue, DAPI; Red, Kid; Green, phospho-H2AX. 
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3.2.1.5  Differences between UV-C and IR treatment 
 
As we observed opposite results for Kids response to the cellular stresses, UV-C and IR, we 
began to investigate the differences between these treatments. There are four known differences 
between IR- and UV-induced damage that may account for the differences observed in the 
experiments above: (1) UV damage causes SSB and is sensed through PARP-1 (poly (ADP-
ribose)-1) (de Murcia, Niedergang et al. 1997) and responded to by ATR (ATM- and Rad3-
related) (Garcia-Muse and Boulton 2005), while IR causes DSB is responded to by ATM (ataxia-
telangiectasia mutated) (Shiloh 2001), (2) UV inhibits transcription, whereas IR does not, (3) 
sufficiently high exposure of UV causes disassembly of the nucleolus while IR appears to have 
no effect on the nucleolus, (4) damaged DNA is repaired rapidly in response to IR treatment, 
whereas DNA damage response is slower in UV treatment due to the formation of bulky adducts 
(Parrilla-Castellar, Arlander et al. 2004).  
3.2.1.6  Kid remains within the nucleolus after H2O2 treatment to cause SSBs 
 
To begin to dissect the differences in Kid localization, SSBs and DSBs were examined in more 
detail. As UV-C treatment causes SSB, resulting in a redistribution of Kid from the nucleolus to 
the nucleus, while IR causes DSBs and exerts no effect on the localization of Kid, we sought to 
determine if Kid is responding to the presence of SSB. Hydrogen peroxide (H2O2) treatment is 
known to cause SSBs at low doses (< 30 mM) and DSBs at high doses (>30 mM) leading to 
oxidative stress and DNA base damage (Dahm-Daphi, Sass et al. 2000; Karmakar and Bohr 
2005). Therefore, cells were treated with low doses of 0.1 mM and 0.5 mM of H2O2 for 10 and 
30 min, followed by a 1 hr recovery and immediate fixation. Interestingly, Kid localization 
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remained almost unchanged; a small 20% reduction was observed, but was not similar to the 
effect seen after UV-C treatment causing SSBs (Figure 3.9). Therefore, it seems as though Kid 
may be responding to a secondary effect of the UV-C treatment rather than directly localizing in 
response to the presence of SSBs.  
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Figure 3.9: Kid localization in response to H2O2 treatment. 
 
 
 
 
RPE1 cells were treated with either 0.1 or 0.5 mM of H2O2 for 10 min or 30 min, 
followed by a 1 hr recovery. Blue, DAPI; Red, Kid; Green, Phospho-H2AX.  
Immunofluorescent images are shown above and quantitation of Kid nucleolar 
localization is below. No change in Kid localization was observed after DNA breaks were 
induced by H2O2. 
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3.2.1.7 Kid does not localize to the site of DNA damage 
 
We next determined if Kid may be localizing in response to sites of DNA damage. In these 
experiments, a filter containing an 8 µm pore membrane was placed on top of a coverslip 
containing cells and was exposed to UV-C. The size of the pores are so small that most of the 
cell will be covered by the membrane except for a small 8 µm area. If Kid was a DNA damage 
response protein, then in the presence of the damage, Kid would robustly localize to the area of 
the cell that was exposed to the damage in order to begin to repair the damage. The dosage of 
UV used varied from 10-80 J/m2, and cells were allowed to recover from 5 min to 4 hrs, after 
which cells were fixed and stained with antibodies to Kid or cyclopyrimidine dimers (CPD), 
bulky adducts that form after UV treatment. First, we analyzed the localization of Kid in 
response to this treatment with cells that contained only one CPD lesion within the nucleus; in 
each of these cases, Kid did not to shuttle, move or localize to these sites of damage, therefore 
arguing against the interpretation that Kid may change localization in response to DNA damage 
only in the nucleolus. (Figure 3.10).  We next investigated whether Kid may function as a 
general cellular stress sensor by examining cells with more than one lesion per nucleus. In each 
of the 300 cells examined, Kid retained localization within the CPD region unless, the CPD 
region was found to occur within the nucleolus. When a CPD dimer was found in the nucleolus, 
we found Kid to no longer localize there; hence, Kid may respond to this damage specifically in 
the nucleolus by reducing its presence in the nucleolus.  
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Figure 3.10: Kid does not localize to sites of DNA damage. 
 
 
 
 
3.2.1.8 Cells are more sensitive to UV-C treatment after Kid knockdown 
 
Next, we inquired whether cells may be more sensitive to UV-C treatment (i.e., DNA damage) 
after Kid knockdown. Cells were treated with siRNA constructs targeted against Kid for 72 hrs 
prior to being treated with 5-200 J/m2 of UV-C, after which cells were allowed to recover for up 
to 24 hrs and an MTS cell proliferation assay was completed. Although general trends did 
emerge from this experiment such as at doses between 100-200 J/m2 little to no change in 
viability is observed between siControl and siKid. Additionally, at lower doses of 5-80 J/m2, a 
20-50% reduction in cell proliferation was observed after Kid knockdown. However the results 
Localized UV-C damage experiments were conducted by placing an 8 micron pore 
membrane on top of a glass coverslip, prior to UV-C treatment. Cells were fixed 1 hr 
after UV-C, and were co-stained for Kid or CPD.  
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of the experiments were difficult to interpret due to variability in Kid localization; this result can 
likely be attributed to cellular arrest due loss of Kid (Figure 3.11).  
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Figure 3.11: RPE1 cells are more sensitive to UV-C damage after Kid knockdown. 
 
 
 
 
3.2.1.9 Kid translocated from the nucleolus after caffeine treatment 
 
Next, another type of DNA damage treatment was used, caffeine when used at low 
concentrations is a known inhibitor of PI3K, which in turn inhibits ATM/ATR and the DNA 
damage response pathway, and at high concentrations to cause DNA strand breaks(Araya, Hirai 
Left: Kid was knocked-down for 72 hrs in RPE1 cells prior to treatment with various 
doses of UV-C and completion of the MTS cell proliferation assay. Untreated cells and 
H2O2 treatment were used as positive controls for this experiment. Right: 
Immunoblotting demonstrating equal loading and Kid knockdown. 
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et al. 2005). Therefore, we inquired how Kid would respond to these DNA strand breaks. Cells 
were treated for 1 hr with 4 mM of caffeine, prior to fixation and staining. Interestingly, as 
observed with UV treatment, Kid changed localization from the nucleolus to the nucleus, 
suggesting that Kid localization to the nucleolus is quite sensitive to damage within the nucleolus 
(Figure 3.12).  
 
 
no caffeine 
Kid NPM
1.5 h caffeine
20 J/m2
UV-C only 
Figure 3.12
 
 
 
 
  88 
Figure 3.12: Caffeine treatment causes Kid to change localization. 
 
 
 
 
 
3.2.2 Kid translocates from the nucleolus in a p53-independent manner 
As we have shown Kid localizes to the nucleolus >80% in normal cells, while in cancer cells Kid 
localizes to the nucleolus <35% of cells. As a common feature of a great majority of cancer cell 
lines is loss or mutated p53 (Collins, Jacks et al. 1997) especially within DNA binding sites, we 
first inquired whether Kid localization to the nucleolus was dependent on p53 and secondly, if 
Kid shuttling from the nucleolus to the nucleus after UV treatment was dependent on p53. To 
investigate the first question, we used mouse embryonic fibroblast cells, proficient or deficient in 
p53. Kid was found to localize to the nucleolus in both p53+/+ cells and p53-/- cells. There was a 
15% decrease in the number of cells localizing to the nucleolus in p53-/- cells, but it was 
insignificant, therefore suggesting that Kid localizes to the nucleolus in a p53-independent 
manner and this cannot account for the difference observed in noncancer versus cancer cells 
(Figure 3.13). 
 
 
 
 
RPE1 cells treated with or without 4 mM caffeine for 1.5 hrs , followed by fixation, 
staining, and quantitfication. Images demonstrate similar diffuse localization as UV-C 
treatment. 
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Figure 3.13: Kid localization to the nucleolus and Kid’s shuttling ability after UV-C 
treatment is independent of p53. 
 
 
 
3.2.3 Kid translocates from the nucleolus after RNA pol I inhibition 
 
As we previously identified that Kid is not responding to a specific type of DNA damage, SSBs 
or DSBs, it is possible that Kid is responding to a secondary effect caused by the UV-C damage 
within the nucleolus. Therefore, we sought to investigate the hypothesis that Kid changes 
localization in response to transcriptional inhibition in the nucleolus. As mentioned previously, 
as a difference between UV-C and IR treatment is that UV-C inhibits transcription, whereas IR 
does not (Parrilla-Castellar, Arlander et al. 2004). Response to transcriptional inhibition within 
Mouse embryonic fibroblasts proficient or deficient in p53 were subjected to UV-C 
treatment and allowed to recover for 1-6 hrs. Blue bars=MEF; Red Bars=p53 -/-. 
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the nucleolus finds support in the localized UV-C treatment experiments wherein Kid only 
altered its localization in response to damage with the nucleolus, while remaining within the 
CPD foci when the damage occurred in the nucleus. Consequently, we used two different 
transcriptional inhibitors to test this hypothesis. The first was actinomycin D which is an 
inhibitor of RNA polymerase I, the main polymerase that transcribes rRNA with the exception of 
the 5S rRNA (Shcherbik, Wang et al. 2010). The second is the RNA polymerase II inhibitor α-
amanitin. RNA polymerase II transcribes all nonribosomal genes (Lindell, Weinberg et al. 1970). 
α -amanitin when used at concentrations lower than 1 µg/ml preferentially inhibits RNA 
polymerase II; however at high concentrations (>1 µg/ml) inhibition of RNA polymerase III is 
observed. RNA polymerase III is responsible for the transcription of 5S rRNA, tRNAs and other 
small RNAs. 
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3.2.3.1 Kid translocates from the nucleolus after actinomycin D treatment 
 
Cells were treated with varying concentrations of actinomycin D, ranging from 0.01 to 1 µg/ml 
and as previously published data suggests, higher concentrations of actinomycin D will not only 
inhibit RNA polymerase I, but it will also lead to nucleolar breakdown, as once ribosomal RNA 
transcription is completely inhibited, the nucleolus will break apart (Misteli 2003). In RPE1 
cells, nucleolar breakdown began to occur at concentrations above 0.5 µg/ml, as fibrillarin, the 
nucleolar control, began to relocalize with the granular component of the nucleolus rather than 
the fibrillar center. Such loss of localization is suggestive of loss of nucleolar integrity.  
Interestingly, while observing Kid localization in response to actinomycin D, with concentrations 
as low as 0.01 µg/ml, Kid was found to leave the nucleolus in response to RNA polymerase I 
inhibition, suggesting that inhibition of nucleolar transcription is a signal for Kid to leave the 
nucleolus (Figure 3.14). 
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Figure 3.14: Kid was no longer concentrated in the nucleolus after RNA pol I inhibition. 
 
 
 
 
 
3.2.3.2 Kid remains within the nucleolus after α -amanitin treatment 
 
We next investigated whether Kid also changes localization in response to α -amanitin treatment 
using three different concentrations and two different time points of 1 hr or 3 hrs of treatment. 
Interestingly, at concentrations known to preferentially inhibit RNA polymerase II (less than 1 
µg/ml) (Lindell, Weinberg et al. 1970), Kid remained within the nucleolus. However, at 
concentrations greater than 1 µg/ml, we observed a 10-20% loss in Kid nucleolar localization 
(Figure 3.15). The known loss selectivity of α -amanitin at these concentrations could suggest 
that Kid is responding to inhibition of RNA pol III, the polymerase involved in rRNA synthesis 
of the 5S rRNA. Therefore these experiments are consistent with changes in Kid localization 
from the nucleolus to the nucleus in response to transcription inhibition of rRNA.  
 
RPE1 cells were treated with actinomycin D, to inhibition RNA pol I. for 30 min, 
followed by fixation and staining. Top represent images after treatment, bottom 
represents quantification of Kid nucleolar localization (blue bars) or fibrillarin (red 
bars). Blue, DAPI; Red, Kid; Green, fibrillarin. 
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Figure 3.15: Kid remained within the nucleolus after RNA pol II inhibition. 
 
 
 
 
3.2.4 Kid is dephosphorylated after UV-C treatment 
Two-dimensional gel electrophoresis was used in the presence or absence of UV-C treatment in 
order to identify post-translational modifications of Kid that may occur under the same 
conditions which induced a change in nucleolar localization. Cells were treated with or without 
20 J/m2 of UV-C treatment, followed by a 1 hr recovery, prior to subjection to 2D gel 
electrophoresis and subsequent western blot analysis. Interestingly, in the absence of UV-C 
treatment, 3-5 different bands representing Kid were observed (Figure 3.16A).  These bands 
ranged in pI from 3-10, suggesting that under normal homeostasis, Kid contains various post-
Cells were treated with various amounts of alpha-amanitin for 1 or 3 hrs to inhibit RNA 
pol II or mRNA transcription. After treatment, cells were fixed and stained for Kid and 
fibrillarin. 
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translational modifications. However, after the 20 J/m2 of UV-C treatment, followed by a 1 hr 
recovery, the bands corresponding to Kid uniformly shifted to a pI of 10 representing basic or 
more negative post-translational modifications (Figure 3.16B). This shift in the pI of the protein 
occurs under conditions known to cause Kid translocation to the nucleus. 
 Next, as Kid is known to contain various sites for phosphorylation, we inquired whether 
this shift to a more negative state was due to phosphorylation of Kid after UV-C treatment. 
Therefore, cells were treated with and without shrimp alkaline phosphatase (SAP) in the 
presence and absence of UV-C treatment (Figure 3.16C). Interestingly, the changes observed in 
the presence of SAP indicated that the prominent form of Kid is dephosphorylated after UV-C 
treatment (corresponding to the band at a pI of 10). It is an open question as to whether this 
dephosphorylation event triggers the translocation of Kid or whether the Kid translocates to the 
nucleus and becomes dephosphorylated.  
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Figure 3.16: Kid is phosphorylated in the nucleolus. 
 
 
 
 
2D gel electrophoresis before (A) or after(B) UV-C treatment or after phosphatases (C) 
treatment. B and C look similar suggesting that Kid is dephosphorylated after UV-C 
treatment, when it is found in the nucleus.  
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3.3 SUMMARY 
Collectively the sum of this data demonstrates that Kid localizes to the nucleolus only during 
conditions of rRNA gene transcription. Therefore, suggests that Kid likely functions in the 
ribosome pathway, rather than DNA damage or other types of stress response.  
3.4 DISCUSSION 
3.4.1 Kid function in ribosomal biology 
As this data demonstrate Kid changes localization in response to rRNA transcription, it is 
hypothesized that Kid may play a role in ribosome biogenesis, similarly to NPM (Lim and Wang 
2006). As Kid does contain a nucleic acid-binding domain, which has been shown to bind DNA 
during mitosis (Tokai, Fujimoto-Nishiyama et al. 1996), it is very plausible that Kid can also 
bind RNA or pre-ribosomes during interphase, especially given that Kid is found to localize 
where rRNA transcription and processing takes place. The function of Kid is demonstrating to be 
quite similar to NPM is more ways than one, which was discussed in Chapter 2 and was further 
discussed in Chapter 3, and it is interesting that Kid may function in similar roles as NPM in 
ribosomal processing and even transport. The similarities between Kid and NPM include: 
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1) They localize to the same part of the nucleolus. 
2) They both utilize a GTP-dependent shuttling mechanism. 
3) Localization of both of these proteins are cell-cycle dependent, such that during S-
phase they localize outside of the nucleolus. 
4) They both co-fractionate with pre-ribosomes (as will be discussed in chapter 4). 
5) Both localize to chromosome arms during mitosis (Okuwaki, Tsujimoto et al. 2002).  
6) Both are required for congression of chromosomes and proper mitotic spindle 
formation (Amin, Matsunaga et al. 2008).  
7) Both are phosphorylated by cdc2 at the onset of mitosis (Okuwaki, Tsujimoto et al. 
2002).  
 
As NPM is involved in ribosomal processing and even transport, it is very possible that 
Kid performs the same or very similar function as NPM. 
Furthermore, as Kid is found to also localize to where the rRNA genes are located, future 
experiments using chromatin immunoprecipitation experiments would prove useful to identify if 
Kid may bind to the rRNA genes, similar to NPM.   
3.4.2 Kid as a proliferation marker? 
It is interesting to note that when cells are greater than 90% confluent, we have found that cells 
enter senescence, and during this time Kid becomes degraded (Figure 3.17). Senescence was 
determined by proliferation marker Ki67 and Kid by immunoblotting. Therefore experiments 
with Kid should always be completed with subconfluent populations of cells.  
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Figure 3.17: Kid levels decrease when cells are over confluent. 
 
 
 
 
 
 
 
RPE1 cells were grown and lysed at 70%, 90% or over 100% confluency. These lysates 
were run on 10% SDS-PAGE gels and subjected to immunoblotting. 
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4.0  CHAPTER IV:  IDENTIFICATION AND CHARACTERIZATION OF 
MICROTUBULE MOTOR EG5 FUNCTION IN SUPPORT OF THE RIBOSOMES 
PROCESSIVITY 
4.1 INTRODUCTION 
As discussed in chapter 3, the localization of Kid changes in response to DNA damage and 
inhibition of transcription in the nucleolus, thus it seems Kid’s localization may depend on 
ribosome biogenesis. To determine whether Kid functions in this process, we began examining 
whether Kid, along with the other nucleolar-associating motors Eg5 and MKLP1, may associate 
with the pre-ribosomal subunits via fractionation of the nucleus. 
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4.2 RESULTS 
4.2.1 Functional association of nucleolar-associating motors with various ribosomal 
subunits 
4.2.1.1 Association of nucleolar-associating motors with pre- and/or mature ribosomes 
 
Nuclear lysates from 30 million RPE1 cells were layed on a 10-25% sucrose gradient before 
being centrifuged and collected in one milliliter fractions with constant monitoring at an 
absorbance of 260 nm. Each fraction was TCA-precipitated and subjected to immunoblot 
analysis. In this assay, Kid was found to co-fractionate with both the pre-40S and pre-60S 
ribosomal subunits, as confirmed by co-localization with the ribosomal protein S7 (rpS7), which 
is part of the pre-40S ribosome, and NPM, which is a component of the pre-60S ribosome (Yu, 
Maggi et al. 2006) (Figure 4.1A); it should be noted that rpS7 was found co-fractionating with 
the pre-40S and pre-60S subunits, but this is not uncommon, as ribosomal proteins sequences are 
quite similar and antibody cross-reactivity between different subunits is frequently observed 
(Bartsch 1985). Under the same fractionation conditions, MKLP1 was found to co-fractionate 
with pre-60S, while Eg5 was not detected in the nuclear extracts. These results can be 
rationalized by noting the subnucleolar localization of each motor. Antibodies to both Kid and 
MKLP1 reacted strongly with the nucleolus, while antibodies to Eg5 bound less efficiently. Thus 
the absence of Eg5 from the pre-ribosomal subunits was not entirely unexpected.   
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As Kid and MKLP1 co-fractionated with pre-ribosomal subunits, we sought to determine 
if any of the nucleolar motors may also associate with mature cytoplasmic ribosomes, where 
translation occurs.  Accordingly, whole cell lysates from 30 million RPE1 cells were layed on 
10-25% sucrose gradients, centrifuged, fractions were collected, TCA-precipitated and 
immunoblotted as described above previously. After immunoblot analysis, Kid and Eg5 were 
found to co-fractionate with the 40S, 60S, 80S, and polysomal fractions, while MKLP1 was 
found to co-fractionate with the mature 60S ribosome Figure 4.1B); Eg5 co-fractionation with 
polysomes can be better observed in Figure 4.1C. In addition, all of the Eg5 protein was found to 
co-fractionate with the ribosomes, as none of the Eg5 was found in the discarded DNA pellet, 
(data not shown) while a majority of the Kid associated with both the ribosomes and the DNA 
pellet. This data demonstrates that these motors remain associated with the ribosomes during 
translation. We believe Eg5, MKLP1, and Kid are pioneering members of a new class of motors,  
the ribosomal motors. However it is important to note that not all proteins or motors co-
fractionate with ribosomes, as two other proteins tested, cytoskeletal actin and the microtubule 
motor dynein, were found to not co-fractionate with ribosomes (Figure 4.1B).  
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Figure 4.1: Eg5, Kid and MKLP1 co-fractionate with ribosomes. 
 
 
 
 
 
 
(A) RPE1 nuclear fractions were layed on a 10-25% sucrose gradient, centrifuged, and 1 
mL fractions were collected with constant monitoring at an absorbance of A260. RPS7, 
represents the pre-40S subunit, and NPM, represents the pre-60S subunit. (B) RPE1 
whole cell lysates were layed on a 10-25% sucrose gradient, centrifuged, and 1 mL 
fractions were collected with constant monitoring at an absorbance of A260. rpL4 and 
NPM represents the 60S subunit; actin and dynein are negative controls. (C)  Left:  
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4.2.1.2 rpS5 and rpL10A co-immunoprecipitate with Eg5 
 
To further confirm the association of Eg5 with the ribosomal subunits immunoprecipitation (IP) 
studies were conducted. IP-enrichment of Eg5 from whole cell lysates validated the association 
between Eg5 and the various mature ribosomal subunits, wherein rpS5 represents a marker for 
the 40S ribosome, and rpL10A represents a marker for the 60S ribosome (Figure 4.1D). This 
confirms the association of Eg5 with ribosomes in addition to the immunofluorescence analysis 
of co-localization between Eg5 and rpS7 (Figure 4.1E). Because of the availability of inhibitors 
and the well-studied view of this motor, from this point on, the majority of our studies for this 
chapter will be focused on the Eg5 ribosomal motor.  
 
 
Figure legend 4.1 continued:  Polysome profile of control RPE1 cells. Right: Polysome 
fractions from polysome profile (on right) and immunoblot of Eg5 and rpS5 found in the 
polysomal fractions. D rpS5 (left), rpL10A (middle), co-immunoprecipitated with Eg5. 
Right: Eg5 IP demonstrating co-IP with rpS5, and a MYPT1 negative control did not 
co-fractionate with Eg5, lane two. E Immunofluorescence of co-localization between Eg5 
(red), rpS7 (green), and DAPI (blue).  
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4.2.2 Protein synthesis is decreased after loss of Eg5 
4.2.2.1 In vivo 35S Met/Cys translation incorporation assays 
4.2.2.2 Protein synthesis is decreased in whole cell lysates after loss of Eg5 
 
As we observed that Eg5 associates with mature ribosomal subunits, we wanted to determine 
whether Eg5 participates in translation. To begin, 35S methionine and cysteine (35S Met/Cys) 
incorporation assays were employed to measure the rate of newly synthesized proteins  
in the presence or absence of Eg5. DMEM media without methionine and cysteine was added to 
the cells in the presence of 100 µCi of 35S Met/Cys for 30 min, followed by the addition of 
cycloheximide to inhibit translation and by cell lysis in RIPA buffer, resulting in whole cell 
lysates (WCLs). Interestingly, 24 hrs after Eg5 knockdown with a siRNA targeting to the C-
terminus of the Eg5 gene (siRNA #1), a 40% decrease in protein synthesis was observed (Figure 
4.2A). In order to ensure that this decrease in protein synthesis after Eg5 knockdown was not due 
to off-target effect exerted on cells by the siRNA, a well-established Eg5 inhibitor, monastrol, 
was used. Monastrol is a chemical inhibitor of Eg5 that binds to the motor domain of Eg5 and 
inhibits the ATPase activity of Eg5, therefore preventing Eg5 from translocating on microtubules 
(Mayer, Kapoor et al. 1999; Kapoor, Mayer et al. 2000). Monastrol can arrest cells in mitosis at 
pro-metaphase resulting in monopolar spindles as early as 4 hrs after treatment. Therefore, 35S  
Met/Cys incorporation assays were completed 4 hrs after monastrol treatment to inhibit Eg5’s 
ATPase activity prior to significant mitotic arrest. Monastrol treatment resulted in a 60% 
decrease in newly synthesizing proteins in WCLs (Figure 4.2B). Additionally, when monastrol 
was washed out and cells were allowed to recover for an additional 4 hrs, protein synthesis 
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returned back to DMSO control levels. This data demonstrates that loss of Eg5, by inhibition or 
knockdown, results in decreased protein synthesis in RPE1 cells and it also reveals that the 
ATPase activity of Eg5 is needed for its function during translation.  
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Figure 4.2: Loss of Eg5 causes a defect in protein synthesis of WCLs. 
 
 
 
 
 
 
 
4.2.2.3 Decreased protein synthesis after loss of Eg5 is observed in multiple cell lines 
 
We next inquired whether the observed decrease in translation efficiency after Eg5 inhibition 
was cell line specific or if it was a general effect observed in a variety of cell lines from different 
cellular backgrounds. Therefore, three different noncancer and seven different cancer cells were 
chosen for this analysis. After a 4 hr treatment with monastrol, 35S  Met/Cys was added to cells 
prior to cell lysis. Loss of Eg5 activity was found to decrease translation(~30-60%) in each of the 
noncancer and four out of the seven cancer cell lines (Figure 4.2C); thus, demonstrating that the 
function of Eg5 in translation is not a cell line or cell type specific phenomena. The cancer cells 
that were resistant to Eg5 inhibition will be discussed further in section 4.3.1.  
4.2.2.4 Both membrane and cytosolic protein synthesis was decreased after loss of Eg5 
 
The use of WCLs to measure the decrease of newly synthesizing proteins after inhibition of Eg5 
ignores the fact that proteins can be translated in two different compartments. Thus, we inquired 
35S Met/Cys incorporation assays completed after (A) a 24 hr knockdown of Eg5  in 
RPE1 cells, (B) after a 4 hr monastrol  or 4 hr monastrol washout in RPE1 cells, (C) or 
after a 4 hr monastrol treatment in a variety of cell lines.  Immunoblot shown below for 
knockdown and even loading. CHX, used as a positive control. Results are shown as 
mean ± s.d. and are representative of at least three independent experiments, P values 
represent students’ t-test. 
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whether Eg5 may facilitate translation of either cytosolic or membrane proteins, or both. 
Therefore 24 hrs after knockdown of Eg5, by siRNA #1, or after a 4 hr treatment with monastrol, 
35S  Met/Cys was added to the cells prior to cell lysis; after cell lysis the cytosolic and membrane 
proteins were separated by centrifugation, and subjected to analysis. Interestingly, a significant 
40-50% decrease in protein synthesis was observed in both the cytosolic and membrane proteins 
(Figure 4.3A,B). A second siRNA (#2) targeted to the N-terminus of the Eg5 gene resulted in a 
similar decrease in protein synthesis in both cytosolic and membrane proteins, thus confirming 
the findings that Eg5 facilitates translation of both cytosolic and membrane proteins (Figure 
4.3C).  
It is interesting to note that similar experiments were initially attempted with trypsinized 
cells left in suspension after knockdown of Eg5. Intriguingly, a marked reduction in newly 
synthesized proteins was observed, greater than 80%, but such a change was only observed in the 
cytosolic fraction (Figure 4.4). Although these results are interesting, we feel that the use of 
adherent cells is more likely to reflect the typical cellular physiology and thus have not pursued 
the detached translation assays any further.  
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Figure 4.3: Protein synthesis of cytosolic and membrane proteins are reduced after Eg5 
knockdown or inhibition. 
 
 
 
 
 
 
 
35S Met/Cys incorporation assays completed (A) after a 4 hr monastrol treatment or (B) 
24 hr Eg5 knockdown with siRNA #1 or (C) siRNA #2 in RPE1 cells after fractionation 
into cytosolic and membrane proteins. Immunoblots are shown below for knockdown of 
Eg5, equal loading, and fractionation. Calnexin is a marker for ER proteins, and 
GAPDH is used as a marker for the cytosolic fraction.  CHX was used as a positive 
control. Results are shown as mean ± s.d. and are representative of at least three 
independent experiments, P values represent students’ t-test. 
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Figure 4.4: Reduction in protein synthesis of cytosolic, but not membrane proteins after 
Eg5 knckdown in suspended cells. 
 
 
 
 
Left. 35S Met/Cys incorporation assays completed in suspended cells after a 24, 48, or 72 
hrs of Eg5. Supernatant fractions, representing the cytosolic proteins are shown on the 
left. Middle: The pellet fractions, Right: controls for the translation assays. CHX was 
used as a positive control. 
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4.2.3 Decrease in protein synthesis is specific to Eg5 
Next to provide additional lines of evidence that the decrease in  protein synthesis after Eg5 
knockdown or treatment with monastrol was due to on-target effects, we performed the same 35S  
Met/Cys experiment after a 24 hr Eg5 knockdown by siRNA #1 and followed it by treatment 
with monastrol for 4 hr. The rationale for this experiment is that if the decrease in protein 
synthesis observed after monostrol treatment is indeed specific to inhibiting Eg5, then one would 
anticipate that removing the target protein by siRNA knockdown of Eg5 would not exert any 
further decrease in translation efficiency. Gratifyingly, after knockdown of Eg5 and subsequent 
monastrol treatment no greater decrease in protein synthesis was observed in addition to the 60% 
caused by knockdown of Eg5 (Figure 4.5). From these results, as well as the decrease in 
translation after the use of two different siRNAs and a small molecule inhibitor to Eg5,  
demonstrate that the decrease in translation is specific to loss of Eg5 activity.  
Previously published data has suggested that prolonged exposure to Eg5 inhibition (by 
small molecule inhibition or by knockdown) will result in an elevated mitotic index and 
apoptosis (Chin and Herbst 2006). If the knockdown and/or small molecule inhibition of Eg5 in 
our experiments were causing apoptosis/cell death or an elevated mitotic index, this would result 
in decreased protein synthesis as during either of these circumstances, protein synthesis seizes. 
Therefore, to test whether the decreased protein synthesis observed after Eg5 knockdown was a 
primary result of loss of Eg5 or a secondary effect of cell death or an elevated mitotic index, 
several assays were completed including MTS cell proliferation assay, mitotic index analyses, 
and immunoblotting for caspase 3 cleavage. 
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Figure 4.5: Reduction in protein synthesis after loss of Eg5 is not due to off target effects. 
 
 
 
 
 
 
 
4.2.3.1 Mitotic index does not increase after loss of Eg5 
 
First we investigated whether an increase in the mitotic index was observed after Eg5 
knockdown or monastrol treatment and whether this could be responsible for the decrease in 
24 hrs after knockdown of Eg5, cells were treated with or without monastrol. No greater 
decrease in protein synthesis was observed after treatment with both, Eg5 knockdown 
or monastrol, in comparison to treatment with monastrol or knockdown of Eg5 
independently. Results are shown as mean ± s.d. and are representative of at least three 
independent experiments, P values represent students’ t-test. 
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protein synthesis. It is well-established that during mitosis protein synthesis is inhibited (Fan and 
Penman 1970; Sivan, Kedersha et al. 2007). Therefore, a time course analysis was completed 
after Eg5 knockdown with siRNA #1 where cells were fixed and stained with DAPI for 
visualization of nuclei and counted for the mitotic index at 24, 48, and 72 hrs after knockdown. 
24 hrs after Eg5 knockdown, an increase in the mitotic index was not observed; time points at 48 
or 72 hrs knockdown of Eg5 did cause a 50% increase in the mitotic index. Although this 
increase is consistent with previous literature precedent (Chin and Herbst 2006), these later time 
points are not a concern as the time point used for translational inhibition was 24 hrs (Figure 
4.6A). Next, mitotic index was examined after a 24 hrs after Eg5 knockdown with siRNA #1 or 
siRNA #2 or after a 4 hr monastrol treatment. In these experiments an increase in the mitotic 
index was not observed after Eg5 knockdown by siRNA #1, as demonstrated above, or after 
monastrol treatment (Figure 4.6B). Although it should be noted that a slight increase of ~15% 
was observed in the mitotic index after Eg5 knockdown by siRNA #2, however this 15% 
increase could not account for ~40% decrease in protein translation that was observed; therefore 
an increase in the mitotic index after loss of Eg5 can likely be ruled out as a possible reason for 
the decrease in protein synthesis.  
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Figure 4.6: Reduction in protein synthesis after loss of Eg5 is not due to an increase in the 
mitotic index. 
 
 
 
 
 
(A) 24 hrs after Eg5 knockdown by siRNA #1 or #2 or even monastrol treatment did not 
cause a large increase in the mitotic index. (B) Time course analysis of Eg5 knockdown 
in RPE1 cells 24, 48, or 72 hrs. Results are shown as mean ± s.d. and are representative 
of at least three independent experiments, P values represent students’ t-test. 
  116 
4.2.3.2 Cell proliferation does not decrease after loss of Eg5  
 
Next, the MTS cell proliferation assay is a colorimetric assay wherein metabolically active cells 
convert reduced tetrazolium compounds to a soluble colored formazan product utilizing NADPH 
as a cofactor (Berridge, Herst et al. 2005). In order to identify if the decreased protein synthesis 
was due to decreased cell proliferation, cells were treated with siRNA #1 targeted to Eg5 for 24, 
48 or 72 hrs (Figure 4.7A, B). At the time point of 24 hrs, which was the time used to complete 
the translation assays, a decrease in cell proliferation was not observed. However, we did 
observe an expected decrease in cell proliferation after the later time points following 
knockdown of Eg5. The later time point data is of a lesser concern because the translation assays 
were completed at 24 hr after knockdown which is a time when no decrease in cell proliferation 
is observed. Additionally, a second siRNA targeted to Eg5 was also employed and 24 hrs after 
Eg5 knockdown cell proliferation did not decrease (Figure 4.7B). Finally, monostrol treatment 
was also examined for a decrease in cell proliferation. In this case, 4 hrs after monastrol 
treatment, a 40% decrease in protein proliferation was initially observed, however after a 4 hr 
washout, cell proliferation recovered and returned to similar levels as control cells. This suggests 
that although there was a reduction in cell proliferation after an acute monastrol treatment, the 
decrease was not due to cell death as the cells recovered. Rather it is likely that after monastrol 
treatment, a reduction in cellular metabolism was observed similar to what is expected when 
translation is inhibited. 
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Figure 4.7: Reduction in protein synthesis after loss of Eg5 was not due to a decrease in cell 
proliferation or apoptosis. 
 
 
 
 
 
 
 
 
4.2.3.3 Cell death does not occur after Eg5 inhibition 
 
Finally, we examined whether the decrease in translation of newly synthesizing proteins was due 
to cell death after monastrol treatment. RPE1 cells were treated with monastrol for varying 
periods of time, ranging from 4-16 hrs, followed by subjection to immunoblotting for caspase-3 
cleavage, a hallmark of apoptosis. At all time points, caspase-3 was not cleaved in the monastrol-
treated cells suggesting that the decrease (Belmokhtar, Hillion et al. 2001) in protein synthesis 
was not due to apoptosis (Figure 4.7C). Staurosporine, a highly promiscuous kinase inhibitor 
known to induce apoptosis was used as a positive control in these experiments wherein caspase-3 
cleavage was observed.  
From these controls, it was determined that the decrease in protein synthesis was due to 
loss of Eg5 and not due to decreased cell proliferation, an increase in the mitotic index or due to 
cell death.  
(A) MTS cell proliferation assay was completed after a 24 hr, 48 hr, or 72 hr knockdown 
of Eg5. (B) MTS cell proliferation assays after a 24 hr knockdown of Eg5 by siRNA #1 
or siRNA #2 or after a 4 hr monastrol treatment. (C) RPE1 cells were treated 130 mM of 
monastrol and various time points were taken to examine apoptosis induction, via 
caspase 3 cleavage. Staurosporine was used as a positive control. Results are shown as 
mean ± s.d. and are representative of at least three independent experiments, P values 
represent Students’ t-test. 
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4.2.4 Ribosomes associate with microtubules through Eg5 
4.2.4.1 Microtubules are also needed for protein synthesis 
 
As Eg5 is a molecular motor and few motors have ever been identified to function without the 
use of microtubules and given that previously it has been shown that the cytoskeleton is quite 
important for multiple processes leading up to translation (Jansen 1999), we turned our attention 
to the role of microtubules in the Eg5-mediated translation efficiency.  To begin to examine the 
role of microtubules in translation, 35S Met/Cys incorporation assays were completed after 2 hr 
microtubule depolymerization by either nocodazole or colecimid. As anticipated, a significant 
20% reduction of protein synthesis was observed after microtubule inhibition, consistent with a 
role for motors in protein synthesis (Figure 4.8A). As a decrease in translation was observed and 
previous published data has suggested that prolonged nocodazole treatment can lead to 
apoptosis, cells were treated with varying concentrations of nocodazole for 2-16 hrs prior to cell 
lysis and immunoblotting for caspase-3 cleavage (Figure 4.8B). At all times tested, caspase-3 
was not cleaved therefore demonstrating that the decrease in translation was specific to 
microtubule inhibition and not apoptosis.  
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Figure 4.8: Reduction in protein synthesis was observed  after microtubule inhibition. 
 
 
 
 
 
 
4.2.4.2 40S ribosomal subunit and the 80S ribosome is bound to microtubules through Eg5 
 
Identification as to how microtubules are involved in translation lead us to hypothesize that in 
mammalian cells ribosomes may associate with microtubules, similar to that seen in sea urchin 
embryos, and that this association may be microtubule motor-dependent (Suprenant, Tempero et 
(A) RPE1 cells were treated with nocodazole or colcemid  for 2 hrs prior to 35S Met/Cys 
incorporation assays.  Immunoblots are shown below representing equal loading. (B) 
Apoptosis was investigated after nocodazole treatment for various time points.  
Staurosporine was used as a positive control for caspase 3 cleavage. Results are shown 
as mean ± s.d. and are representative of at least three independent experiments, P values 
represent students’ t-test. 
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al. 1989). Therefore, to investigate this, in vivo WCL microtubule binding assays were 
completed in the presence or absence of Eg5 and/or microtubules. To complete these assays, 
whole cells were lysed, the DNA pellet was omitted, and cells were either treated under 
conditions to polymerize microtubules (34˚C + taxol) or to depolymerize microtubules (4˚C + 
nocodazole). Cells were then incubated in a binding reaction for 30 min prior to centrifugation, 
three washes of microtubule pellet, and immunoblotting. In the presence of microtubules, 
ribosomes, as demonstrated by the antibody to rpL4, were found to pellet in the presence of 
microtubule stabilizing conditions, but not under microtubule depolymerizing conditions; 
therefore suggesting that ribosomes associate to microtubules in a microtubule-dependent 
manner (Figure 4.9A). Next, we investigated whether Eg5 may be mediating the interaction of 
ribosome association to microtubules. Therefore, the exact assay was completed again, but in 
absence of Eg5.  Notably, after Eg5 knockdown, the association of ribosomes with microtubules 
was significantly reduced by 42%, suggesting that Eg5 may act as a linker between ribosomes 
and microtubules in vivo.  
Subsequently, we inquired exactly which ribosomal subunits (40S or 60S) and or 
ribosomes (80S complex) associate to microtubules via Eg5 in mammalian cells. In vitro 
microtubule binding reaction were performed where ribosomal subunits and ribosomes were first 
isolated through sucrose gradient fractionation and each ribosomal fraction (as determined by 
continuous monitoring at an absorbance of 260) from each ribosome/ribosomal subunits were 
pooled together and incubated in a binding reaction, either with the addition of polymerized 
microtubules (from purified α -tubulin) or without microtubules. These reactions were incubated 
for 45 min, centrifuged, providing a supernatant and a pellet, washed to rid of nonspecific 
binding, and subjected to immunoblotting. The supernatant is interpreted to contain non-
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microtubule binding proteins, while the pellet contains microtubules and microtubule-bound 
proteins. Interestingly, the 40S ribosomal subunit and the 80S ribosome, but not the 60S 
ribosomal subunit, were found to pellet only in the presence of microtubules, and not in the 
absence of microtubules, confirming that ribosomal subunits and ribosomes associate to 
microtubules (Figure 4.9B). Additionally, the same experiment was completed after Eg5 
knockdown, and we observed the 40S ribosomal subunit and the 80S ribosome no longer 
associating to microtubules in the absence of Eg5. These data are highly suggestive of a role for 
Eg5 as a linker protein between the 40S ribosomal subunit and the 80S ribosome. It is interesting 
to note that the association between Eg5 and the mature ribosomes is not microtubule dependent 
as polysome fractionation studies completed after microtubule depolymerization with 
nocodazole for 2 hrs prior to cell lysis revealed that Eg5 continued to cofractionate with 
ribosomes in the absence of microtubules (Figure 4.9C). Additionally, polysomes were not 
mentioned above because they were found to pellet independent of microtubules, even at 4˚C, 
therefore suggesting nonspecific pelleting and thus could not be used for further analysis. 
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Figure 4.9: Ribosomes are bound to microtubule through Eg5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.2.5 Which step in protein synthesis requires Eg5 function? 
4.2.5.1 Polysome profiling after loss of Eg5  
 
As loss of Eg5 causes a decrease in protein synthesis, the exact step in translation in which Eg5 
functions was next investigated. There are three independent steps in translation, which I 
(A) In vivo microtubule binding assays were completed in the presence and absence of 
Eg5 and microtubules.  WCLs were lysed under conditions to either polymerize 
microtubules (34˚C+taxol) or depolymerized microtubules (nocodazole+4 ˚ C). Left: 
immunoblot analysis of rpL4. Right: Graph representing quantification of immunoblots. 
(B) In vitro microtubule binding assays. Ribosomes or ribosomal subunits from each 
fraction after polysome profiling, in the presence or absence of Eg5, were pulled 
together and incubated in the presence of absence of microtubules. Left: 
Immunoblotting for designated proteins. Right: Control completed at 4 ˚ C in the 
absence of microtubules. (C) Polysome profiling completed in the absence of 
microtubules, 2 hrs after nocodazole treatment.  Immunoblots are shown from TCA-
precipitations of the indicated fractions. Results are shown as mean ± s.d. and are 
representative of at least two independent experiments, P values represent Students’ t-
test.nocodazole treatment.  Immunoblots are shown from TCA-precipitations of the 
indicated fractions. Results are shown as mean ± s.d. and are representative of at least 
two independent experiments, P values represent Students’ t-test. 
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discussed previously in section 1.1.2 (Chan, Khan et al. 2004) of the introduction, initiation, 
elongation and termination. To begin to dissect at which step in translation Eg5 functions, we 
began by completing sucrose gradient fractionation and polysome profiling analysis to examine 
the ribosome distribution in the absence of Eg5; examining the ribosomal distribution profiles in 
comparison to known translation inhibitors will help to aid the identification in which step of 
translation Eg5 is functioning 24 hrs after Eg5 knockdown a ~40% increase in the 80S ribosome 
was observed when compared to control cells (Figure 4.10). This increase in the 80S ribosome 
was further confirmed after a 4hr monastrol treatment (Figure 4.11A). Additionally 2 hr 
nocodazole resulted in a more subtle, but similar increase in the 80S ribosome (Figure 4.11B).  
Typically, an initiation defect is coupled with an increase in the 80S ribosome. This is 
observed with arsenite treatment, a known translation initiation inhibitor (Li, Ohn et al. 2010), 
which yielded an increase in the 80S and a decrease in polysomes (Figure 4.12B). However this 
increase in the 80S and corresponding decrease in the polysomes was not seen with Eg5 
inhibition, where instead polysome abundance remained stable.  The Eg5 inhibited polysome 
profiles could be reproduced with low levels of puromycin, a known translation elongation 
inhibitor which causes premature termination of the polypeptide chain (Figure 4.11C) (Chan, 
Khan et al. 2004). Although it should be noted that experiments using high concentrations of 
puromycin resulted in a ~90% increase in the 80S and loss of polysomes due to its ability to 
cause premature termination of the polypeptide chain (Figure 4.12C). As the polysomes 
remained stable after loss of Eg5, it suggests that Eg5 may be involved in the elongation step of 
protein synthesis. 
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Figure 4.10: Polysome profiling after Eg5 knockdown causes an increase in 80S ribosomes 
and stabilization of polysomes. 
 
 
 
 
 
 
 
 
Polysome profiling  of 30 million cells was completed after a 24 hr knockdown of Eg5 
using 10-45% sucrose gradients. Quantitation of the area under the peaks for the 80S 
and polysome fractions are demonstrated on the right. CHX was added 10 min before 
cell lysis in all samples above. 
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Figure 4.11: Polysome profiling after Eg5 inhibition, microtubule depolymerization or low 
levels of puromycin leads to an increase in 80S and stabilization of polysomes. 
 
 
 
 
 
Polysome profiling  of 30 million cells was completed after a 4 hr monastrol treatment 
(A), 2 hr nocodazole treatment to depolymerize microtubules (B), or low levels of 
puromycin (C), a elongation inhibitor. Samples were centrifuged on 10-45% sucrose 
gradients. Quantitation of the area under the peaks for the 80S and polysome fractions 
are demonstrated on the right. CHX was added 10 min before cell lysis in all samples 
above. 
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Figure 4.12: Polysome profiling in the absence of CHX still leads to an increase in the 80S 
ribosomes and polysome stabilization after Eg5 inhibition. 
 
 
 
 
 
 
 
4.2.5.2 Polysome profiling without the addition of cycloheximide 
 
As mentioned previously, the standard literature protocol for polysome profiles entails the 
addition of cycloheximide to halt translating ribosomes on the mRNA, thus preventing actively 
translating ribosomes from “running-off”. Given this, one would hypothesize that if Eg5 
participated during the initiation phase of translation, the polysomes would decrease in response 
to Eg5 inhibition and furthermore leaving cycloheximide out of the same experiment would 
magnify the decreased polysomes, as ribosomes would be able to “run-off” the mRNA, but not 
initiate new translational complexes.  To test this hypothesis, the same experiment was 
completed in the presence or absence of monastrol and the presence or absence of 
cycloheximide. Interestingly, stabilization of polysomes was observed after a 4 hr monastrol 
treatment and in the absence of cycloheximide (Figure 4.12A). This is in stark contrast to 
DMSO-treated and arsenite-treated polysome profiles wherein a further loss of polysomes was 
Polysome profiling  of 30 million cells was completed after a 4 hr monastrol treatment 
(A), 1 hr arsenite treatment (a translation initiation inhibitor) (B), or high levels of 
puromycin (C). Samples were centrifuged on 10-45% sucrose gradients. Quantitation of 
the area under the peaks for the 80S and polysome fractions are demonstrated on the 
right. CHX was omitted from experiments in samples A and B, but added 10 min before 
cell lysis in Figure C. 
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observed in both cases; recall arsenite is a translation initiation inhibitor. Therefore, from this 
data, we hypothesize that Eg5 is playing a role in translation after the initiation step.  
4.2.5.3 Increase in 80S ribosome and stabilization of polysomes is not due to an increase in 
mitotic index or cellular stress 
 
Next, polysome profiling was used to confirm that the translational phenotype of Eg5 inhibition 
was not due to mitotic arrest or cellular stress. To test this, a double thymidine block and release 
experiment was completed wherein ~18% of cells were captured in mitosis; this percentage of 
cells in mitosis is reflective of the levels typically observed in noncancer cells (Figure 4.13A). 
Also, this percentage of cells captured in mitosis is 3.4-fold higher than control cells and similar 
to the mitotic index observed after Eg5 knockdown by siRNA #2. When these cells were 
subjected to polysome profiling, we in fact observed a decrease in the 80S ribosomes. These data 
are entirely consistent with previously published data which supports the observation of an 
increase in mitosis leading to diminished levels of translating ribosome complexes (Sivan, 
Kedersha et al. 2007). Furthermore, to confirm that the increase in the 80S complex was not due 
to cellular stress, we mimicked cellular stress using serum starvation, which is also known to 
inhibit translation (Seal, Temperley et al. 2005). Cells were serum starved for 32 hours prior to 
polysome profiling, and again we also observed a decrease in the 80S ribosome and polysomes 
by a striking 80%; these data suggest that the increase in the 80S ribosome is specific to loss of 
Eg5 function and not a generic response to an increase in mitotic cells or cellular stress (Figure 
4.13B).  
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Figure 4.13: Polysome profiling after mitotic arrest or cellular stress does not cause an 
increase in the 80S ribosome, rather causes a decrease. 
 
 
 
Polysome profiling  of 30 million cells was completed after a double thymidine block 
arresting ~18% of cells in mitosis in RPE1 cells (A), or cellular stress through a 32 hr 
serum starvation (B). Quantitation of the area under the peaks for the 80S. CHX was 
added 10 min before cell lysis.  
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4.2.5.4  Eg5 knockdown causes a decrease in both cap-dependent and cap-independent 
translation 
 
To further support the hypothesis that Eg5 facilitates translation after the initiation step, a 
bicistronic vector was used, which can differentiate between cap-dependent and cap-independent 
translation (Nie and Htun 2006). Cap-dependent translation on this plasmid occurs through the 
CMV promoter and leads to expression of YFP, while cap-independent translation occurs via 
internal ribosome entry site (IRES) and allows for expression of CFP. This bicistronic 
construction allows one to differentiate between defects in translation initiation and translation 
elongation because the IRES element recruits the 80S complex directly, thus bypassing the 
traditional initiation phase entirely (Nie and Htun 2006). Thus if Eg5 participated during 
initiation, then inhibition of Eg5 would selectively decrease YFP. However, if Eg5 functions 
during elongation, than a decrease in both YFP and CFP would be expected. Interestingly, 36 hrs 
after Eg5 knockdown in U2OS cells (chosen because of their high transfection efficiency), and 
24 hrs after bicistronic plasmid transfection, a significant  55% and 52% reduction in YFP and 
CFP protein, respectively was observed (Figure 4.14). This decrease could not be due to mitotic 
arrest, as only a 14% increase in the mitotic index was observed after a 36 hr knockdown of Eg5 
in U2OS cells.  The decrease under cap-dependent and cap-independent translation strongly 
suggests that loss of Eg5 effects translation after the initiation step and confirms the data from 
polysome profiling which indicates that Eg5 plays some role during elongation.  
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Figure 4.14: Reduced cap-dependent and cap-independent translation is observed after 
Eg5 knockdown. 
 
 
 
 
 
4.2.5.5 Ribosome half-transit time increases after loss of Eg5 
 
Thus far we have accumulated a wealth of data which indicates that Eg5 facilitates translation 
elongation; however, much of the data has been indirect evidence supported by inference. Thus 
to conclusively demonstrate a role for Eg5 during translation elongation the half-transit time of 
the ribosome were investigated. The half-transit time of a ribosome refers to the time it takes for 
one ribosome to traverse an average sized mRNA (Sivan, Kedersha et al. 2007). In these 
U2OS cells were first knockdown with Eg5 for a total of 36 hrs and were transfected 
with the bicistronic promotor plasmid for a total for 24 hrs. Data is representative of 5 
independent experiments; graph represents quantitation of immunoblotting. Results are 
shown as mean ± s.d. , P values represent students’ t-test. 
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experiments, cells were treated with monastrol for 4 hr, followed by 10 µCi/ml of 35S Met/Cys, 
and every 2 min, time points were taken by adding cycloheximide, cells were lysed, and DNA 
pellet was omitted. Half of the cell lysate was removed which contained total proteins (post 
mitochondrial supernatant), those proteins that completed protein synthesis as well as those still 
attached to the ribosome, while the other half was layed on a 20-60% stepwise sucrose gradient 
and subjected to ultra-centrifugation, pelleting out those nascent proteins still attached to the 
ribosome and removing the completed proteins (post ribosomal supernatant). Each of these 
fractions was then TCA precipitated on GF/C filters and subjected to scintillation counting, 
followed by linear regression analysis. In the control cells, ribosome half-transit time was 
calculated to be 59.3 seconds, while after monostrol treatment the half-transit time increased ~3-
fold to 145.7 seconds (Figure 4.15A). Puromycin was used as our positive control in this 
experiment and exhibited a 2-fold increase in the ribosome half-transit assay (Figure 4.15B). 
This provides direct evidence that the decreased protein synthesis observed after loss of Eg5 
resulted from decreased peptide chain elongation.  
4.2.5.6 Rate of protein synthesis after loss of Eg5 
 
The rate of protein synthesis was also investigated after Eg5 knockdown or monastrol treatment. 
For this assay, 35S Met/Cys incorporation assay was preformed, with the exception that two time 
points were taken and the protein concentration was taken into consideration. After a 24 hr 
knockdown of Eg5, a 2.2-fold decrease in the rate of protein synthesis was observed, whereas 
after Eg5 inhibition by monastrol, a 1.5 fold-decrease in the rate of protein synthesis was 
observed (Figure 4.15C). Intriguingly, knockdown of Eg5 actually effects the rate of protein 
synthesis more than inhibition with a small molecule. However, this data are not surprising as 
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monastrol locks Eg5 onto the microtubule, therefore Eg5 is actually still present and may aid in 
retaining the ribosomes on mRNA. This data suggest that protein-protein interactions mediated 
by Eg5 as well as its ATPase activity are essential for the function of Eg5 during translation.  
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Figure 4.15: A 3-fold increase is observed in the ribosome half-transit time after Eg5 
inhibition. 
 
 
 
 
 
 
 
 
 
 
4.2.6 Eg5 functions to aid the ribosomes processivity 
As the data so far suggests that Eg5 functions during elongation, it is interesting that after Eg5 
inhibition an increase in the 80S is observed, which is typically thought of as an initiation defect. 
Initiation defects usually result in an increase in the 80S complex and a loss of polysomes (Li, 
Ohn et al. 2010), because 80S complexes are forming on the mRNA but never leave the initiation 
site and actively translating ribosomes continue to translate resulting in decreased polysomes. An 
elongation defect typically leads to a decrease in the 80S and an increase in polysomes resulting 
from hindered elongation and no new 80S complex formation (Sivan, Kedersha et al. 2007). So 
the question of how loss of Eg5 slows elongation and causes an increase in 80S ribosomes at the 
same time is quite intriguing. The sum of all the data collected thus far leads us to hypothesize 
Ribosome half-transit time (A) after a 4 hr monastrol treatment or (B) after a 1 hr 
puromycin treatment. Graph in A represents analysis of four independent experiments 
after Eg5 inhibition. Incorporation of 35S Met/Cys into total proteins or completed 
proteins released from the ribosome.  The transit time was calculated as the difference in 
time between the two lines and was obtained by linear regression analysis. C Rate of 
protein synthesis assays after Eg5 knockdown (top) or after monastrol treatment 
(bottom). The transit time was calculated as the difference in time between the two lines 
and was obtained by linear regression analysis. C Rate of protein synthesis assays after 
Eg5 knockdown (top) or after monastrol treatment (bottom). 
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that after loss of Eg5 the translating 80S complexes are “falling-off” the mRNA; therefore the 
function of Eg5 is to hold/stabilize the 80S ribosome onto the mRNA.    
Previous quantitative models have stated that the 80S does not fall off the mRNA, 
(Bretscher 1968; Bergmann and Lodish 1979) but recent data has since demonstrated that the 
80S ribosome can actually fall-off or drop-off the mRNA during translation for a variety of 
reasons, a few of which I will discuss. The first is when cells, prokaryotes as well as eukaryotes, 
have been treated with elongation inhibitors such as puromycin or phyllanthoside and 
nagilactone C (Chan, Khan et al. 2004). Each of these inhibitors cause premature termination of 
protein synthesis at the elongation step and it has been demonstrated through polysome profiling 
analysis that the 80S ribosomes have been shown to fall-off the mRNA in a stop-codon 
independent manner. A second example occurs under diminished amino acid levels, which leads 
to slowed elongation and ribosomal drop-off leading to decreased protein synthesis (Caplan and 
Menninger 1979; Goldman 1982). Finally, a third example comes from microRNAs which have 
been demonstrated to be cause ribosomes to drop-off prematurely as a way of controlling protein 
synthesis (Petersen, Bordeleau et al. 2006). Given these precedents it is quite conceivable that 
Eg5 functions in such a way as to stabilize the mRNA/ribosomes, aiding the ribosome to prevent 
them from dropping-off the mRNA during translation and thus enhancing the ribosomes’ 
processivity. If Eg5 is functioning to aid in processivity during translation, then upon loss of Eg5 
or its motor activity the ribosome has an increased probability of  dropping-off the mRNA, 
leading to an increase in the 80S ribosomes. As a direct corollary, fewer proteins would be fully 
translated, and loss of Eg5 would lead to decreased elongation and increased ribosome half-
transit time, which is exactly what we find after Eg5 knockdown.  
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The relevance of the above example of microRNAs bears further explanation. The 
prevailing notion of the translating ribosome is analogous to a moving locomotive. Defects in 
translation are generally thought to occur during the initiation phase or just as the ribosome 
begins translating, but once the ribosome begins moving nothing except reaching a stop codon 
will prevent the ribosome from translating. The ability of microRNAs to bind to a coding region 
in order to inhibit translation deflates the notion that a translating ribosome as an unstoppable 
molecular machine. One could argue that the ribosome is so susceptible to ‘dropping-off’ that the 
cell has evolved ways to exploit this tendency by targeting microRNAs to coding regions in 
order to inhibit translation. Given this apparent tendency for ‘dropping-off’, it seems reasonable 
that the cell would also have evolved fail-safe mechanisms to prevent termination of translation 
in codon-independent manner. Collectively our data suggests that Eg5 perform this exact 
function; that is, ensure processivity of the ribosome. 
 
4.2.6.1 Eg5 knockdown affects protein synthesis of longer polypeptides more than shorter 
polypeptides 
 
Therefore to test the hypothesis that Eg5 facilitates the ribosomes processivity, we developed a 
processivity assay to look at newly synthesizing proteins in the presence or absence of Eg5. In 
developing this assay, we argued that if Eg5 functioned to aid the ribosomes’ processivity, then 
loss of Eg5 would be expected to impact larger proteins more than smaller proteins. This would 
be anticipated as the longer the mRNA the greater the probability a ribosome could drop-off due 
to the increased drag of the protein on the ribosome and the greater the processivity required to 
complete protein synthesis of longer proteins. For this assay, proteins were classified into two 
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groups, high molecular weight proteins, pertaining to proteins greater than 37 kDa in size (as 
determined by a molecular weight marker) and low molecular weight proteins, those proteins 
that are less than 37 kDa. As a positive control in developing this assay, low concentrations of 
puromycin was used; recall that low concentrations of puromycin produced polysome profiles 
very similar to monastrol-treated or siEg5-treated cells. Furthermore, puromycin is known to 
cause premature termination of the polypeptide chain, thus simulating decreased processivity. 
After 1 hr of 0.1 mg/ml of puromycin treatment, 100 µCi/mL of 35S Met/Cys was added to cells, 
prior to cell lysis, followed by gel electrophoresis, and scintillation counting. Indeed treatment of 
low levels of puromycin caused a decrease in translation of larger molecular weight proteins 
relative to proteins less than 37 kDa. (Figure 4.16A) 
In order to determine whether Eg5 facilitates the processivity of translating ribosomes 
cells were subjected to 24 hr Eg5 knockdown prior to completing the processivity assay. The 
results from this assay confirm the hypothesis the Eg5 aids in the ribosomes processivity, as loss 
of Eg5 caused the translation of proteins greater than 37 kDa to be decrease significantly as 
compared to proteins lower than 37 kDa (Figure 4.16B). This is precisely what is to be expected 
if Eg5 was functioning in stabilizing ribosome/mRNA interaction and aiding the ribosomes’ 
processivity. 
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Figure 4.16: Decreased processivity of longer proteins more than shorter proteins is 
observed after Eg5 inhibition or puromycin treatment. 
 
 
 
 
 
 
 
 
35S Met/Cys incorporation assays were completed (A) after Eg5 inhibition or (B) after 
puromycin treatment, proteins separated by SDS-PAGE, and subjected to scintillation 
counting based on the proteins MW. Results are shown as mean ± s.d. and are 
representative of at least three independent experiments, P values represent students’ t-
test. 
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4.2.6.2 Difference between puromycin and Eg5 knockdown during the processivity assay 
 
Additionally, our developed processivity assay reveals differences between Eg5 inhibition and 
low levels of puromycin treatment that we feel are reflective of the differences in the underlying 
Eg5 mechanism. In addition to inhibiting translation of larger molecular weight proteins, low 
levels of puromycin treatment causes an increase in lower molecular weight proteins. This is in 
contrast to Eg5 inhibition where a decrease is observed for both high and low molecular weight 
proteins.  This difference can likely be explained by noting that part of the mechanism of 
puromycin is to cause the release of nascent growing polypeptides from the ribosome. Thus, 
treatment of puromycin not only prevents the translation of higher molecular weight proteins, but 
causes an apparent increase in lower molecular weight proteins by releasing the nascent peptide. 
Conversely, our processivity model for Eg5 would lead to decreased translation of higher 
molecular weight proteins without an increase in lower molecular weight proteins because loss 
of Eg5 is not expected to induce dissociation of the nascent polypeptide. That is, although larger 
molecular weight proteins are more affected by loss of Eg5, larger and lower molecular weight 
proteins are affected because the ribosome ‘drops-off’ without release of the nascent 
polypeptide.  
Therefore, this data would suggest the ribosome have acquired other mechanisms to aid 
in protein translation outside of those known. These mechanisms include anchoring itself via Eg5 
to non-translating structures (i.e., microtubules) while Eg5 binds to the ribosome, stabilizing the 
ribosome/mRNA interaction and aiding the processivity of the ribosome. 
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4.2.6.3 Increase in the 80S ribosome after loss of Eg5 requires ongoing translation 
 
To further demonstrate that Eg5 functions in the processivity of ribosomes, we envisioned that if 
we could physically block translation concurrently with Eg5 inhibition, then the 80S ribosome 
should not be able to fall-off and should remain bound to the mRNA, if the increase in the 80S 
ribosome was due to ribosome drop-off in the absence of Eg5 function.   To test this, cells were 
treated in the presence or absence of CHX and/or monastrol for 4 hrs, followed by cell lysis and 
polysome profiling; CHX was added concurrently with the treatment of monastrol to block the 
80S ribosome drop-off caused by the monastrol treatment (Figure 4.17A,B).  In the absence of 
CHX and the presence of monastrol, we observed an increase in the 80S ribosome; however 
when CHX and monastrol were added simultaneously to cells for 4 hrs, polysome profiles 
looked identical to control cells, therefore demonstrating that ongoing translation was required to 
cause the 80S ribosome to drop-off the mRNA in the absence of Eg5. This result was opposite of 
what we observed when cells were treated with CHX and arsenite, a translation initiation 
inhibitor. In this case, the 80S increased even in the presence of CHX.  
In order to demonstrate that the increase in the 80S after monastrol inhibition was due to 
ongoing translation, cells were treated with or without monastrol and CHX was simultaneously 
added for 4 hrs, followed by a washout of the CHX and the re-addition of either DMSO, for 
control cells, or monastrol. In this experiment, after washout of CHX, the 80S ribosome fraction 
increased as compared to control. This experiment further confirmed that the increase in the 80S 
is due to ribosomal drop-off after Eg5 inhibition in mammalian cells (Figure 5.18 Model).  
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Figure 4.17: Increase in 80S ribosome after loss of Eg5 is due to ongoing translation. 
 
 
 
 
Polysome profiling of 30 million cells in the (A) presence and absence of monastrol and 
(B) after a 4 hr CHX treatment in the presence and absence of monastrol, (C) In the 
presence or absence of monastrol with a 4 hr CHX treatment followed by a 4 hr washout 
and re-addition of monastrol or DMSO, or (D) in the presence or absence of arsenite, 
with a 4 hr CHX addition.  The 4 hr of CHX in each case was used to block ongoing 
translation. 
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Figure 4.18: Model of Eg5 functioning in translation elongation. 
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4.3 DISCUSSION 
4.3.1 Inhibition of Eg5 causes a decrease in most but not all cell lines tested 
As mentioned previously in section 4.2.2.2 monastrol treatment caused a decrease in translation 
in the majority of cell lines tested. However, in two of the ten different cell lines tested, 
translation did not decrease upon monastrol treatment. The cells lines were UPCI:SCC103 and 
an oral squamous and A549, a lung cancer cell line. Although there are many common hallmarks 
of cancer, there are also many differences making it very difficult, if not impossible, to a priori 
predict why these cell lines were resistant to monastrol-induced inhibition of translation. Some 
possible scenarios are that Eg5 may be overexpressed in these cell lines, thus lowering the 
effective concentration of monastrol, or it could be due to cell permeability issues, or due to an 
off-target protein that binds to monastrol that is present in those cell lines, or even due to multi-
drug efflux pumps. Future experiments will be needed to directly pinpoint their resistance to 
monastrol treatment. 
It has previously been demonstrated in clinical trials of small lung carcinoma cells, the 
Eg5 clinical inhibitor, Ispinesib, does not work effectively to inhibit or decrease tumor formation 
unless it is used in combination with radiotherapy (Saijo, Ishii et al. 2006).  Therefore, the 
defects that are observed in these small lung carcinoma tumors and even A549 cells, may 
represent a defect such that monastrol does not efficiently inhibit Eg5 tumors or cells lines 
originating from the lung. Accordingly, future experiments examining translation in these cell 
lines should be completed with Eg5 knockdown, which may be more effective that monastrol.  
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4.3.2 Ribosome half-transit time reveals further evidence for Eg5’s function in elongation 
During analysis of the half-transit time of the ribosome after Eg5 inhibition, we observed a 3-
fold increase. However, close examination of the data reveals Eg5 does not follow the same 
pattern of 35S Met/Cys incorporation as a typical elongation inhibitor does during the half-transit 
assay. Usually elongation inhibitors have a decreased rate of incorporation in this assay, such 
that in control cells, the first time point is typically 1,000 cpm and the last time point is ~20,000 
cpm (for both PMS and PRS), but for elongation inhibitors, the amount of incorporation is such 
that the first time point is generally 500 cpm and the last around 10,000 cpm (see puromycin 
ribosome half-transit time in figure 4.12B for example). That is, elongation inhibitors generally 
cause a decrease by ~50% throughout the entire time course. This is due to the decreased 
incorporation of 35S Met/Cys because of the slowed/inhibited elongation. However, in similar 
experiments after Eg5 inhibition, the first and the last time points (of the PMS and PRS) both in 
control and monastrol–treated, were remarkably consistent. This suggested that Eg5 is clearly not 
functioning as a traditional elongation inhibitor. In fact, if one calculates the number of 
ribosomes with attached nascent proteins after Eg5 inhibition (by subtracting PMS values from 
PRS values); in this analysis, it yields approximately 1-2 more ribosomes with attached nascent 
polypeptides than control cells, suggesting ribosomal drop-off and retention of the polypeptide. 
This is in contrast to canonical elongation inhibitors, in this case puromycin, where there is 1-2 
less nascent polypeptides bound to each ribosome because elongation is stalled but not 
dissociated. That is, ribosomes stalled during elongation prevent other ribosomes from initiating 
translation.  From this data, it is suggesting that Eg5 is functioning in elongation different from 
the traditional elongation inhibitors such that Eg5 aids in mRNA/ribosome interactions and/or 
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processivity. One could anticipate observing more ribosomes bound to nascent proteins after Eg5 
inhibition for two reasons: 
 
1) In order for Eg5 to aid in processivity its ATPase activity is required. Thus one could 
hypothesize that the ribosome is exploiting a conformational change that takes place 
as Eg5 cycles between ATP-bound and ADP-bound forms. This cycle of 
conformational changes may be needed to ensure the association of Eg5 with various 
ribosomal subunits or to stabilize the translating complex with its transcript. 
Inhibition of Eg5 with monastrol would block the cycling of conformations and thus, 
loss of the ATPase activity of Eg5 would increase ribosome ‘drop-off’ rate by 
destabilizing the translating complex. 
 
2) Even though the ribosome is hindered by the locked Eg5, one can imagine that the 
Eg5 is exerting a “pull” on the ribosome because it wants to keep translating but as it 
is not able to move efficiently. It is possible that the ribosome may pull to try and 
translate the protein, thus breaking its interaction with Eg5 and eventually “dropping-
off” the mRNA, because Eg5 is no longer aiding in the stabilization. 
4.3.3 Revisiting Eg5 as an ideal drug target 
After decades of cancer therapies which entailed treating patients generally with cytotoxic 
compounds (i.e., etoposide, cisplatin, etc.), pharmaceutical companies have made a push to 
selectively target cancer cells over their healthy normal counterparts. Although proteins which 
are only present in cancer cells represent the ideal proteins (i.e, the BCR-ABL kinase), the 
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strategies to target other proteins in rapidly dividing cells are gaining momentum (Burris, Jones 
et al.) (Lad, Luo et al. 2008). Eg5 has emerged as promising drug target because its inhibition 
prevents dividing cells from completing mitosis. Inhibitors of Eg5 are in stages I and II of 
clinical trials with the assumption that Eg5 function only during mitosis, however the data 
presented here argues that Eg5 also functions during interphase in protein synthesis. This 
interphase function is likely a vital process that not only is needed in dividing cells, but in resting 
cells as well. Future studies examining Eg5 as a potential anticancer target will need to take into 
consideration this interphase function in translation as well.  
4.3.4 Mitotic and interphase functions of Eg5 
Additionally, inhibiting Eg5 for prolonged periods of time does lead to mitotic arrest and 
monopolar spindles, but whether mitotic and interphase roles are different or one in the same is 
yet to be answered. It is tempting to speculate that the mitotic and interphase roles of Eg5 are not 
different functions for the same protein; during mitosis it is known that protein translation is 
inhibited at the elongation stage, and it is during this time Eg5 is phosphorylated and begins to 
complete its mitotic function. The inhibition of elongation has been determined to occur by 
phosphorylation of eEF2, but it is possible that inhibition of translation during mitosis may still 
be linked to Eg5, at least in part, and only future experiments would fully determine if Eg5 
phosphorylation also inhibits translation elongation. 
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5.0  CHAPTER V: IDENTIFICATION AND CHARACTERIZATION OF EG5 AND 
KID MOTORS IN STRESS GRANULE FORMATION 
5.1 INTRODUCTION 
During the examination of the interphase localization of Kid after high levels of UV-C treatment, 
Kid was found to localize to circular punctuate structures in the cytoplasm. Upon examination of 
the literature, I found that during conditions of translational inhibition or oxidative stress, such as 
the UV-C treatment, cells form structures called stress granules (Kedersha and Anderson 2002; 
Kedersha and Anderson 2007). Stress granules, as mentioned previously in the introduction 
section 1.2.3, are induced by eIF2α phosphorylation triggering inhibition of translation and 
leading to abortive initiation complexes. Stress granules harbor silenced mRNP complexes and 
are an assessment center for untranslated mRNAs. When these punctuate structures begin to 
form, they are small, but over times they coalesce to form large structures. When untranslated 
mRNAs localize to stress granules the mRNAs have three different fates: 1) reinitiate translation, 
2) become degraded, or 3) remain within the stress granule for storage (Balagopal and Parker 
2009).   
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5.2 RESULTS 
5.2.1 Localization of nucleolar-associating motors to stress granules 
5.2.1.1  Kid localizes to stress granules 
 
In order to determine whether the cytoplasmic foci of Kid represented the localization of Kid to 
stress granules, co-localization studies with the stress granule marker eIF4E were conducted. 
Indeed, these studies confirmed the distinct cytoplasmic foci as stress granules. Furthermore, Kid 
was found to localize to stress granules when cells were induced to form stress granules by the 
typical dual puromycin- and arsenite-treatment (Figure 5.1A). Puromycin, causes premature 
termination of the polypeptide chain and enhances stress granule formation by increasing the 
formation of both pre-initiation complexes and availability of free 40S subunits, while arsenite 
treatment causes oxidative damage leading to phosphorylation of eIF2alpha (Roybal, Hunsaker 
et al. 2005). Thus, after treatment Kid was found to localize to stress granules under translational 
stress conditions. Future experiments will be conducted with arsenite treatment alone, as more 
recently published data demonstrated that arsenite alone is sufficient to induce stress granules 
and are more physiologically relevant (Roybal, Hunsaker et al. 2005).  
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Figure 5.1: Kid and Eg5 localized to stress granules, but not P-bodies. 
 
 
 
 
(A) RPE1 cells were treated with either puromycin and arsenite and stained for Kid and 
eIF4E, a stress granule marker. (B) RPE1 cells were treated with 0.5 mM arsenite and 
co-stained for Eg5 and eIF4E or (C) MKLP1 and eIF4E, or (D) Eg5 and TIA-1. Solid 
arrows represent p-bodies; insets shown stress granules co-localization. 
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5.2.1.2 Kid, Eg5, but not MKLP1, localizes to stress granules 
 
As Kid was found to localize to stress granules, we next inquired whether the other ribosomal 
motors Eg5 or MKLP1 associated with stress granules. After 0.5 mM arsenite treatment, Eg5 but 
not MKLP1 robustly localized to stress granules (Figure 5.1B, C), as determined by co-
localization with eIF4E and/or TIA-1, an RNA binding protein and structural component of 
stress granules (Figure 5.1D) (Kedersha, Gupta et al. 1999).  
5.2.2 Kid, Eg5, and MKLP1 do not localize to P-bodies 
As eIF4E is a marker not only for stress granules but for P-bodies, the localization of Eg5, 
MKLP1 and Kid to P-bodies was also investigated. P-bodies are distinct foci that are found in 
unstressed and stressed cells that contain mRNA as well as enzymes involved in mRNA turnover 
(Kedersha, Stoecklin et al. 2005). Stressed and unstressed cells were co-stained for Eg5, MKLP1 
or Kid motor and eIF4E; in all cases the motor failed to localize to P-bodies (Figure 5.1A-C, as 
indicated by white solid arrows). This data would suggest that Kid and Eg5 are not associating 
with mRNA but rather associating with components of the translation complexes, consistent with 
our previous conclusions derived from polysome profiling.  
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5.2.3 Kid and Eg5 participate in stress granule dynamics 
5.2.3.1 Kid knockdown causes a reduction in stress granule formation 
 
As mentioned in section 1.2.3, recently published data has demonstrated roles for the anterograde 
transport of kinesin-1 and the retrograde transport of dynein heavy chain 1 in stress granule 
dissolution and formation, respectively (Loschi, Leishman et al. 2009). Consequently, we 
inquired whether Kid or Eg5 kinesin motors may also be involved in stress granule formation. 
Accordingly, Kid was knocked-down for 48 or 72 hrs, treated with or without arsenite treatment, 
after which stress granule formation was examined.  After Kid knockdown and in the absence of 
arsenite, no induction of stress granules was observed; however, stress granule formation in the 
absence of Kid and presence of arsenite yielded a 20% decrease in the number of cells which 
formed stress granules (Figure 5.2). It should be noted that although a decrease in stress granule 
formation was observed, there was no striking difference in stress granule size between siKid 
and siControl cells when stress granules were present. This suggests a role for Kid in the 
formation or stability of stress granules.  
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Figure 5.2: After knockdown of Kid, a small reduction in stress granule formation is 
observed. 
 
 
 
 
 
 
5.2.3.2 Eg5 knockdown causes a decrease in stress granule formation and coalescence  
 
As Kid was found to contribute to stress granule formation, we next investigated whether Eg5 
may also be important during stress granule assembly. Thus, 48 hrs after Eg5 knockdown, stress 
granule formation was investigated. In the absence of arsenite treatment, knockdown of Eg5 
alone did not cause stress granule formation; however, in the presence of arsenite a nearly 40% 
Kid was knocked-down for 48 hrs prior to arsenite treatment. Additionally, Kid and 
Eg5 were simultaneously knocked-down for 48 hrs prior to arsenite treatment, fixation, 
and quantitation of stress granule formation. Results are shown as mean ± s.d. and are 
representative of at least two independent experiments, P values represent Students' t-
test. 
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reduction was observed the number of cells which formed stress granules (Figure 5.3A, B). 
Additionally, of those cells which did form stress granules the size of the stress granules were 
significantly smaller and much greater in number than those of the siControl cells. Typically in 
control cells, stress granules are known to coalesce together in order to form large stress 
granules, however after Eg5 knockdown the stress granules did not appear to coalesce.  
Therefore, the reduction of cells exhibiting stress granules, as well as the smaller size and greater 
number observed suggests that Eg5 may be involved in stress granule formation, transport or the 
movement of stress granules to the center of the cell and/or coalescence, the joining of stress 
granules.  
5.2.3.3  Live cell imaging reveals a loss in stress granule transport, formation, and 
coalescence after Eg5 knockdown 
 
To examine the role of Eg5 in stress granule physiology, live cell imaging of stress granules in 
RPE1 cells was employed. RPE1 cells were transiently transfected with G3BP-GFP protein, a C-
terminal GFP tagged variant of  RasGAP-associated endoribonuclease, which is a component of 
stress granules and is involved in their assembly (Deigendesch, Koch-Nolte et al. 2006). Cells 
were treated with siEg5 and transiently transfected with G3BP-GFP for 48 hrs prior to live cell 
imaging. At time zero, arsenite treatment was added, and within 30 seconds stress granules 
began to form. However, in the absence of Eg5 the cells that did form stress granules took at 
least 4 times longer (up to 2 min) to initiate formation (Figure 5.4). Additionally, of the cells that 
did form stress granules (66%) the stress granules were smaller in size and more abundant in 
number (n=15), similar to the changes observed in fixed cells (Figure 5.3C). These small stress 
  158 
granules were also found to be less motile and failed to coalesce as frequently. This data confirm 
that Eg5 is needed for stress granule formation/assembly, transport, and/or coalescence.  
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Figure 5.3: Reduction of stress granule formation and size after Eg5 knockdown. 
 
 
 
 
 
 
 
 
 
Furthermore, the reduction in stress granule formation after Eg5 knockdown is consistent 
with the role of Eg5 in translational elongation, as knockdown of elongation proteins does not 
cause stress granule formation in the absence of stress, but is known to cause a loss of granule 
formation under stressed condition. This is in contrast to translation initiation factors where 
knockdown alone is sufficient to cause stress granule formation, even in the absence of stress.  
 
5.2.3.4  Eg5 and Kid function redundantly in stress granule formation 
 
As a 20% reduction is stress granule formation was observed after siKid and a 32% reduction 
after Eg5 knockdown, we next inquired whether simultaneous knockdown of both motors would 
lead to synergistic effect on stress granules. After knockdown of both of these motors, stress 
granule formation did not decrease more than Eg5 knockdown alone (Figure 5.2). Therefore it 
(A) 48 hrs after Eg5 knockdown, cells were treated with 0.5 mM arsenite, fixed, and co-
stained for Eg5 and eIF4E. Percentages represent quantitation of the number of cells 
with that phenotype. (B) Quantitation of fixed cells after Eg5 knockdown.  (C) 
Quantitation of stress granule formation after Eg5 knockdown by live cell imaging. (D) 
Quantification of stress granule formation after Eg5 inhibition by monastrol. Results are 
shown as mean ± s.d. and are representative of at least two independent experiments, P 
values represent Students' t-test. 
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seems as though the mechanism by which these motors induce stress granule assembly is 
balanced or may be redundant.  
5.2.3.5 Loss of Eg5 causes a small percentage of cells to undergo apoptosis 
 
As prolonged exposure of Eg5 knockdown is known to cause mitotic arrest, cell death and 
apoptosis, we investigated whether the decrease in stress granule formation after Eg5 knockdown 
was the result of these well-known side-effects of loss of Eg5. Therefore, we first determined the 
percentage of cells found to be arrested in mitosis. After 48 hrs knockdown of Eg5, a 9% 
increase in the mitotic index was observed in RPE1 cells. However, it should be noted that the 
percentage of cells which were arrested in mitosis were not included in our analysis, as 
previously published data has demonstrated that mitotic cells do not contain stress granules. 
Next, we examined apoptosis by looking for fragmented nuclei by DAPI staining. In the control 
cells, 2% and 5.7% of cells contained fragmented nuclei before or after stress granule formation, 
respectively. In the case of Eg5 knockdown, of the 33% of cells that did not contain stress 
granules, 8% were found to contain fragmented nuclei, and of the 68% that contained small 
stress granules, 9% were found to have fragmented nuclei. Although the knockdown of Eg5 did 
increase the percentage of cells exhibiting fragmented nuclei, this percentage was the same 
between cells which did not form stress granules. Thus, the presence of fragmented nuclei could 
not be contributing to the decreased stress granule formation. (Figure 5.3A, right). 
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5.2.3.6  The ATPase activity of Eg5  is not required for stress granule formation, transport  
 
or coalescence 
 
As knockdown of Eg5 exhibited a decrease in stress granule assembly, we inquired whether this 
is the result of the motor activity of Eg5 or the ability to Eg5 to form complexes through its 
cargo domain. Accordingly, when cells were treated with either 100 µM or 200 µM monastrol 
for 4 hrs, only a 6% decrease in stress granule formation/assembly was observed (Figure 5.3D). 
This strongly suggests that the binding of Eg5 to specific cargo, rather than its ATPase activity, 
is necessary for the role of Eg5 in stress granule formation/assembly. 
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Figure 5.4: .Live cell imaging stills after Eg5 knockdown or microtubule depolymerization. 
 
 
5.2.3.7  Eg5 functions in stress granule dissolution 
 
Given the role of Eg5 in stress granule formation and coalescence, we next inquired whether Eg5 
may play a role in stress granule recovery or dissolution. Cells were treated with monastrol for 4 
hrs prior to 1 hr arsenite treatment, followed by washout, and recovery. During recovery, various 
time points were taken every 20-30 min. Up until the 50 min time point, siControl and siEg5 
cells showed no difference in stress granule dissolution (Figure 5.5A). However, a change in 
Time stamp indicated hr:min.  A) siControl, B) siEg5, or C) nocodazole treated. 
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stress granule dissolution was observed during a 30 min time period from 50-80 min, whereby 
monastrol-treated cells significantly persisted with ~40% of cells containing stress granules. 
However by the end of 90 min, stress granules had almost completely dissolved similar to 
control cells. This demonstrates that the ATPase activity of Eg5 may be needed during stress 
granule dissolution. Similar experiments were completed after knockdown of Eg5 and analogous 
results were observed, however 10-15% of cells retained stress granule formation even after 
siControl cells (Figure 5.5B). It should be noted that at the initial time point of 0 min, there was 
no loss of stress granule formation in this experiment; therefore this results will need to be 
repeated.  
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Figure 5.5: Eg5 inhibition and knockdown delays stress granule dissolution. 
 
 
 
 
(A) 4 hr after monastrol treatment or (B) 48 hrs after Eg5 knockdown cells were treated 
with arsenite, washed-out and released, prior to time points every 20-30 min. Results are 
shown as mean ± s.d. and are representative of at least two independent experiments, P 
values represent Students' t-test. 
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5.2.4 Microtubules are also required for stress granule formation, transport and 
dissolution in RPE1 cells 
5.2.4.1  Microtubules are needed for stress granule formation 
 
Previously published data in COS-7 cells demonstrated that microtubules are required for stress 
granule formation (Ivanov, Chudinova et al. 2003). We tested this conclusion in RPE1 cells, 
using 12 µM nocodazole for 2 hrs prior to arsenite treatment, but only a ~30% loss of stress 
granules was observed (Figure 5.6). Similar to Eg5 knockdown, stress granules were smaller in 
size and greater in number as compared to control cells. This conclusion was confirmed by live 
cell imaging:  80% of cells examined formed stress granules (n=12), but were both significantly 
greater in number and smaller in size as compared to control cells (Figure 5.4). Additionally, 
even though control cells began to form stress granules within 30 seconds, in nocodazole treated 
cells stress granules assembly began around 5 min after arsenite exposure. This apparent loss of 
coalescence of stress granules suggests that microtubule inhibition causes a similar phenotype as 
that observed in the absence of Eg5, consistent with a role for microtubule motors like Eg5 and 
Kid in stress granule formation. 
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Figure 5.6: Microtubules are needed for stress granule formation. 
 
 
 
 
 
 
5.2.4.2  Live cell imaging reveals microtubules are needed for stress granule transport  
 
Finally, during live cell imaging when cells were treated with nocodazole and arsenite at the 
same time, stress granules formed at similar sizes as in control cells, however, they did not move 
Top: Immunofluorescence of a-tubulin or eIF4e in the presence or absence of 
microtubules. Bottom: Quantitation of stress granule dissolution after a 2 hr treatment 
with nocodazole followed by a 0.5 mM arsenite treatment, fixation, and quantitation. 
Results are shown as mean ± s.d. and are representative of at least two independent 
experiments, P values represent Students' t-test. 
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towards the cell nucleus, rather they stayed at the edges of the cells. This suggests that in order 
for stress granules to move and localize around the cell nucleus, microtubules are required.  
5.2.4.3  Microtubules are required for control of stress granule dissolution 
 
Additionally, stress granule dissolution was also investigated after microtubule 
depolymerization. Cells were treated for 2 hrs with nocodazole, followed by a 1 hr arsenite 
treatment, and time points were taken every 20-30 min after arsenite washout. Interestingly, of 
the cells that formed stress granules, dissolution actually occurred faster in the absence of 
microtubules, than in the presence of microtubules (Figure 5.6). This result was quite interesting, 
as it would suggest that microtubules actually hinder the dissolution process.  
5.3 SUMMARY 
In summary, Eg5 is demonstrated to be required for the formation of stress granules, the 
coalescence of smaller stress granules into larger ones, dissolution of stress granules after 
arsenite washout and even transport towards the center of the cell. From these studies, the Kid 
motor was demonstrated to be needed for stress granule formation, but not transport or 
coalescence; however whether Kid may be needed for stress granule dissolution has yet to be 
examined (Figure 5.7). In the case of microtubules, they seem to mirror Eg5s’ function in stress 
granules, but importantly, it seems to be mostly required for dissolution as loss of microtubules 
allowed stress granules to dissolve quicker which can lead to many detrimental effects on the 
cell, as discussed below.   
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Figure 5.7: Stress granule model. 
 
 
 
 
 
 
 
 
 
5.4 DISCUSSION 
5.4.1 Eg5 makes use of protein-protein interactions, rather than its ATPase domain for 
stress granule formation and coalescence 
The identification of Eg5, Kid and microtubules in stress granule assembly, transport, 
coalescence, and even dissolution is generally consistent and supportive with my previous 
conclusions of Eg5 participating in protein translation. As motors typically are known to 
transport cargo along microtubules, our findings suggest that under translational stress, Eg5 plays 
a role in transport of stress granules to aid in stress granule assembly, transport and coalescence, 
whereas Kid may participate only in stress granule assembly. Furthermore, the ATPase activity 
of Eg5 is dispensable for stress granule formation and coalescence, but is needed for its function 
(A) Eg5 has independent roles in ribosome processivity and stress granule formation.  
Under translational stress, Eg5 aids the 40S ribosome into the stress granule complex. 
However, in the absence of Eg5 (B) stress granule formation is decreased and 
coalescence is also inhibited. (C) Additionally, in the absence of Eg5, stress granule 
dissolution is delayed. (D) In the presence of Kid and under translational stress, Kid aids 
silenced mRNA into the stress granule complex, however in the absence of Kid, a loss in 
stress granule formation is observed and less mRNAs are transported into the stress 
granules during translational stress repair. 
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is dissolution.  These data suggest that Eg5 ability to aid in stress granule coalescence is likely 
dependent on protein-protein interactions, rather than its actual motor activity. 
5.4.2 Microtubules are required to control the dissolution of stress granules 
Microtubules were also demonstrated to be important for stress granule formation as well as 
dissolution. Stress granule formation in the absence of microtubules revealed identical results as 
observed after Eg5 knockdown which may actually reflect the loss of Eg5, as motors typically 
use microtubules to carry out their function. However, what was interesting is that during stress 
granule dissolution, an increase rate of dissolution was observed, suggesting that microtubules 
may typically hinder the process. Although microtubules may hinder the process, the cell may 
have evolved for a slower dissolution rate because stress granules should only dissolve once the 
damage has been fixed or the stress conditions removed. If the stress granules dissolve faster 
than the damage is resolved, it could lead to translation of damaged mRNA and decrease the 
resource of the cell. Therefore, hindering stress granule dissolution in the presence of 
microtubules may actually be a safety mechanism for the cell.  
5.4.3 Why do Eg5 and Kid behave differently? 
Eg5 and Kid motors are both plus-end directed kinesins, but our studies are revealing that their 
function in stress granule dynamics is already demonstrating to be different. Eg5 plays a role in 
the coalescence of stress granules and in formation and transport, whereas Kid is only observed 
to function in stress granule formation. These differences in stress granule dynamics are 
consistent with the interphase function of each of these proteins. As discussed in Chapter 4, Eg5 
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directly participates in protein synthesis by directly associating with various ribosomal 
components. Also, as will be discussed in Chapter 6, loss of Kid leads to an increase in protein 
synthesis and loss of localized protein expression; as such, the dominant function of Kid appears 
in mRNA transport or transport of mRNP complexes.  
The stress granule dynamics after loss of Eg5 parallels the interphase function of Eg5. 
The ability of Eg5 to participate in every phase of stress granule dynamics is likely through Eg5's 
association with various ribosomal subunits and consistent with this is the fact that the 40S 
ribosomes and the 43S translation complexes also associate with stress granules throughout the 
entire process (Kimball, Horetsky et al. 2003). Therefore, under stress conditions Eg5 likely 
functions in the transport of the 40S ribosome/43S translational complex to the stress granule 
prior to facilitating stress granule formation.  While Kid's ability to participate in only stress 
granule assembly is consistent with other proteins involved in mRNA transport which have been 
shown to effect stress granule assembly and not stress granule coalescence or transport. 
5.4.4 Is Eg5 function in protein synthesis and stress granule formation one in the same? 
As Eg5 is demonstrated to aid in the processivity of the ribosome, one must inquire whether 
Eg5’s function in stress granule formation is a result of low processivity or if stress granule 
formation causes low processivity or if Eg5 is functioning in these two processes independently. 
There is no reason to speculate that stress granule formation causes low processivity especially 
because stress granule formation occurs after protein translation inhibition. Additionally, the 
decreased processivity after loss of Eg5 does not cause stress granule formation, as treatment 
with siEg5 alone does not induce stress granule formation. Therefore, this leads us to conclude 
that Eg5's function in stress granules and processivity are independent functions for this motor. 
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These separate and distinct functions could be exploited by the cell to uniquely position Eg5 to 
switch between both functions. Under normal conditions Eg5 functions to aid in ribosomal 
processivity, while under conditions of translational stress Eg5 can aid in the transport of the 40S 
ribosome to the stress granule prior to facilitate stress granule formation. Furthermore, once the 
translational stress is removed Eg5 functions to dissolve stress granules and resume its function 
in processivity. However, this cycle has yet to be formally tested. 
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6.0  CHAPTER VI: IDENTIFICATION OF KID IN TRANSPORT OF FOCAL 
ADHESION PROTEINS 
6.1 INTRODUCTION 
Recently, localized translation has been found to occur in a variety of organisms for embryonic 
patterning during embryogenesis (King, Messitt et al. 2005), memory formation (Sanchez-
Carbente Mdel and Desgroseillers 2008) and neuronal development (Kindler, Wang et al. 2005). 
In mammalian cells, it has been proposed that localized translation occurs at focal adhesions 
(Hervy, Hoffman et al. 2006). Focal adhesions are anchoring junctions containing clusters of 
diverse adhesion proteins, which mechanically link the actin cytoskeleton to the extracellular 
matrix. This connection provides the cell with structural anchorage as well as signaling 
information regarding association with the extracellular environment.  
6.2 RESULTS 
6.2.1 Kid, Eg5, and MKLP1 localize to focal adhesions 
Interestingly, we have identified that Kid, Eg5 and MKLP1, associate with focal adhesions in 
RPE1 cells, colocalizing with vinculin, a known focal adhesion protein (Turner, Glenney et al. 
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1990) and in a variety of cells lines including HeLa, fibroblasts, and NIH3T3 cells (Figure 6.1A, 
B). We chose to focus our efforts on characterizing the function of Kid at sites of focal 
adhesions. siRNA knockdown of  siKid for 72 hrs yielded an increase in focal adhesions  
not only at the edges of the cells, but also at multiple foci throughout the entire cell (Figure 
6.2A). In addition, after Kid knockdown a thinning of the cellular processes was observed, such 
that they cells became extremely long and flat (Figure 6.2B).  
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Figure 6.1: Kid, Eg5, and MKLP1 localize to foal adhesions. 
 
 
(A) RPE1 or NIH3T3 cells were fixed and co-stained for Kid and vinculin, a focal 
adhesion protein. (B) Eg5 and MKLP1 immunofluorescence demonstrate similar 
staining to focal adhesions in RPE1 cells. 
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Figure 6.2: Knockdown of Kid causes an increase in focal adhesions and a change in cell 
morphology. 
 
 
 
(A) Immunofluorescence analysis of RPE1 cells with Kid knockdown and stained for 
vinculin (left). Immunoblot demonstrating Kid knockdown (right). (B) 
Immunofluorescence analysis of Kid and vinculin, 72 hrs after Kid knockdown under 
100X (B) or 40X (C). 
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6.2.2 Loss of Kid causes an increase in focal adhesions randomly distributed throughout 
the cell 
As an increase in focal adhesions was observed after Kid knockdown and focal adhesions were 
identified proximally in the cell, we hypothesized that Kid may be involved in focal adhesion 
mRNA transport. That is, in the absence of Kid the vinculin mRNA may not be properly 
transported and instead distributed and translated inappropriately at interior points of the cell. 
6.2.3 Kid localizes to the ends of microtubules 
This phenotype may be consistent with Kid functioning as a motor. If Kid were to participate in 
transport of focal adhesion components, then one would expect Kid to localize along 
microtubules and concentrate at the edges of microtubules where microtubules meet focal 
adhesions. Accordingly, cells were co-stained for Kid and microtubules and as anticipated Kid 
was found to localize to the ends of microtubules, exactly where focal adhesions begin to form 
(Figure 6.3). Consistent with our model Kid may localize focal adhesion assembly to the distal 
portions of the cell.  
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Figure 6.3: Kid localizes to ends of microtubules. 
 
 
 
6.2.4 Kid knockdown causes an increase in protein synthesis 
Additionally, after Kid knockdown, immunofluorescence analysis demonstrated an increase in 
the number of focal adhesion. Given that Kid was found to associate with ribosomes, we 
RPE1 cells were fixed to observe partial a-tubulin staining and Kid. Insets demonstrate 
blown-up images. 
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inquired whether Kid may be involved in suppressing focal adhesions protein synthesis until the 
mRNA reached the ends of the microtubules. To begin to investigate this, we began by first 
examining the efficiency of translation in the absence of Kid, similar to Eg5. Accordingly, 24, 
48, and 72 hrs after Kid knockdown, a significant 50% increase in protein translation was 
observed (Figure 6.4A). This increase in protein translation is precisely the opposite effect that 
was observed after Eg5 knockdown and lends support to the hypothesis that Kid may play a role 
in suppression of translation of specific proteins like focal adhesion components. This increase in 
translation is not due to an increase in the mitotic index (Figure 6.5B). 
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Figure 6.4: Translation increase after Kid knockdown. 
 
 
 
(A) 35S Met/Cys incorporation assays were completed after a 48 hr Kid knockdown. (B) 
Mitotic index analysis after a 48 hr Kid knockdown. Results are shown as mean ± s.d. 
and are representative of at least two independent experiments, P values represent 
students’ t-test.   
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6.3 SUMMARY 
Typically, an increase in translation after the knockdown of a given protein is suggestive of a 
translational repressor function for that given protein. Generally, translation repressors act by 
binding to the mRNA and blocking its translation (Vessey, Vaccani et al. 2006). Such proteins 
are typically found as part of the mRNP complexes. mRNP complexes contain silenced mRNAs 
and are typically assembled in the nucleus, transported into the cytoplasm, and carried to their 
final destination to be translated (di Penta, Mercaldo et al. 2009). Kid immunoblotting is very 
robust in the nucleolus, consistent with this model. Based on this data and previous data (Chapter 
2-4), we hypothesize that Kid may act as a translational repressor and may be a part of the 
mRNP complexes assembled within the nucleus (Figure 6.5).  
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Figure 6.5: Focal adhesion model. 
 
 
 
 
 
 
 
Left: With Kid : We propose that Kid may function as a translational repressor, 
silencing mRNA (vinculin) in the nucleus, transporting it through the cytoplasm, until it 
reaches its destination (the edge of the cell) for translation. Right: However without Kid, 
focal adhesions are found to be distributed movre randomly in the cytoplasm and are 
found in different orientations, suggesting that vinculin mRNA is not silenced and when 
it enters the cytoplasm, translation occurs prematurely before focal adhesion mRNA 
reaches the edge of the cell. 
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6.4 DISCUSSION 
After Kid knockdown, an increase in focal adhesions was observed throughout the cell, which is 
consistent with the 50% increase in protein translation observed after siKid treatment. Even 
though an increase in focal adhesions was observed after Kid knockdown, this single protein 
could not account for the 50% increase in protein translation. Therefore, there are likely other 
unidentified mRNAs that are silenced and transported for translation by Kid. These data hint at 
the possibility that Kid may function as a translational repressor and may mediate the transport 
of multiple mRNAs. Further evidence regarding the role of Kid as a translational repressor could 
be provided by identifying an association of Kid with specific mRNP complexes. 
6.4.1 Kid localization at the ends of microtubules 
Kid localization to the ends of microtubules is not surprising, as other motors with a role in 
transport of cargoes/organelles have also been shown to localize to the ends of microtubules. 
Additionally, this localization is consistent with Kid function in focal adhesion component 
transport. At the end of microtubules, focal adhesions begin to form (Wehrle-Haller and Imhof 
2003), thus it is logical that Kid is found at the ends of microtubules because it is transporting 
those focal adhesion components there to be translated.   
6.4.2 Kid silencing mRNA 
Furthermore, as focal adhesion proteins are needed in the distal parts of the cell and not the 
proximal, the transport and silencing function of Kid explains how focal adhesion proteins are 
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selectively and site-specifically translated. We believe Kid is able to silence focal adhesion 
proteins because Kid has a nucleic acid binding sequence. Our initial studies have provided the 
first physiological relevance of the RNA-binding function of Kid. A working model for the 
function of Kid in mRNA silencing and transport is as follows: Kid associates and silences the 
mRNA for focal adhesions early on in the nucleus and transports them into the cytoplasm where 
Kid uses microtubules to transport the focal adhesion protein to the end of the microtubule. Once 
the Kid-bound focal adhesion component cargo reaches the end of the microtubules, the complex 
becomes unsilenced and the focal adhesion protein can be translated. However, when Kid is not 
present, the focal adhesion proteins are not silenced and instead are translated immediately after 
leaving the nucleus without being transported, ending up within the proximal regions of the cell. 
Furthermore, given the significant increase in protein synthesis after knockdown of Kid suggests 
that Kid is likely important for silencing more mRNAs other than focal adhesions mRNAs.   
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7.0  CHAPTER VII: FINAL DISCUSSION 
Until this study, interphase functions for mitotic motors were uninvestigated and were thought to 
be nonexistent. Accordingly, the identification of interphase functions for the motor proteins Eg5 
and Kid is quite intriguing as before this discovery, mitotic motors were only thought to function 
in mitosis. This finding is critical and needs to be taken into consideration when mitotic motors 
are being considered as drug targets. Not only have these two proteins been identified as 
ribosomal motors, but they function in protein synthesis which occurs throughout the entire cell 
cycle. Inhibition of these essential interphase functions may outweigh the potential therapeutic 
benefit derived from inhibiting their mitotic functions.  
Microtubule motors are known to possess not only redundant functions but they are also 
well known to function in a balance of forces (Sharp, Rogers et al. 2000); that is, antagonize each 
other’s movements in order produce the correct amount of force to achieve the desired result. 
Furthermore, disruption of this dynamic balance can lead to pleiotropic effects on cells (Sharp, 
Rogers et al. 2000).  In this study, the two motors, Eg5 and Kid, were found to function in 
protein translation. Interestingly, the antagonizing nature of mitotic motors is even reflected in 
our newly discovered interphase functions, as loss of Eg5 causes a decrease in protein synthesis 
which suggests that Eg5 acts as a translational activator, whereas loss of Kid causes an increase 
in protein synthesis which suggests Kid acts as a translational repressor.  The reciprocal 
relationship of these proteins was conserved all the way down to knockdown of Eg5 resulting in 
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an increase in Kid expression, while Kid knockdown caused an increase in Eg5 expression 
(Figure 7.1). This suggests that Kid and Eg5 function uniquely to ensure efficient and proper 
translation, and altering this balance disrupts translation.  
 
 
 
Figure 7.1: Recipical relationship of Kid and Eg5s balance of forces is demonstrated by 
immunoblotting of indicated proteins after knockdown. 
 
 
 
The microtubule motor Kid was found to be associated with the nucleolus through a 
GTP-dependent shuttling mechanism. This shuttling mechanism was similar to NPM, a protein 
that functions prominently in ribosome biogenesis (Finch, Revankar et al. 1993). More 
importantly, Kid and NPM share many distinct similarities including cell cycle-dependent 
localization, co-fractionation with pre- and mature ribosomes, their localization during mitosis, 
and their phosphorylation by the same kinase at the onset of mitosis. Given these similarities, it 
Cells were knocked –down for 24 hrs in each case for Kid and Eg5.  
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seems very likely that in addition to participating in stress granule formation, mRNA transport 
and silencing, Kid may function similarly to NPM in participating in ribosome biogenesis.   
Previous quantitative models of protein synthesis assumed that ribosomes do not fall off 
the mRNA during translation, however our analysis and the analysis of others disputes this claim 
(Chan, Khan et al. 2004) (Caplan and Menninger 1979; Goldman 1982) (Vuppalanchi, Coleman 
et al.). Loss of Eg5 causes an increase in the 80S subunit and stabilization of polysomes, and this 
increase in the 80S ribosome requires ongoing translation. Additionally, our newly developed 
processivity assay demonstrates that after loss of Eg5, longer polypeptides were less frequently 
translated than shorter polypeptides. From this we conclude that Eg5 functions to aid the 
ribosomes processivity and provides a fail-safe mechanism against unwanted ribosomal drop-off. 
Recently published literature has shown that certain microtubule motors were found to function 
in stress granule formation and/or dissolution. Dynein was involved in stress granule formation, 
while kinesin was involved in stress granule dissolution (Loschi, Leishman et al. 2009). 
Therefore, we investigated whether Eg5, Kid or MKLP1 were involved in stress granule 
dynamics. Under translational stress Eg5 and Kid were found to co-localize to stress granules, 
while MKLP1 did not. Additionally, it was determined that Eg5, Kid, and microtubules were 
required for stress granule formation, while Eg5 was also needed for stress granule transport, 
coalescence and dissolution. Our studies add to the existing body of literature by expanding the 
number of motor proteins known to be involved in stress granule dynamics. Interestingly, 
although the defects observed after loss of Eg5 are not as dramatic as those seen after loss of 
dynein or kinesin alone, Eg5 is able to perform the function of both of these motors 
simultaneously. 
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7.1 FUTURE DIRECTIONS 
MKLP1 was found to associate with both pre-ribosomes and mature ribosomes, but during this 
analysis we did not investigate the function of MKLP1 in protein synthesis. It is likely, 
considering MKLP1 associates with ribosomes similarly to Eg5 and Kid, which MKLP1 may 
function in protein synthesis as well.  
MKLP1 was not included during our investigations with Eg5 and Kid for two main 
reasons. The first is that the expression level of MKLP1 is barely detectable and the second 
reason is that the antibodies available for MKLP1 are of poor quality. Given the need to reliably 
detect and measure MKLP1 levels in our studies investigating MKLP1 would have proven 
difficult, if not intractable. 
Now that we have the proper assay conditions in place from our studies with Kid and 
Eg5, it may be possible to examine the function of MKLP1 in these same assays by using 
siRNAs against MKLP1 and validating knockdown by RT-PCR.  Once successfully knocked-
down, MKLP1 function in protein synthesis, through polysome profiling and 35S Met/Cys 
incorporation assays can be investigated in order to determine if MKLP1 does function in protein 
synthesis.  Alternatively, MKLP1 can be tagged and transiently transfected into cells. Increasing 
the expression of MKLP1 may enhance our ability to reliably detect it; additionally, tagging 
MKLP1 would allow us to use quality antibodies which would greatly facilitate our studies. 
Although the prolonged overexpression may lead to cytokinesis defects, looking at short time 
points may prove to be useful. Finally, we may need to develop a quality antibody in-house with 
the help of an antibody production facility by bacterial overexpression and eliciting an immune 
response in a model animal. This might prove useful, as the commercially available antibodies 
purchased far lack the desired specificity needed for our studies. 
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Finally, if after the completion of these initial studies no change in protein translation is 
observed, it will be worth conducting these same studies in absence of Kid, Eg5, or both Kid and 
Eg5. It may be possible that both Kid and Eg5 are the dominant motor proteins effecting 
translation; thus, in order to determine the role of MKLP1 in translation we may need to remove 
these more dominant proteins.  
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8.0  CHAPTER VIII: MATERIALS AND METHODS 
8.1 METHODS USED THROUGHOUT 
8.1.1 Cell culturing 
Most cell lines were obtained from the American Type Culture Collection (ATCC), with the 
exception of UPCI cell lines which were a gracious gift from Susan M. Gollin (University of 
Pittsburgh). RPE1 (human retinal pigmented epithelial cells stably transfected with human 
telomerase reverse transcriptase (hTERT)) cells were cultured in Dulbecco’s Modified Eagle 
Medium plus F-12, (#D6421, DMEM-F12), supplemented with 10% Fetal Bovine Serum (FBS) 
(#511150, Atlanta Biologicals). UPCI:SCC103, A549, and SKHEP cells were cultured in 
minimal essential medium (M4655, MEM) supplemented with 10% FBS, 2 mM L-Glutamine, 
and 1% MEM non-essential amino acids (Invitrogen). HFF-hTERT, NIH-3T3, FB and HeLa, 
were maintained in DMEM supplemented with 10% FBS and 2 mM L-Glutamine. MESSA, 
U2OS, and HCT116 cells were maintained in McCoy’s media (#16600082, Invitrogen) 
supplemented with 10% FBS. All cultures were grown at 37˚C with 5% CO 2. All culture media 
and supplements were purchased from Sigma, unless otherwise stated. 
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8.1.2 Antibodies 
The following antibodies were used in this study: Kid – rabbit anti-Kid (AKIN12), Eg5 – rabbit 
anti-Eg5 (AKIN03), Mklp1 – rabbit anti-MKLP1 (AKIN06), Actin – rabbit anti-Actin (AAN01) 
(Cytoskeleton); Eg5 – mouse anti-Eg5 (#627802, Biolegend); RPS7 – mouse anti-RPS7, 
(#H00006201-M03, Abnova); RPS5 – mouse anti-RPS5 (#AB58345), RPL10A mouse anti-
RPL10A (#Ab55544), Fibrillarin – mouse anti-fibrillarin (#AB18380) (Abcam); RPL4 – rabbit 
anti-RPL4 (#11302-1-AP, Protein Tech Group); Dynein Intermediate Chain (#MAB1618, 
Chemicon); Nucleophosmin - mouse anti-nucleophosmin (# 32-5200, Zymed); GAPDH – rabbit 
anti-GAPDH (14˚C10) #2118 (Cell Signaling); Calnexin; Caspase-3 – rabbit anti-caspase 3 
(8G10) #9665 (Cell Signaling); FLAG – mouse anti-FLAG #4049 (Sigma); HA – mouse anti-
HA # 1 583 816 (Roche), eIF4E – mouse anti-eIF4E (#SC-9976, Santa Cruz). 
8.2 CHAPTER 2 METHODS 
8.2.1 Microscopy analysis: 
All cells were analyzed on an Olympus BX60 epifluorescence microscope with 100x oil 
immersion objectives, unless specified. Hamamatsu Argus-20 CCD camera was used to capture 
images. 
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8.2.2 Immunofluorescence 
For Kid, MKLP1, MCAK, Kif14, and Cenp E staining, cells were fixed for 45 min in 4% 
paraformaldehyde followed by either 1 min Methanol or 15 min extraction in 0.2% triton X-100. 
Cells were blocked in 1.5% BSA in PBST (PBS plus 0.1% Tween 20), treated with primary 
antibodies, washed, treated with secondary antibodies, and finally 4',6-Diamidino-2-
phenylindole (DAPI) for DNA staining. For Eg5 staining, cells were fixed in either a 5 min -
20˚C Metanol or a 1:1 ratio of -20˚C Metanol:acetone for 1 min, followed by the same procedure 
stated above.  All antibodies were diluted 1:500, unless otherwise noted. Primary antibodies used 
were: Kid, MKLP1, Eg5, MCAK, Kif14, Cenp E, NPM and fibrillarin. 
8.2.3 Fixation and immunofluorescence of 8-week old frozen mouse intestine tissue 
Intestine tissue from 8-week old mice were harvested in O.C.T. medium and placed on dry ice. 
Tissue was cryo-sectioned at a thickness of 5-10 µm and mounted on slides. Frozen tissues were 
fixed in 2% paraformaldehyde for 10 min at room temperature followed by three washes in 0.2% 
triton-X-100 for 5 min each. Tissues were blocked in blocking buffer (1.5% BSA, 0.1% Tween-
20 in PBS) and incubated in anti-Kid and anti-nucleophosmin (1:250) antibodies for 30 min. 
Cells were washed three times in PBS, incubated in secondary for 30 min, washed three more 
times in PBS, and incubated in DAPI for 3 min before being mounted. Slides were analyzed and 
viewed by Olympus BX60 epifluorescence microscope with 100x oil immersion objectives. 
Hamamatsu Argus-20 CCD camera was used to capture images. 
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8.2.4 Subcellular  fractionation of RPE1 cells 
Nuclear and cytoplasmic fractions from RPE1 cells were isolated using the PARIS kit 
(#AM1921M, Ambion) following the manufactures’ protocol. Samples were run on 10% SDS-
PAGE gels and analyzed for Kid, Eg5, KU80 (nuclear control), and cytokeratin (cytoplasmic 
control).  
8.2.5 Synchronization of noncancer and cancer cells 
Equal numbers of cells were treated with 3 µM of nocodazole for 16 hrs, followed by an 8 hr 
release, and then treatment again with 3 mM of nocodazole for 12 hrs, prior to trypsinization, 
cell were lysed in RIPA buffer (150 mM NaCl, 50 mM Tris pH 7.2, and 1% NP40). Lysates were 
run on 10% SDS-PAGE gels and the mitotic index was counted. 
8.2.6 MPA and Ribavirin treatments 
Cells were treated with varying concentrations of MPA or Ribavirin for 4 hrs. For specific 
experiments, cells were also released from MPA or Ribavirin (washed times in FBS) for an 
additional 2-4 hrs in guanosine or guanosine was added in the presence of MPA or ribavirin to 
block GTP-shuttling from the nucleolus or guanosine alone. Cells were fixed and stained, with 
antibodies to Kid, MKLP1, or fibrillarin, as mentioned above or were trypsinized, and subjected 
to immunoblotting. 
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8.2.7 Quantitation of mitotic defects or mitotic indexes 
Cells were fixed in 4% paraformaldehyde plus 0.02% triton X 100 for 15 min, prior to the 
addition of DAPI. A minimum of 300 cells were counted per trial. All reagents were purchased 
from Sigma unless specified. 
8.3 CHAPTER 3 METHODS 
8.3.1 Microscopy analysis 
All cells were analyzed on an Olympus BX60 epifluorescence microscope with 100x oil 
immersion objectives, unless specified. Hamamatsu Argus-20 CCD camera was used to capture 
images. 
8.3.2 UV-C treatment 
RPE1 cells were subjected to various amounts of UV-C treatment. The amount of UV-C 
treatment was quantitated with the use of a UVP radiometer; for the most part the UV bulb 
emitted approximately 0.3 J/m2/s, therefore for 20 J/m2 experiments, cells were subjected to UV-
C light for about 69 sec.  After UV-C treatment, cells were allowed to recover anywhere from 5 
min to 24 hrs, followed by immediate fixation, immunofluorescence staining of Kid, fibrillarin, 
or NPM, mounted, and analyzed. MEF proficient or deficient in p53 were also used in the above 
experiment.  
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8.3.3 Microtubule inhibition 
Cells were treated with or without 0.1 µg/ml or 1 µg/ml, and in some cases followed by washout 
and/or UV-C treatment. Cells were then fixed and stained as mentioned above.  
8.3.4 IR 
RPE1 or UPCI:SCC103 cells were treated with various Grays (Grys) of IR treatment and 
allowed to recover for times ranging from 5 min – 24 hrs. At these times, cells were fixed, and 
co-stained for the indicated antibodies: Kid, phospho-H2AX, or fibrillarin. Cells were analyzed 
by microscopy. 
RPE1 or UPCI:SCC103 cells were treated with 0.1 or 0.5 mM of hydrogen peroxide for 
either 10 min or 30 min, with or without recovery. Cells were then fixed and stained with the 
indicated antibodies.  
8.3.5 Localized UV-C studies 
For micropore UV irradiation, cells grown on glass coverslips were covered with an 8 µm filter, 
irradiated with 10 J/m2 – 100 J/m2 of UV-C radiation, and allowed to recover for 1.5 hrs. Cells 
were then fixed in 2% paraformaldehyde for 15 min at room temperature, washed in 0.2% 
Triton, blocked for 20 min in 5% BSA, and DNA was denatured with 0.4M NaOH at room 
temperature for 4 min. Primary antibodies were diluted in antibody dilution buffer consisting of  
0.2% Glycine, 0.5% BSA in PBS and cells were incubated for  90 min.  Cells were then washed 
three times prior to a 60 min incubation in secondary, followed by three washes in PBS, and a 5 
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min incubation with DAPI. For Figure 3.10, cells were treated with 40 J/m2 of UV-C and were 
allowed to recover for 1 hr prior to fixation.  
8.3.6 MTS cell proliferation assay 
Kid was knocked-down for 72 hrs, treated with varying amounts of UV-C, and followed by a 
MTS cell proliferation assay. MTS assay was conducted according to the manufactures protocol. 
Control was media alone, negative control was untreated cells, and positive control was H2O2 
treated cells.  
8.3.7 Caffeine treatment 
RPE1 cells were treated with or without 4 mM caffeine for 1.5 hrs prior to fixation and staining. 
UV-C treatment was used as a control. Antibodies used are indicated. 
8.3.8 Actinomycin-D (AD) treatment 
RPE1 cells were treated with 0.01-0.5 mg/ml of (AD) for 30 min, prior to fixation and 
immunofluorescence staining with the indicated antibodies.  
8.3.9 α-amanitin treatment 
RPE 1 cells were treated with various concentrations ranging from 0.5-30 µg/ml of alpha-
amanitin for 1 or 3 hrs, followed by fixation, staining, and analysis.  
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8.3.10 2-D gel electrophoresis 
2D gel electrophoresis was conducted in collaboration with Dr. Jason White in Dr. Chris 
Bakkenists Lab. Briefly, prior to 1D and 2D gel electrophoresis, RPE1 cells were treated with or 
without UV, followed by subcellular fractionation under low salt conditions to isolate nuclei. 
8.4 CHAPTER 4 METHODS 
8.4.1 Inhibitor treatments 
For treatments with inhibitors, the following times and concentrations were used unless 
otherwise specified: 4 hr monastrol at 130 µM, 2 hr nocodazole at 12 µM, 2 hr Colecimid at 
0.002 mg/mL, 30 min of low levels of puromycin treatment at 100 µg/mL, cycloheximide  at0.1 
mg/mL, 1 mg/ml high levels of puromycin. All reagents were purchased from Sigma. 
8.4.2 Transfections 
8.4.2.1 siRNA transfections 
Cells were reverse-transfected with 1.5 µg/60mm tissue culture plate of siRNA against Eg5 
using HiPerfect transfection reagent following the manufactures’ protocol and incubated 24 hrs 
prior to immunoblot analysis or further experimental procedures. Fluorescently labeled 
scrambled siRNA was used (cat# 1022563) as the control for all siRNA experiments. Briefly, 1.5 
µg siRNA was mixed with 100 µL of opti-mem (#31985, Invitrogen) and 20 µL of HiPerfect, 
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prior to 5 min incubation. Following this incubation, the transfection mixture was placed in the 
60 mm plate, the cells were added to this mixture, and opti-mem was added to a final volume of 
2 mL. Cells were grown for 8 hrs in opti-mem plus transfection mixture, prior to the addition of 
full medium for the remainder of the time. All reagents were purchased from Qiagen unless 
specified. siRNA #1 (SI02653770) and siRNA #2 (s7904)(Ambion). 
8.4.2.2 Plasmids 
Bicistronic plasmid transfection (Addgene plasmid 18673) into U2OS cells was completed using 
FuGene6 (#1814443, Roche) transfection reagent for 24 hrs (following the manufactures’ 
protocol), after a 12 hr knockdown of Eg5. Antibodies used were FLAG for cap-dependent 
translation or HA for cap-independent translation.  
8.4.3 Pre-ribosome fractionation 
20 million cells were trypsinized, washed twice in PBS, and nuclear fractions from RPE1 cells 
were isolated using the PARIS kit (#AM1921M, Ambion) following the manufactures’ protocol. 
The nuclear fractions were placed on a continuous 10-25% (wt/wt) sucrose gradients (25 mM 
Tris (pH 7.5), 100 mM KCl, 1 mM DTT, 2 mM EDTA). Gradients were centrifuged at 27,000xg 
for 4 hrs at 4˚C using a Beckman L7 Ultracentrifuge (Model L7 -65) in a Sorval AH629 rotor, 
after which gradients were fractionated by upward displacement through a ISCO UA-5 with 
constant UV monitoring at an absorbance of 260 nm and one milliliter fractions were collected.  
Fractions were precipitated using 10% final concentration of trichloroacetic acid for immunoblot 
analysis. 
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8.4.4 Polysome profiling 
20-30 million RPE1 cells were trypsinized and incubated in the presence or the absence of 0.1 
mg/mL of cycloheximide (CHX) for 10 min, prior to cell lysis. Cells were lysed in lysis buffer 
(20 mM Tris-HCl (pH 7.2), 130 mM KCl, 30 mM MgCl2, 2.5 mM DTT, 0.2% NP-40, 0.5% 
sodium deoxycholate, 10 mg/mL of cycloheximide, 0.2 mg/mL of heparin, 1 mM PMSF), and 
incubated on ice for 10 min; to rid of DNA pellet, samples were centrifuged in a tabletop 
centrifuge for 10 min at 10,000 rpm. The supernatants were incubated at 4˚ C before being placed 
on top of a  10-45% (wt/wt) sucrose gradients (10 mM Tris-HCl (pH 7.2), 60 mM KCl, 10 mM 
MgCl, 1 mM DTT, 0.1 mg/mL of heparin), unless otherwise specified. Samples were collected, 
and precipitated as mentioned previously for immunoblot analysis. For analysis of Eg5 in the 
absence of microtubules, cells were treated with 12 µM of nocodazole prior to polysome 
profiling. 
For polysome profiling in the presence of a 4 hr cycloheximide treatment to block 
ongoing translation, cells were treated for 4 hrs in addition to other treatments or washout out for 
4 hrs to allow cells to recover prior to polysome profiling protocol, as listed above.  
For quantitation of polysome peaks, the polysome profile was mechanically amplified on 
a Xerox copy machine, and the lower point on the graph was used as the baseline. Each peak was 
carefully cut out in triplicate, and weighed on an analytical balance.  
8.4.5 Immunoprecipitation 
10 million cells were trypsinized, pelleted, lysed in lysis buffer (50 mM Hepes [pH 7.5], 150 mM 
NaCl, 0.1% Triton X-100, 1mM EDTA, 2.5 mM Glycerol, 1 mM NaF, 0.1 mM Na3VO4, 10 
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mM Beta-glycerophosphate, 1 mM PMSF), and incubated on ice for 10 min prior to a 10 min 
centrifuge spin at 10,000 rpm on a table top centrifuge, for removal of DNA pellet. Supernatant 
was placed in a new tube, 10% was saved for whole cell lysate (WCL) analysis, while the other 
90% was pre-cleared for 1 hr at 4˚ C with protein A beads , to rid of nonspecific protein binding, 
(#17078001, GE Healthcare), centrifuged at 2,000 rpm for 2 min, before partitioning equal 
portions of the supernatant into two tubes. Each tube received either 2 µg of rabbit anti-Eg5 
antibody or 4 µL of 30% glycerol, (Eg5 antibody was originally diluted in 30% glycerol), was 
incubated for 1.5 hrs at 4˚ C with constant rotation, after which protein A beads were added, and 
incubated at 4˚C with constant rotation for an additional 1.5 hrs. Tubes were removed from 4˚ C, 
centrifuged briefly for 2 min at 2,000 rpm, and the supernatant was removed. The pelleted beads 
were then washed with lysis buffer, centrifuged for 1 min at 2,000 rpm, and supernatant was 
removed. This procedure was repeated three times, prior to the addition of 1X SDS dye to pellet, 
and boiling the sample for 10 min before loading the sample of a 12% SDS PAGE gel. Each 
sample loaded on the gel represented 50% of the total IP pellet except for the WCL lane which 
contained 10% of the total initial sample. MYPT1 was used as a negative control, to demonstrate 
the specificity of Eg5 association with ribosomes; IP procedure was completed as mentioned 
above, except with the addition of 2.5 µg of antibody.  
8.4.6 In vitro microtubule binding assays 
Purified tubulin (isolated from the brains of bovine) was thawed on ice on 15 min with the 
addition of an equal volume of 1X PM (10 mM PIPES (pH 7.0), 5 mM Mg Acetate, and 1 mM 
EGTA (pH 7.0)) buffer and 2 mM GTP added, incubated on ice for 30 min, followed by a 30 
min centrifugation at 13,000 rpm at 4˚ C in a table top centrifuge. Supernatant was removed, and 
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grow buffer (1X PM buffer, 0.1 mM Taxol (Sigma), 5 mM GTP (final volume of 200 µL)) was 
added to it in a 4:1 ratio (tubulin : grow buffer), followed by a 15 min incubation at 34˚C with 
constant rotation.  Each fraction for each ribosomal subunit from the polysome profiling was 
pulled together, inverted and split: half of which received the binding reaction (5X PM buffer, 
100 mM NaCl, 0.04 mM Taxol, 1 mM GTP) plus 12% tubulin and was incubated at 34˚C for 45 
min with constant rotation, while the other half received the binding reaction without tubulin, 
Taxol, or GTP and remained at 4˚ C with constant rota tion for 45 min. After the binding reaction, 
lysates were centrifuged for 30 min at 34˚ C or 4˚C at 13,000 rpm. The supernatant was removed 
(containing non-microtubule bound proteins), pellets were briefly washed in PBS, re-centrifuged 
for 5 min, and the supernatant was discarded. The pellet contained microtubules and anything 
that bound to the microtubules. 2X SDS loading dye was added to each sample, boiled for 5 min, 
prior to loading 20% of the supernatant and 50% of the pellet on 12% gels.  
8.4.7 In vivo microtubule binding assays 
10 million RPE1 cells were lysed in polysome profiling cell lysis buffer, incubated on ice for 10 
min and DNA pellet was omitted by centrifugation for 10 min at 10,000 rpm. The supernatant 
was removed and split: half of which received a final concentration of 0.1 mM Taxol and 5 mM 
GTP and was incubated for 45 min at 34˚C with constant rotation, while the other half received 
12 µM of nocodazole followed by incubation at 4˚C for 45 min with constant rotation. After the 
45 min incubation, binding buffer was added; Taxol-stabilized tubulin received binding buffer 
with 0.04 mM Taxol and 1 mM GTP, whereas the nocodazole-depolymerized tubulin did not. 
Samples where then reincubated for 45 min at either 34˚C or 4˚C, prior to a 30 min 
centrifugation at 13,000 rpm. Supernatants were removed and pellets were washed once in PBS, 
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prior to repelleting, and resuspending the pellet in 2X SDS dye. 50% of supernatant and 50% of 
pellet was loaded on 12% SDS PAGE gels.  
8.4.8 35S Met/Cys incorporation assays 
Cells were grown in 60 mm plates and media was changed to DMEM without methionine and 
cystine (#D0244, Sigma) plus 5% dialyzed FBS (#F0392, Sigma) and 2 mM L-glutamine for 30 
min at 37˚C, prior to the addition of 100 µCi/60 mm plate of 35S Metionine and 35S cystine 
(#NEG072007MC, Perkin Elmer). To stop reactions, 0.1 mg/mL of CHX was added, cells were 
trypsinized, and washed in PBS prior to cell lysis in RIPA buffer (150 mM NaCl, 50 mM Tris 
[pH 8.0], 1% NP40). The Lowry assay was used to normalize samples prior to splitting the 
samples in half and subjecting them to scintillation counting or immunoblot analysis. For 
scintillation counting, duplicate samples of each lysate was placed on GF/C filters (#28497-743, 
VWR), washed three times with 10% TCA, once with 100% ethanol, and dried before 
scintillation counting. The duplicate samples were separated on 12% SDS PAGE gels, for 
visualization of equal loading or confirmation of Eg5 knockdown.  
For fractionation of cell lysates into cytosolic and membrane fractions, a digitonin 
fractionation protocol was used. Briefly, cells were trypsinized, washed, and the cell membrane 
was broke open by pipetting 25x’s with a cut-pipette tip in digitionin buffer solution (10 mM 
Pipes [pH 6.8], 300 mM Sucrose, 3 mM MgCl2, 5 mM EDTA, 0.01% Digitonin, 1 mM PMSF). 
Lysates were incubated for 8 min on ice, centrifuged at 5,000 rpm for 4 min, and the cytosolic 
fraction was removed. Pellet was washed once in PBS, centrifuged and resuspended in RIPA 
buffer to retain the membrane fraction.  
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8.4.9 35S Met/Cys translation incorporation assay in suspended cells 
RPE1 cells were trypsinized and incubated for 30 min with 100 µCi of 35S at 37°C. Cells were 
then centrifuged for 3 min at 0.6xg and washed once with PBS. Next, cells were lysed in lysis 
buffer and incubated on ice for 15 min, after which time cells were centrifuged again at 9000xg 
for 10 min, yielding a supernatant and a pellet.  The supernatant was subjected to acetone 
precipitation prior to running samples on a 10% SDS PAGE gel. Gel was fixed in 25% 
isopropanol and 10% acetic acid for 20 min, dried for 1 h, and exposed to phosphoimager for 18-
24 h.  
8.4.10 Rate of protein synthesis assay 
Assay was completed similar to the 35S Met/Cys incorporation assay above, except two different 
time points were taken, one at 30 min and one at 120 min. 
8.4.11 Ribosome ½ transit time assay 
30 million cells were trypsinized, washed, and resuspended in Basal Medium Eagle (BME) 
(#B1522, Sigma) plus 10% dialyzed FBS and 2 mM L-glutamine prior to the addition of 10 
µCi/ml of 35S Met/Cys. Samples remained in a 37˚C water bath, until the time point was taken. 
At each time point, 500 µL of cells were removed, placed in an ice cold tube, and 500 µg/mL of 
CHX was added, inverted, and placed on an ice/water bath for at least 10 min. At this time, cells 
were centrifuged at 5,000 rpm for 5 min on a tabletop centrifuge, washed with ice cold PBS 
containing 250 µg/mL CHX, recentrifuged and lysed (0.02 M Tris [pH 7.2], 130 mM KCl, 30 
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mM MgCl2, 1% NP40, 0.05% Sodium deoxycholate, 0.2 mg/mL Heparin, 0.25 mg/mL CHX, 1 
mM DTT, 1 mM PMSF, RNAsin Inhibitor (Promega)). The lysed cells were then centrifuged for 
10 min at 10,000 rpm to remove DNA pellet, prior to splitting the lysates in half: 500 µL of the 
lysate was placed in a new tube and labeled PMS fraction, containing total proteins, while the 
other 500 µL was placed on top of a stepwise 20% sucrose buffer (10 mM Tris-HCl [pH 7.2], 60 
mM KCl, 10 mM MgCl2, 0.1 mg/mL Heparin, 1 mM DTT) and 60% sucrose cushion. Samples 
were then centrifuged in a S100-AT5 ultra-centrifuge rotor at 55,000xg for 27 min, after which 
500 µL of the sample was removed (PRS) containing completed proteins released from the 
ribosomes. The PMS and PRS fractions were then TCA-precipitated on GF/C filters and 
subjected to scintillation counting. Transit times were calculated by comparing the incorporation 
of radioactivity into total proteins (PMS) and completed proteins (PRS) released from the 
ribosomes.  
8.4.12 Mitotic Index analyses 
Cells were fixed in 4% paraformaldehyde plus 0.02% triton X 100 for 15 min, prior to the 
addition of DAPI. A minimum of 300 cells were counted per trial. All reagents were purchased 
from Sigma unless specified. 
8.4.13 Apoptosis assay 
Cells were treated with monastrol for 4-16 hrs or nocodazole for 2–16 hrs prior to lysing cells 
and running samples on a 12% SDS page gel. Caspase-3 antibody (1:500 dilution) was used to 
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determine apoptosis. As a positive control, cells were treated with 1 µM staurosporine (Sigma) 
for 16 hrs to demonstrate caspase-3 cleavage.   
8.4.14 MTS assay 
Cell proliferation assays were performed according to the manufactures’ protocol (Promega).  
8.4.15 Processivity Assay 
35S Met/Cys incorporation assay was preformed as described above with the following 
exceptions, 10 million cells were used and 35S Met/Cys was added to the cells for 1 hr, prior to 
the addition of CHX. Cells were trypsinized, washed, lysed in RIPA buffer, and the Lowry assay 
was completed to equalize protein levels. 100 µg of protein was loaded on 15% SDS PAGE gels, 
with the addition of 5 µL of Bio-Rad broad range marker (#161-0318, Bio-Rad); gels were 
divided into 4 equal sections, based on size; section 1 – stacking, section 2 – above 37 kDa, 
section 3 – below 37 kDa, section 4 – the bottom 2 cm of the gel. Sections 1 and 4 were omitted 
from analysis, while the two other sections were placed in scintillation vials, and were subjected 
to scintillation counting.   
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8.5 CHAPTER 5 METHODS 
8.5.1 siRNA transfections 
Protocol is as described above with the following changes: Kid was knocked-down for 72 hrs 
using siRNA from Qiagen (Kif22-7), Eg5 was knocked-down for 48 hrs, or both proteins were 
knocked-down together for 48 hrs. 
8.5.2  Small molecule inhibitions 
RPE1 cells were treated with the following concentrations: 100 or 200 µM Monastrol for 4 hr, 
0.01 mg/ml nocodazole for 2 hrs. 
8.5.3 Microscopy analysis 
All cells were analyzed on an Olympus BX60 epifluorescence microscope with 100x oil 
immersion objectives, unless specified. Hamamatsu Argus-20 CCD camera was used to capture 
images. 
8.5.4 Stress granules formation assays 
RPE1 cells were treated with or without either 0.01 mg/ml puromycin for 30 min followed by a 
0.5 mM arsenite treatment for 1 hr or with 0.5 mM arsenite only for 1 hr. Cells were fixed for 20 
min in a 2% or 4% paraformaldehyde/0.2% Triton-X-100 solution at 4°C, followed by a 30 min 
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incubation in blocking buffer (1.5% BSA, 0.1% Tween-20 in PBS). Cells were then incubated 
overnight at 4°C in primary antibodies Kid (1:500) and eIF4E (1:500). Cells were washed three 
times in PBS, incubated for 30 min in secondary, followed by PBS washes, and DAPI staining.  
8.5.5 Live cell imaging 
Cells were seeded with a density of 2x105 on 35 mm glass-bottom Petri dishes (AmtTek Corp) 
and viewed after siRNA or DNA transfections. Cells were maintained at 37°C with a 
moisturized-warm air microscope chamber (Life Imaging Services, Reinach, Switzerland). 
Epifluorescence microscopy was performed on a Nikon TE2000-U inverted microscope with a 
Coolsnap HQ digital camera (Roper Scientific Photometrics). Images were taken by MetaMorph 
(Molecular Devices) and converted to TIFF format and exported to Adobe Photoshop. 
8.5.6 Stress granule dissolution assays 
RPE1 cells were treated with 0.5 mM arsenite for 1 hr, followed by 3 washes in fresh media, and 
were allowed to recover. Time points were taken every 20-30 min. Cells were fixed, stained and 
quantitation was completed.  
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8.6 CHAPTER 6 METHODS 
8.6.1 Immunofluorescence 
Cells were fixed in 4% paraformaldehyde plus 0.1% triton for 30 min at 4˚C, followed by 
blocking and staining as mentioned in Chapter 2. Antibodies are used an indicated.  
8.6.2 siRNA transfection 
RPE1 cells were transfected as mentioned above, except Kid was knocked-down for 72 hrs prior 
to fixation, staining and analysis. 
8.6.3 35S Met/Cys incorporation assays 
Assays were performed as described in chapter 4. 
8.6.4 Mitotic index analysis 
Cells were fixed in 4% paraformaldehyde plus 0.02% triton X 100 for 15 min, prior to the 
addition of DAPI. A minimum of 300 cells were counted per trial. All reagents were purchased 
from Sigma unless specified. 
  209 
8.7 CHAPTER 7 METHODS 
8.7.1 siRNA transfection 
RPE1 cells were treated with siKid or siEg5 24 hrs, according to protocol listed in Chapter 4, 
followed by samples being resolved on 12% SDS-PAGE and immunoblotting with indicated 
antibodies.  
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